Advanced textiles for wound care
The Textile Institute and Woodhead Publishing The Textile Institute is a unique organisation in textiles, clothing and footwear. Incorporated in England by a Royal Charter granted in 1925, the Institute has individual and corporate members in over 90 countries. The aim of the Institute is to facilitate learning, recognise achievement, reward excellence and disseminate information within the global textiles, clothing and footwear industries. Historically, The Textile Institute has published books of interest to its members and the textile industry. To maintain this policy, the Institute has entered into partnership with Woodhead Publishing Limited to ensure that Institute members and the textile industry continue to have access to high calibre titles on textile science and technology. Most Woodhead titles on textiles are now published in collaboration with The Textile Institute. Through this arrangement, the Institute provides an Editorial Board which advises Woodhead on appropriate titles for future publication and suggests possible editors and authors for these books. Each book published under this arrangement carries the Institute’s logo. Woodhead books published in collaboration with The Textile Institute are offered to Textile Institute members at a substantial discount. These books, together with those published by The Textile Institute that are still in print, are offered on the Woodhead web site at: www.woodheadpublishing.com. Textile Institute books still in print are also available directly from the Institute’s website at: www.textileinstitutebooks.com. A list of Woodhead books on textile science and technology, most of which have been published in collaboration with The Textile Institute, can be found at the end of the contents pages.
Woodhead Publishing in Textiles: Number 85
Advanced textiles for wound care Edited by S. Rajendran
Oxford
Cambridge
New Delhi
Published by Woodhead Publishing Limited in association with The Textile Institute Woodhead Publishing Limited, Abington Hall, Granta Park, Great Abington Cambridge CB21 6AH, UK www.woodheadpublishing.com Woodhead Publishing India Private Limited, G-2, Vardaan House, 7/28 Ansari Road, Daryaganj, New Delhi – 110002, India Published in North America by CRC Press LLC, 6000 Broken Sound Parkway, NW, Suite 300, Boca Raton, FL 33487, USA First published 2009, Woodhead Publishing Limited and CRC Press LLC © Woodhead Publishing Limited, 2009 The authors have asserted their moral rights. This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. Reasonable efforts have been made to publish reliable data and information, but the authors and the publishers cannot assume responsibility for the validity of all materials. Neither the authors nor the publishers, nor anyone else associated with this publication, shall be liable for any loss, damage or liability directly or indirectly caused or alleged to be caused by this book. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfi lming and recording, or by any information storage or retrieval system, without permission in writing from Woodhead Publishing Limited. The consent of Woodhead Publishing Limited does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific permission must be obtained in writing from Woodhead Publishing Limited for such copying. Trademark notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation, without intent to infringe. British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library. Library of Congress Cataloging in Publication Data A catalog record for this book is available from the Library of Congress. Woodhead Publishing ISBN 978-1-84569-271-1 (book) Woodhead Publishing ISBN 978-1-84569-630-6 (e-book) CRC Press ISBN 978-1-4200-9489-3 CRC Press order number WP9489 The publishers’ policy is to use permanent paper from mills that operate a sustainable forestry policy, and which has been manufactured from pulp which is processed using acid-free and elemental chlorine-free practices. Furthermore, the publishers ensure that the text paper and cover board used have met acceptable environmental accreditation standards. Typeset by SNP Best-set Typesetter Ltd., Hong Kong Printed by TJ International Limited, Padstow, Cornwall, UK
Contents
Contributor contact details Woodhead Publishing in Textiles Preface
Part I The use of textiles in particular aspects of wound care 1 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 2
2.1 2.2 2.3 2.4 2.5 2.6 2.7
xi xv xxi
1
Wound management and dressings S. Ather and K. G. Harding, Cardiff University, UK
3
Introduction Types of wound Mechanism of wound healing Factors affecting wound healing: why wounds fail to heal Wound healing: treatment options Future trends Conclusions References
3 3 4
Testing dressings and wound management materials S. T. Thomas, formerly of Surgical Materials Testing Laboratory, Medetec, UK Introduction The need for laboratory testing Fluid-handling tests Low-adherence tests Conformability tests Microbiological tests Odour control tests
11 13 17 18 18
20
20 21 23 36 37 38 42 v
vi
Contents
2.8 2.9
Biological tests References
3
3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 4
4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 5 5.1 5.2 5.3 5.4
Textile materials and structures for wound care products B. S. Gupta, North Carolina State University, USA, and J. V. Edwards, United States Department of Agriculture – Agricultural Research Service, USA Introduction The role of wound dressings Categorization of wounds Minor wounds Healing mechanisms Wound dressings Types of dressings available Bandages Materials used in dressings and bandages Textile processes involved in formation of dressings and bandages Acknowledgement References Interactive dressings and their role in moist wound management C. Weller, Monash University, Australia
44 45
48
48 49 50 51 53 55 60 70 71 79 92 92
97
Introduction Normal wound healing Wound characteristics Dressings Interactive wound dressings Future trends Conclusions Sources of further information and advice References
97 98 100 102 105 110 111 112 112
Bioactive dressings to promote wound healing G. Schoukens, Ghent University, Belgium
114
Introduction Physiology of wound healing Principles and roles of bioactive dressings Types and structures of bioactive dressings
114 115 117 118
Contents 5.5 5.6 5.7 5.8 6
Example of bioactive dressing: di-O-butyrylchitin (DBC) Future trends Acknowledgements References
vii
127 144 146 146
Advanced textiles for wound compression S. Rajendran and S. C. Anand, University of Bolton, UK
153
6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9
Introduction Elastic compression bandages Venous leg ulcers Venous leg ulcer treatment Applications of bandages Present problems and novel bandages Three-dimensional spacer compression bandages Conclusions References
153 154 155 157 163 165 169 175 175
7
Antimicrobial textile dressings in managing wound infection Y. Qin, Jiaxing College, China
179
7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 8
8.1 8.2 8.3 8.4
Introduction Topical antimicrobial agents in wound care Main types of antimicrobial wound dressings Wound dressings containing silver Applications of modern antimicrobial wound dressings containing silver Future trends Sources of further information and advice References Novel textiles in managing burns and other chronic wounds H. Onishi and Y. Machida, Hoshi University, Japan Introduction: current practice in the management of deep skin wounds or ulcers Normal treatment options for deep skin wounds or ulcers Novel wound dressings for managing deep skin wounds or ulcers Future trends
179 181 183 187 190 193 195 195
198
198 201 205 212
viii
Contents
8.5 8.6
Sources of further information and advice References
Part II Types of advanced textiles for wound care 9
215 215
221
Drug delivery dressings P. K. Sehgal, R. Sripriya and M. Senthilkumar, Central Leather Research Institute, India
223
9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9
Introduction Wounds: defi nition and types Wounds which require drug delivery Delivering drugs to wounds Types of dressings for drug delivery Applications of drug delivery dressings Future trends Conclusions References
223 224 226 231 235 240 244 246 247
10
The use of ‘smart’ textiles for wound care J. F. Kennedy and K. Bunko, Advanced Science and Technology Institute, UK
254
10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9
Introduction Basic principles and types of smart textiles Characteristics of smart textiles Textiles in control of exudate from wounds Examples of ‘smart’ textiles for wound care Response of dressings to bacteria Future trends Sources of further information and advice References
254 255 256 262 265 267 268 271 272
11
Composite dressings for wound care M. Joshi and R. Purwar, Indian Institute of Technology Delhi, India
275
11.1 11.2 11.3 11.4
Introduction Defi nition of composite dressings Structure of composite dressings Materials and textile structures used in composite dressings
275 276 277 279
Contents
ix
11.5 11.6 11.7 11.8
Types of composite dressings Trends in composite dressings: embroidery technology Conclusions References
284 286 288 288
12
Textile-based scaffolds for tissue engineering M. Kun, C. Chan and S. Ramakrishna, National University of Singapore, Singapore
289
12.1 12.2 12.3 12.4
Introduction: principles of tissue engineering Properties required for fibrous scaffolds Materials used for scaffolds Relationship between textile architecture and cell behavior Textiles used for tissue scaffolds and scaffold fabrication Applications of textile scaffolds in tissue engineering Future trends Sources of further information and advice References
289 290 293 294 298 303 308 310 312
Index
323
12.5 12.6 12.7 12.8 12.9
Contributor contact details
(* = main contact)
Chapter 3
Chapter 1
Professor Bhupender S Gupta* Department of Textile Engineering, Chemistry & Science College of Textiles North Carolina State University Raleigh, NC 27695-8301 USA
Shahzad Ather and Keith G Harding* Wound Healing Research Unit Department of Surgery Cardiff University Cardiff UK E-mail:
[email protected]
Chapter 2 Dr Stephen Thomas MEDETEC 1 Radyr Farm Road Radyr Cardiff CF15 8EH UK
E-mail:
[email protected] Dr J Vincent Edwards USDA-ARS Southern Regional Research Center 1100 Robert E Lee Blvd New Orleans LA 70124 USA E-mail:
[email protected]. gov
E-mail:
[email protected] [email protected]
xi
xii
Contributor contact details
Chapter 4
Chapter 7
Carolina Weller Department of Epidemiology and Preventative Medicine School of Public Health and Preventative Medicine Monash University Level 3 Burnet Building, DEPM The Alfred 89 Commercial Road Melbourne Vic 3004 Australia
Dr Yimin Qin Biochemical Materials Research and Development Center Jiaxing College 56 Yuexiu Road South Jiaxing 314001 Zhejiang Province China
E-mail: Carolina.Weller@med. monash.edu.au
Chapter 5 Professor Gustaaf Schoukens Ghent University Faculty of Engineering Sciences Department of Textiles Technologiepark 907 B-9052 Zwijnaarde (Gent) Belgium E-mail: gustaaf.schoukens@ UGent.be
Chapter 6 Dr S Rajendran* and S C Anand Centre for Materials Research and Innovation University of Bolton Bolton BL3 5AB UK E-mail:
[email protected]
E-mail:
[email protected]
Chapter 8 Hiraku Onishi* and Yoshiharu Machida Department of Drug Delivery Research Hoshi University 2-4-41, Ebara Shinagawa-ku Tokyo 142-8501 Japan E-mail:
[email protected]
Chapter 9 Dr P K Sehgal*, Dr R Sripriya and Dr M Senthilkumar Bioproducts Laboratory Central Leather Research Institute Adyar, Chennai 600 020 Tamil Nadu India E-mail:
[email protected]
Contributor contact details
xiii
Chapter 10
Chapter 11
John F Kennedy* and Katarzyna Bunko Advanced Science and Technology Institute 5 The Croft, Buntsford Drive Stoke Heath, Bromsgrove Worcestershire B60 4JE UK
M Joshi* and Roli Purwar Department of Textile Technology Indian Institute of Technology Delhi New Delhi 110016 India
E-mail:
[email protected]
Chapter 12
Formerly of Chembiotech Laboratory University of Birmingham Research Park Vincent Drive Birmingham B15 2SQ UK
E-mail:
[email protected] [email protected]
Ma Kun, Casey K. Chan and Seeram Ramakrishna* Division of Bioengineering & Dept. of Mechanical Engineering, Faculty of Engineering National University of Singapore Singapore 119077 E-mail:
[email protected]
Woodhead Publishing in Textiles
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Watson’s textile design and colour Seventh edition Edited by Z. Grosicki Watson’s advanced textile design Edited by Z. Grosicki Weaving Second edition P. R. Lord and M. H. Mohamed Handbook of textile fi bres Vol 1: Natural fi bres J. Gordon Cook Handbook of textile fi bres Vol 2: Man-made fi bres J. Gordon Cook Recycling textile and plastic waste Edited by A. R. Horrocks New fi bers Second edition T. Hongu and G. O. Phillips Atlas of fi bre fracture and damage to textiles Second edition J. W. S. Hearle, B. Lomas and W. D. Cooke Ecotextile ’98 Edited by A. R. Horrocks Physical testing of textiles B. P. Saville Geometric symmetry in patterns and tilings C. E. Horne Handbook of technical textiles Edited by A. R. Horrocks and S. C. Anand Textiles in automotive engineering W. Fung and J. M. Hardcastle Handbook of textile design J. Wilson High-performance fi bres Edited by J. W. S. Hearle Knitting technology Third edition D. J. Spencer
xv
xvi 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
Woodhead Publishing in Textiles Medical textiles Edited by S. C. Anand Regenerated cellulose fi bres Edited by C. Woodings Silk, mohair, cashmere and other luxury fi bres Edited by R. R. Franck Smart fi bres, fabrics and clothing Edited by X. M. Tao Yarn texturing technology J. W. S. Hearle, L. Hollick and D. K. Wilson Encyclopedia of textile fi nishing H-K. Rouette Coated and laminated textiles W. Fung Fancy yarns R. H. Gong and R. M. Wright Wool: Science and technology Edited by W. S. Simpson and G. Crawshaw Dictionary of textile fi nishing H-K. Rouette Environmental impact of textiles K. Slater Handbook of yarn production P. R. Lord Textile processing with enzymes Edited by A. Cavaco-Paulo and G. Gübitz The China and Hong Kong denim industry Y. Li, L. Yao and K. W. Yeung The World Trade Organization and international denim trading Y. Li, Y. Shen, L. Yao and E. Newton Chemical fi nishing of textiles W. D. Schindler and P. J. Hauser Clothing appearance and fit J. Fan, W. Yu and L. Hunter Handbook of fi bre rope technology H. A. McKenna, J. W. S. Hearle and N. O’Hear Structure and mechanics of woven fabrics J. Hu Synthetic fi bres: nylon, polyester, acrylic, polyolefi n Edited by J. E. McIntyre Woollen and worsted woven fabric design E. G. Gilligan Analytical electrochemistry in textiles P. Westbroek, G. Priniotakis and P. Kiekens
Woodhead Publishing in Textiles 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Bast and other plant fi bres R. R. Franck Chemical testing of textiles Edited by Q. Fan Design and manufacture of textile composites Edited by A. C. Long Effect of mechanical and physical properties on fabric hand Edited by Hassan M. Behery New millennium fi bers T. Hongu, M. Takigami and G. O. Phillips Textiles for protection Edited by R. A. Scott Textiles in sport Edited by R. Shishoo Wearable electronics and photonics Edited by X. M. Tao Biodegradable and sustainable fi bres Edited by R. S. Blackburn Medical textiles and biomaterials for healthcare Edited by S. C. Anand, M. Miraftab, S. Rajendran and J. F. Kennedy Total colour management in textiles Edited by J. Xin Recycling in textiles Edited by Y. Wang Clothing biosensory engineering Y. Li and A. S. W. Wong Biomechanical engineering of textiles and clothing Edited by Y. Li and D. X-Q. Dai Digital printing of textiles Edited by H. Ujiie Intelligent textiles and clothing Edited by H. Mattila Innovation and technology of women’s intimate apparel W. Yu, J. Fan, S. C. Harlock and S. P. Ng Thermal and moisture transport in fi brous materials Edited by N. Pan and P. Gibson Geosynthetics in civil engineering Edited by R. W. Sarsby Handbook of nonwovens Edited by S. Russell Cotton: Science and technology Edited by S. Gordon and Y-L. Hsieh Ecotextiles Edited by M. Miraftab and A. Horrocks
xvii
xviii 61 62 63 64 65 66 67 68 69 70 71 72 73 74
75 76 77 78 79 80 81
Woodhead Publishing in Textiles Composite forming technologies Edited by A. C. Long Plasma technology for textiles Edited by R. Shishoo Smart textiles for medicine and healthcare Edited by L. Van Langenhove Sizing in clothing Edited by S. Ashdown Shape memory polymers and textiles J. Hu Environmental aspects of textile dyeing Edited by R. Christie Nanofi bers and nanotechnology in textiles Edited by P. Brown and K. Stevens Physical properties of textile fi bres Fourth edition W. E. Morton and J. W. S. Hearle Advances in apparel production Edited by C. Fairhurst Advances in fi re retardant materials Edited by A. R. Horrocks and D. Price Polyesters and polyamides Edited by B. L. Deopora, R. Alagirusamy, M. Joshi and B. S. Gupta Advances in wool technology Edited by N. A. G. Johnson and I. Russell Military textiles Edited by E. Wilusz 3D fi brous assemblies: Properties, applications and modelling of three-dimensional textile structures J. Hu Medical textiles 2007 Edited by J. Kennedy, A. Anand, M. Miraftab and S. Rajendran Fabric testing Edited by J. Hu Biologically inspired textiles Edited by A. Abbott and M. Ellison Friction in textile materials Edited by B. S. Gupta Textile advances in the automotive industry Edited by R. Shishoo Structure and mechanics of textile fi bre assemblies Edited by P. Schwartz Engineering textiles: Integrating the design and manufacture of textile products Edited by Y. E. El-Mogahzy
Woodhead Publishing in Textiles 82 83 84 85 86 87
Polyolefi n fi bres: industrial and medical applications Edited by S. C. O Ugbolue Smart clothes and wearable technology Edited by J. McCann and D. Bryson Identification of textile fi bres Edited by M. Houck Advanced textiles for wound care Edited by S. Rajendran Fatigue failure of textile fi bres Edited by M. Miraftab Advances in carpet technology Edited by K. Goswami
xix
Preface
It is apparent that quality of life is a key issue in the healthcare of people. Textile materials play an important and crucial role in designing appropriate structures for the healthcare of people and medical companies. With the increasing threat from new strains of bacteria and viruses and the growing problems such as Deep Vein Thrombosis (DVT) and leg ulcers, it is vital that new or enhanced medical devices should be developed to cope with the situation. The market potential for medical textile products is considerable. The UK has one of the largest medical device markets in the world. The market is dominated by the National Health Service (NHS), accounting for approximately 80% of healthcare expenditure. There is a considerable high market potential for advanced wound dressings. The wound care industry generated between US$3.5 and 4.5 billion for the period between 2003 and 2006, mostly from the USA and Europe. The wound care market is predicted to grow to US$12.5 billion in 2012 and the global advanced wound care segment is the fastest growing area with growth of 10% a year. In Europe the advanced wound care market is expected to grow by an average of 12.4% a year to US$1.23 billion in 2010. The growth forecast for antimicrobial wound dressing is 25.9% per annum. In the USA alone there are over 100 000 surgeries performed daily which can result in surgical wounds. Ageing population creates increased demand for all types of surgical intervention. In 1991 the estimated annual cost of treating pressure ulcers in the UK was over £750 million, and in 2004 the total costs were £1.4–£2.1 billion or 4% of the total NHS budget. The annual cost of treating diabetic foot ulceration accounts for 5% of the total NHS budget in the UK. The annual cost for treating venous leg ulceration in Britain is £650 million and in the USA it is around $1 billion. While traditional dressings currently dominate the wound care market, raising awareness of the clinical benefits provided by advanced wound dressings is bound to widen their uptake. Continued research and development into developing high-tech wound dressings that fulfi l the principal xxi
xxii
Preface
essential requirements of keeping the wound moist to accelerate healing, being nonadherent to wound bed and having antibacterial and antiodour properties not only promotes wound healing with special reference to difficult-to-heal wounds but also reduces the treatment cost considerably which, in turn, has a direct impact on the economy. Wound management is a global problem and the need for a comprehensive book which links textiles and wounds for better wound management has been felt for a long time. This interdisciplinary state-of-the art book has been designed to meet the growing challenges in advanced wound care management. The chapters are carefully written by multinational authors who have vast experience in medical and/or textile disciplines. During editing I found that the chapters not only provide a wealth of information on wound management but also problem-solving techniques. The book is organised into two parts. The chapters in Part I address the principles and physiology of wounds and wound healing, and how textiles play a vital role in managing acute and chronic wound healing. Part I emphasises the fact that wound healing depends not only on medication but also on the use of proper dressing techniques and suitable dressing materials. Dressings vary with the type of wound and wound management, and no single dressing is universally applicable in enhancing wound healing. The role of interactive dressings, bioactive dressings, antimicrobial dressings and special dressings for managing burn wounds is critically discussed in Part I. In addition, a chapter in Part I demonstrates that textile bandages are the only treatment option to enhance the healing of difficult-to-heal venous leg ulcers. The testing and characterisation of wound dressings are also critically reviewed taking account of the real laboratory scenario. The high-tech dressings such as drug delivery dressings, temperature control dressings, smart dressings and composite dressings are focused in Part II. A unique last chapter covers the cultivation of human organs and body parts on textile scaffolds. Each chapter includes a wealth of bibliographical information which can serve as a ‘ready reckoner’ for finding additional information in specific subject area. Efforts have been exerted to edit the chapters to be easily readable by medical professionals, textile scientists and researchers as well as wound dressing manufacturers. This book provides readers with much needed information in the interdisciplinary subject areas of nursing and textiles. I am deeply indebted to the authors of this publication and have no doubt that their contribution will be a useful resource document making a greater contribution to this emerging discipline. S. Rajendran The University of Bolton
1 Wound management and dressings S. AT H E R and K. G. H A R DI NG, Cardiff University, UK
Abstract: The various types of wounds and their mechanisms of healing are described and factors affecting the management of wound healing are outlined. For chronic wounds, a number of factors when present in combination lead to the non-healing of wounds. Wound management should therefore be multifactorial and aim at correcting the underlying abnormalities. Options for treatment are described with no single treatment being universally effective owing to the multiple molecular and cellular events involved so that a combination of different therapies is required. Future trends include application of gene therapy and stem cell therapy. Key words: wound healing, wound management, chronic wounds.
1.1
Introduction
A wound is defi ned as a break in the epithelial integrity of the tissues. This disruption can be deeper and involve subepithelial tissues including dermis, fascia and muscle. They can be caused accidentally, intentionally or be a part of a disease process.1 A wound is caused by physical trauma where the skin is torn, cut or punctured (an open wound), or where a blunt force trauma causes a contusion (a closed wound). The history of wound care spans from prehistory to modern medicine and has evolved from simple wound covers ranging from vinegar-soaked dressings, through topical antibiotics to topically applied growth factors. 2 Even during early historical periods several factors were noted that speeded up or assisted the process of healing. The necessity for hygiene, the prevention of bleeding and, later on, the germ theory of disease paved the way for modern wound management.
1.2
Types of wound
Wounds can be classified in many ways, by acute or chronic, by cause (e.g., pressure, trauma, venous leg ulcer, diabetic foot ulcer), by the depth of tissue involvement, or other characteristics such as closure (primary or secondary intention). 3
4
Advanced textiles for wound care
1.2.1 Acute wound An acute wound is defi ned as a recent wound that has yet to progress through the sequential stages of wound healing. 3 An acute wound is acquired as a result of an incision or trauma and heals in a timely and orderly manner. Surgically created wounds include all incisions, excisions, and wounds that are surgically debrided. Surgical wounds include all skin lesions that occur as a result of trauma (e.g. burns, falls), as a result of an underlying condition (e.g. leg ulcers), or as a combination of both.
1.2.2 Chronic wounds Wounds that fail to heal in an anticipated time frame and orderly fashion and often recur are considered chronic. 3 Venous leg ulcers, pressure ulcers and diabetic foot ulcers are some examples of chronic wounds.
1.2.3 Open and closed wounds Wounds are also differentiated as open or closed wound types: Open wounds: examples include incision or incised wounds, laceration, abrasions, punctured wounds and penetrating wounds, Closed wounds: examples include contusions, haematoma and crush injuries.
1.3
Mechanism of wound healing
The aim of wound healing is homeostasis and restoration of tissue integrity. It is a well-orchestrated and complex process which is triggered by tissue injury and ends by regeneration or repair. Typically healing is divided into categories based on the anticipated nature of the repair process (Fig. 1.1).
1.3.1 Healing by primary intention Wound edges are approximated with sutures, staples or adhesive within hours of its creation with no defect. This enables closure to occur quickly with minimal tissue needed to repair the defect and minimal scarring.
1.3.2 Healing by secondary intention The wound is left open and no formal closure is done. Healing occurs by epithelialisation and contraction, e.g. healing associated with a large and/or deep wound in which the tissue edges cannot be approximated. The
Wound management and dressings
5
Differential wound healing Wound healing
Scarless Foetal skin, oral mucosa
Scarring Adult skin
Non-healing Chronic wounds
Excessive scarring Hypertrophic scars, keloid scars
1.1 Differential wound healing.
size of the gap determines the degree of new tissue matrix and epidermal surface needed for complete closure.4
1.3.3 Delayed primary/tertiary healing Wound closure is delayed for several days; this is usually employed for infected wounds. Irrespective of the cause, wounds heal in a very similar fashion. Studying this process and how to optimise this remains the central focus of attention for the clinicians. It is a dynamic and interactive process that involves a variety of blood and parenchymal cells, extracellular matrices and soluble mediators. During this process, wound healing passes through four phases of haemostasis, inflammation, proliferation and remodelling. These phases are clinically indistinct and overlap in time. Tissue injury sets in motion a cascade of cellular and biochemical activities which leads to healing of the wound. In the following sections, stages in the process of wound healing are described (Fig. 1.2).
1.3.4 Haemostasis The fi rst step in the process (immediate up to 2–4 h) of inflammation is haemostasis, which is characterised by vasoconstriction and coagulation. It starts soon after injury and is usually completed within the first few hours. Injury to the tissues causes disruption of blood vessels and lymphatics exposing the platelets to fibrin and collagen. This activates the
6
Advanced textiles for wound care Wound biology Injury
Platelet activation Fibrin clot
Macrophages
Provisional Growth factors matrix Proteases ECM production Re-epithelialisation Migration Granulation tissue
Fibroblast ↓ ↓ ↑ ↑ ↑
Cellular density Blood supply Contraction Collagen orientation Epithelial thickness
Scar formation/ maturation
1.2 Biology of wound healing.
platelets and complement cascade. Platelets also interact with the injured tissue, causing the release of thrombin, which converts soluble, circulating fibrinogen to fibrin, which in turn traps, and activates platelets and forms the physical entity of the hemostatic ‘plug’. 5 The activated platelet releases cytokines and growth factors including thromboxane A-2 and serotonin which are important inflammatory mediators and also cause vasoconstriction The clot also serves to concentrate the elaborated cytokines and growth factors including platelet-derived growth factor (PDGF) and transforming growth factor (TGF) β1.6 Coagulation leads to hemostasis, which initiates healing by leaving behind messengers that bring on an inflammatory process. Deficiency of clotting factors (Factor VII. IX, XII) leads to impaired wound healing.7
1.3.5 Inflammation The stage of inflammation starts soon after haemostasis (immediate up to 2–5 days) and is usually completed within the first 48 to 72 h but it may last as long as 5 to 7 days.8 The initial vasoconstriction is followed by vasodilatation and increased vascular permeability in response to histamine and other vasoactive mediators. Role of neutrophils The net result of this change in vascular permeability is an influx of polymorphonuclear cells (PMN) and monocytes in the injured area in a protein-
Wound management and dressings Phases of wound repair
Maximum response
I Inflammation
II Cell proliferation and matrix deposition
7
III Matrix remodelling
Fibroplasia Angiogenesis Re-epithelialization Extracellular matrix synthesis -Collagens Extracellular matrix -Fibronectin synthesis, degradation -Proteoglycans and remodelling Granulocytes ↑ Tensile strength Bleeding Phagocytosis ↓ Cellularity Coagulation ↓ Vascularity Platelet activation Complement activation Macrophages Cytokines
0.1
0.3
1
3 10 30 Days after wounding (log scale)
100
300
1.3 Wound biology: phases of wound repair.
rich fluid. Neutrophils phagocytise debris and bacteria, they also kill bacteria by releasing caustic proteolytic enzymes and free radicals in a process called ‘respiratory burst’.9 The surrounding tissue matrix in unwounded tissue is protected by protease inhibitors which can be overwhelmed and penetrated if the inflammatory response is extremely robust leading to damage to normal tissue. Unless stimuli for neutrophil recruitment persist at the wound site, the neutrophil infi ltration ceases after a few days, they undergo apoptosis and are engulfed and degraded by macrophages.10 Macrophages Macrophages start appearing in the wound two days after the injury and dominate the wound cell population over the next few days. Beside resident macrophages, the majority of macrophages at the wound site are recruited from the blood. Monocytes extravasate from the blood vessel, become activated and differentiate into mature tissue macrophages. Macrophages are crucial to wound healing and perform a number of functions. They act as antigen-presenting cells and remove debris and dead cells by phagocytosis. Perhaps their more important role in the process of healing is synthesis of numerous potent growth factors, such as TGF-β, TGF-α, basic fibroblast growth factor (bFGF), platelet-derived growth factor, and vascular endothelial growth factor, which promote cell proliferation and the synthesis of extracellular matrix molecules by resident skin cells.11 These factors also help in angiogenesis, migration and activation of
8
Advanced textiles for wound care
fibroblast thus setting the stage of proliferation.12 It has been shown experimentally that macrophage depletion using antisera results in a significant delay in healing.13 Role of inflammatory mediators Inflammatory mediators play a central and major role in the process of wound healing. They include a collection of soluble factors present either in plasma in an inactive form or released by damaged and nearby cells and leukocytes in an attempt to control the damage and initiate healing. Mechanisms of inflammatory resolution Inflammation performs several important functions. It clears the wound of infectious organism and debris, and brings about a change in the micro-environment of the wound to set the stage for proliferation. However, successful repair after injury requires resolution of the inflammatory response. The mechanisms controlling this down-regulation of the inflammatory response are poorly understood and for years it was thought that the inflammatory response would just ‘burn itself out’. Recent evidence, however, suggests that this process is organised as a series of reactions to produce stop signals referred to as ‘check point controllers of inflammation’.14 Lipoxins and aspirin-triggered lipoxins are the stop signals for inflammation. Autocoids also display potent anti-inflammatory actions and are termed resolvins.15 Down-regulation of pro-inflammatory mediators and the reconstitution of normal microvascular permeability, which contributes to the cessation of local chemoattractants, synthesis of antiinflammatory mediators, apoptosis, and lymphatic drainage also play their role. An excessive or prolonged inflammatory response results in increased tissue injury and poor healing.
1.3.6 Proliferation This phase starts around the second or third day after injury and continues for up to 3 or 4 weeks. This is marked by the appearance of fibroblasts in the wound and overlaps with the inflammatory phase. As in other phases, the changes in this phase do not occur in a series, but overlap in time. Granulation tissue formation Fibroblasts start to appear in the wound from the third to fourth day and their numbers peak between the seventh and fourteenth days. They migrate from the wound margins using the fibrin-based provisional matrix created
Wound management and dressings
9
during the inflammatory phase of healing. Under the influence of bFGF, TGF-β, and PDGF secreted by macrophages they proliferate and synthesise glycosaminoglycans and proteoglycans, elastins and fibronectin, the building blocks of the new extracellular matrix of granulation tissue, and collagen. As the number of macrophages diminishes, fibroblasts themselves begin to secrete bFGF, TGF-β, and PDGF. They also begin producing keratinocyte growth factor and insulin like growth factor I. After secretion of collagen molecules, they are organised in the form of collagen fibres which are then cross-linked into bundles. Collagen gives the wound its tensile strength and, in addition, cells involved in inflammation, angiogenesis, and connective tissue construction attach to, grow and differentiate on the collagen matrix laid down by fibroblasts.16 Collagen deposition increases the tensile strength of the wound. Initially collagen levels in the wound increase, but later on homeostasis is reached as the collagen is also being degraded by collagenases. Angiogenesis Angiogenesis accompanies the fibroplasia phase and is essential to scar formation. Endothelial cells located at intact venules are stimulated by vascular endothelial growth factor (VEGF) which is secreted mainly by keratinocytes at the wound edge and also by macrophages, fibroblasts and platelets in response to hypoxia and the presence of lactic acid. Endothelial cells originating from parts of uninjured blood vessels develop pseudopodia and push through the extracellular matrix (ECM) into the wound site. They produce the degradation agents including plasminogen activator and collagenase and invade the wound by the enzymatic degradation of fibrin clot once the new granulation tissue (i.e., extracellular matrix, collagen, capillaries) is laid down.17 Through this activity, they establish new blood vessels which later on join to form capillary loops and establish blood flow in the wound. Cells, when adequately perfused, stop producing angiogenic factors, and migration and proliferation of endothelial cells is reduced.17 Eventually, blood vessels that are no longer needed die by apoptosis; this explains the change in color seen in scar tissue as it matures. Epithelialisation The initial event in epithelialisation is migration of undamaged epithelial cells from the wound margins. Keratinocytes at the wound edges are stimulated by EGF and TGF-α produced by activated platelets and macrophages,15 they proliferate and begin their migration across the wound bed within 12 to 24 h after injury.18 The fi rst step of migration involves separation of the keratinocytes from each other and their anchors to the cell
10
Advanced textiles for wound care
basement membrane.19 The process of migration continues until the migrating cells from opposing sides of the wound touch each other. At the point of contact, migration ceases in a process known as contact inhibition.19 Once this process is complete, keratinocytes stabilise them by forming firm attachments to each other and the new basement membrane. 20 All these changes in the wound lead to the formation of granulation tissue which consists of inflammatory cells, fibroblasts and new vasculature in a hydrated matrix of glycoproteins, collagen and glycosaminoglycans, the components of a new, provisional ECM. The provisional ECM is different in composition from the ECM in normal tissue and includes fibronectin, collagen, glycosaminoglycans and proteoglycans. 21 Contraction About a week after the injury, the fibroblast differentiates into myofibroblasts, pulls the edges of the wound together and the wound begins to contract. 22 Contraction peaks at 5 to 15 days post wounding and continues even after the wound is completely re-epithelialised.23 Contraction reduces the size of the wound and, thus, reduces the amount of ECM needed to fi ll the wound24 and facilitates re-epithelialisation by reducing the distance which migrating keratinocytes must travel. At the end of the granulation phase, fibroblasts begin to undergo apoptosis, converting granulation tissue from an environment rich in cells to one that consists mainly of collagen.23
1.3.7 Maturation and remodelling Maturation and remodelling of the collagen into an organised and wellmannered network is the fi nal stage of the healing process (from day 8 up to 2 years). If this is compromised, then the wound’s strength will be greatly affected. On the other hand, excessive collagen synthesis can lead to the formation of a hypertrophic scar or keloid. The maturation phase can last for two years or longer, depending on the size of the wound and whether it was initially closed or left open. This phase is characterised by the removal of type III collagen and its replacement by mature type I collagen. There is a rapid production of type I collagen but there is no net gain as the old collagen is also being degraded by collagenases. New collagen fibres are rearranged, cross-linked, and aligned along tension lines but they can never become as organised as the collagen found in uninjured skin. 25 The second characteristic feature of this stage is programmed cell death or apoptosis and, thus the number of cell types such as macrophages, keratinocytes, fibroblasts, and myofibroblasts is reduced.18,20 Remodelling is regulated by fibroblasts through the synthesis of ECM components and MMPs that control cell
Wound management and dressings
11
differentiation. 26 All of these changes produce a cell-deficient environment with excessive connective tissue. Blood vessels that are no longer required die by apoptosis and the remainder acquire a basement membrane and become relatively impermeable. All of these factors lead to the increase in tensile strength, decrease in erythema and scar tissue bulk, and the fi nal appearance of the healed scar.
1.4
Factors affecting wound healing: why wounds fail to heal
In most cases, wound healing is a natural, uneventful process which leads to the restoration of tissue integrity. But, in some cases, wounds fail to heal and become a complex medical problem requiring specialised care and treatment. If a wound has not improved significantly in four weeks, or if it has not completed the healing process in eight weeks, it is considered a chronic, non-healing wound. Wound healing is dependent on the interaction of different cells, mediators and growth factors. Alterations in one or more of these components may account for the impaired healing observed in chronic wounds. Chronic wounds may be arrested in any of the healing phases but, most commonly, disruption occurs in the inflammatory or proliferative phase27 with the accumulation of excessive extracellular matrix and matrix metalloproteinases such as collagenase and elastase, which result in premature degradation of collagen and growth factors. 28 An optimum microenvironment and the absence of cytotoxic factors are essential for healing of wounds. Many local and systemic factors have been implicated in the delayed healing of wounds.
1.4.1 Local factors Infection Infection is the commonest local cause for delayed wound healing. Bacteria delay wound healing by activating the alternative complement pathway and exaggerating and prolonging the inflammatory phase of wound healing. The bacteria, themselves elaborate toxins and proteases, also compete for oxygen and nutrients, and this ultimately damages the cells. Tissue ischaemia Local hypoxia is detrimental to cellular proliferation, resistance to infection and collagen production. This may be the result of foreign bodies, infection, suture material, or the presence of peripheral vascular disease.
12
Advanced textiles for wound care
Poor surgical technique Proper tissue handling and closure with appropriate sutures is very important. Wound healing is affected if the tissues are devitalised, strangulated with sutures or improperly debrided. Others Formation of haematomas, presence of foreign bodies and mechanical pressure are some of the other local factors in the pathophysiology of delayed wound healing.
1.4.2 Systemic factors Ageing Healing in the elderly is generally delayed but the fi nal result is qualitatively similar in elderly people. There are many physiological changes associated with ageing which can lead to delayed healing. Reduced skin elasticity and collagen replacement influence healing. Reduced immunity and other chronic diseases can also affect the healing process. Nutritional status Deficiency of various nutrients and vitamins can affect the wound healing process. Proteins are required for all the phases of wound healing and are particularly important for collagen synthesis. In protein deficiency states, cellular and humoral immune responses are blunted, fibroplasia and all aspects of matrix formation are delayed. Glucose balance is essential for wound healing and it provides the energy required for cell function. Insulin may act as a fibroblast growth factor and its deficiency leads to suppression of collagen deposition in the wound. 29 Deficiency of fatty acids can also impair healing. Vitamins Vitamin A deficiency has been associated with slowed re-epithelisation, decreased collagen synthesis and stability and an increased susceptibility to infection. Vitamin C (ascorbic acid) is an essential cofactor during collagen biosynthesis. In scurvy, the collagen formed is unhydroxylated, relatively unstable and subject to collagenolysis. Vitamin K deficiency results in a deficiency in the production of the clotting factors (factors II, VII, IX and X) that are vitamin K dependent
Wound management and dressings
13
resulting in bleeding diathesis, hematoma formation and secondary detrimental effects on wound healing. Iron is required to transport oxygen. Other minerals like zinc and copper are important for enzyme systems and immune systems. Zinc deficiency contributes to disruption in granulation tissue formation. Underlying diseases Diabetes, arthritis, renal disease, heart disease, cancer, immune disorder, lung disease blood disorders and surgery all affect the process of wound healing. Medication Anti-inflammatory, cytotoxic, immunosuppressive and anticoagulant drugs all reduce healing rates by interrupting cell division or the clotting process.
1.5
Wound healing: treatment options
1.5.1 Basic care Wound repair requires the timed and balanced activity of inflammatory, vascular, connective tissue, and epithelial cells and their mediators. It is important to provide an environment that is conducive to wound healing, to treat the underlying origin of the wound, and to correct associated abnormalities.
1.5.2 Wound dressings Dressings do not heal wounds; properly selected dressings do, however, promote healing and prevent further harm to the wound. Wound dressings are passive, active or interactive. 30 Passive dressings simply provide cover while active or interactive dressings are believed to be capable of modifying the physiology of the wound environment. Interactive dressings include hydrocolloids, hydrogels, alginates and foams. An ideal dressing should maintain a moist environment at the wound interface and act as a barrier to micro-organisms. Commonly available dressings include. Alginate These dressings are highly absorbent and are composed of calcium and sodium salts of alginic acid, obtained from seaweed. They are useful in
14
Advanced textiles for wound care
medium to heavily exuding wounds and are also good for bleeding wounds. Examples include Kaltostat, Sorbsan and Algisite. Hydrogels Hydrogels have a high water content which creates a moist wound surface and helps in the debridement of wounds by hydration and promotion of autolysis. As absorption of exudate is poor, they can cause maceration. Examples include Aquafoam, Intrasite, Nu-Gel, Purilon and Sterigel.31 Hydrocolloids Hydrocolloids are composed of a matrix of cellulose and other gel-forming agents, including gelatin and pectin. These dressings promote autolysis and aid granulation. Examples include sheets such as Alione, Combiderm and Duoderm; paste such as GranuGel; and hydrofibre such as Aquacel and Versiva. 31 Semipermeable films Semipermeable dressings are good for low to medium exuding wounds. Examples include Opsite, Flexiguard, Tegaderm, Melfilm and Bioclusive. Foam dressings Foam dressings are useful for moderately exudating wounds as they prevent ‘strike through’ of exudate to the wound surface. They also provide cushion and support to the wound. Examples include Allevyn, Lyofoam, Tielle plus and Biatin Adhesive. Antimicrobial dressings Antimicrobial dressings are good for infected wounds especially in diabetics. Examples include Acticoat, Aquacell Ag, Arglaes, Inadine and iodoflex.
1.5.3 Bioengineered skin Bioengineered skin is generally divided into: 1. 2.
permanent, such as autografts and temporary, such as allografts (including de-epidermised cadaver skin and in vitro reconstructed epidermal sheets), xenografts (i.e. conserved pig skin) and synthetic dressings
Wound management and dressings
15
Allogenic grafts are produced from neonatal fibroblasts and keratinocytes. Available in the form of dermal, epidermal or composite grafts, they are better than traditional skin grafts as they are non-invasive, do not require anaesthesia and avoid potential donor site problems. Epidermal grafts Available in both autograft and allogenic forms, epidermal grafts include Epicell, Laserskin, CellSpray, Bioseed-S and LyphoDerm. 27 They are useful for coverage of large skin defects with acceptable cosmetic results and are indicated for burns and leg ulcers. Their main disadvantages include fragility and difficulty in handling owing to a lack of backing material. They are unsuitable for deep wounds as they only provide temporary cover. They are most successful when placed on a dermal bed. Dermal grafts Dermal grafts are either cellular or acellular, and allogenic in nature, and, hence, available for immediate use. Products include Integra, Alloderm, Biobrane, Transcyte and Dermagraft.27 They are indicated for burns, deep wounds, and for cosmetic procedure. However, they cannot be generated in large quantities and are susceptible to infections. Composite grafts Composite grafts are bilayered skin grafts and contain epidermal and dermal components. Apligraft is a commercially available product and is indicated for diabetic and venous ulcers. It lacks skin adnexal structures but produces all the cytokines and growth factors that are produced by normal skin. Allergy to bovine collagen, limited shelf-life and infection can limit their use. 27
1.5.4 Non-surgical innovations Vacuum assisted closure Vacuum-assisted closure (VAC) therapy entails placing an open-cell foam dressing into the wound cavity and applying a controlled subatmospheric pressure. This produces negative pressure in the wound, leading to improved blood flow and oxygenation. It also helps in removing excessive fluid and slough. 32 This stimulates granulation tissue formation, wound contraction and early closure of wound.
16
Advanced textiles for wound care
Intermittent pneumatic compression This is an effective treatment for chronic ulcers on legs with severe oedema. It provides compression (at 20–120 mm Hg) at preset intervals. 33 It improves lymphatic and venous flow and helps in the healing of chronic ulcers. Hyperbaric oxygen Hyperbaric oxygen is thought to expedite healing as it has been shown that ischaemic lesions heal less well34 and certain growth factors do not work in hypoxic conditions. 35 Debate continues on its value in certain wound conditions. Other therapies Laser, ultrasound, hydrotherapy, versijet, electromagnetic therapy and electrotherapy are some other therapies which are used to stimulate healing.
1.5.5 Drug therapy Drugs affect wound healing by assisting or interfering with specific phases. Drugs can reduce peripheral vascular resistance, reduce blood viscosity and cause local or systemic vasodilatation leading to improved tissue perfusion and oxygenation. Currently available drugs include pentoxifylline, which decreases platelet aggregation leading to decreased viscosity and improved capillary microcirculation. It is useful in patients with chronic venous ulcers who cannot tolerate compression. Iloprost a vasodilator and prostacyclin analogue is good in the treatment of arterial and vasculitic ulcers. 33 Calcium channel blockers and glyceryl trinitrate (GTN) ointment have also been used as vasodilators in cases of vaculitic ulcers caused by Raynaud’s disease and ischaemic ulcers, respectively.
1.5.6 Growth factors Growth factors are soluble signalling proteins which influence wound healing through their inhibitory or stimulatory effect during different stages of the wound healing process. Produced by different cells they act on inflammatory cells, fibroblasts, and endothelial cells to direct the processes involved in wound healing. Recombinant human-platelet derived growth factor-bb (rhPDGF-BB, Becaplermin) is the only FDA-approved
Wound management and dressings
17
growth factor available for clinical use. In clinical trials, this has been shown to increase the incidence of complete wound closure and decrease the time to achieve complete wound healing. Basic fibroblast growth factor (available commercially in Japan) stimulates endothelial cell migration and proliferation. Its topical application leads to faster granulation tissue formation and epidermal regeneration in burn wounds. However, this effect is not seen in diabetic foot ulcers. Preclinical trials have shown promising results for epidermal growth factor and keratinocyte growth factor in venous ulcers and fibroblast growth factor platelet derived growth factor (PDGF) for pressure ulcers. Despite promising preclinical data, results of the clinical trials are disappointing. Inherent instability of these proteins in the hostile environment of the wound makes them ineffective. Time of application, dosage, mode of delivery or the combination of the growth factors may be incorrect and further evaluation is required.
1.6
Future trends
1.6.1 Gene therapy To be clinically effective a high concentration of growth factors is needed, which requires frequent and high dosing, but it is prohibitively expensive. Introduction of the gene rather than the product (growth factor) is thought to be cheaper and more efficient in treating non-healing wounds. It can lead to a sustained local availability of these proteins and can be cost effective. The technology to introduce genes through physical or biological vectors has existed for some time. Long-term expression of the therapeutic gene remains a challenge but only a transient gene expression is required for wound repair. Phase I studies are being conducted at the moment and their results will dictate any further course of action in this field.
1.6.2 Stem cells therapy Stem cells which are thought to be present in every tissue are characterised by their prolonged self-renewal capacity and by their asymmetric replication. There is potential that stem cells may reconstitute dermal, vascular and other elements required for optimum wound healing. Han et al.36 showed the potential of human bone marrow stromal cells to accelerate wound healing in vitro by measuring the amount of collagen synthesis and the levels of basic fibroblast growth factor. Though the technique is still in its infancy, Badiavas et al.37 have shown that direct application of autologous bone marrow and its cultured cells may accelerate the healing process.
18
Advanced textiles for wound care
1.7
Conclusions
Chronic wounds do not have a unique defect but a number of factors, which, when present in combination, lead to the non-healing of wounds. Wound management should therefore be multifactorial and aim at correcting the underlying abnormalities. No single treatment is universally effective owing to multiple molecular and cellular events involved and a combination of different therapies is required.
1.8
References
1. robson mc, Wound infection: a failure of wound healing, caused by an imbalance of bacteria. Surg Clin North Am 1997; 77:637–50. 2. janis je and attinger ce, Current concepts in wound healing. Plast Reconstr Surg 2006; 117(7 Suppl):4S–5S. 3. attinger ce, janis je, steinberg j, schwartz j, al-attar a and couch k, Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg 2006 Jun; 117(7 Suppl):72S–109S. 4. iocono ja, ehrlich hp and gottrup f et al., The biology of healing. In: DL Leaper and KG Harding, Editors, Wounds: biology and management, Oxford University Press, Oxford, England (1998), pp. 12–22. 5. kerstein md, The scientific basis of healing. Adv Wound Care 1997; 10(4):30–36. 6. singer aj and clark ra, Cutaneous wound healing, N Engl J Med 1999; 341:738–746. 7. beck e, duckert f and ernst m, The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing. Thromb Diath Haemorrh 1961; 6:485. 8. haas af, Wound healing, Dermatol Nurs 1995; 7:28–34. 9. greenhalgh dg, The role of apoptosis in wound healing. The International J Biochem Cell Biol 1998; 30(9):1019–1030. 10. martin p and leibovich sj, Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 1998; 15(11):599–607. 11. dipietro la and polverini pj, Role of the macrophage in the positive and negative regulation of wound neovascularisation. Am J Pathol 1993; 143:678–684. 12. witte m and barbul a, Role of nitric oxide in wound repair. Am J Surg 2002; 183:406. 13. leibovich sj and ross r, The role of the macrophage in wound repair. Am J Pathol 1975; 78:71–100. 14. trengove nj, stacey mc and macauley s, Analysis of acute and chronic wound environment: The role of protease and their inhibitors. Wound Repair Regen 1999; 7:442. 15. lawrence w and diegelmann r, Growth factors in wound healing. Clin Dermatol 1994; 12:157. 16. ruszczak z, Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 2003; 55(12):1595–1611.
Wound management and dressings
19
17. greenhalgh dg, The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998; 30(9):1019–1030. 18. iocono ja, ehrlich hp and gottrup f et al., The biology of healing. In: DL Leaper and KG Harding, Editors, Wounds: Biology and Management, Oxford University Press, Oxford, England (1998), pp. 12–22. 19. garrett b, Re-epithelialisation, J Wound Care 1998; 7:358–359. 20. clark raf, Wound repair: Overview and general considerations (ed 2). In: RAF Clark, Editor, The Molecular and Cellular Biology of Wound Repair, Plenum Press, New York, NY (1995), pp. 3–50. 21. ruszczak z, Effect of collagen matrices on dermal wound healing. Adv Drug Del Rev 2003; 55(12):1595–1611. 22. eichler mj and carlson ma, Modeling dermal granulation tissue with the linear fibroblast-populated collagen matrix: A comparison with the round matrix model. J Dermatol Sci 2005; 41(2):97–108. 23. stadelmann wk, digenis ag and tobin gr, Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998; 176(2):26S–38S. 24. calvin m, Cutaneous wound repair, Wounds 1998; 10:12–15. 25. lorenz hp and longaker mt, Wounds: biology, pathology, and management. Stanford University Medical Center, 2003. 26. streuli c, Extracellular matrix remodeling and cellular differentiation, Curr Opin Cell Biol 1999; 11:634–640. 27. enoch s, grey je and harding kg, Recent advances and emerging treatments. BMJ Apr 2006; 332:962–965. 28. diabetes care, american diabetes association. Consensus development conference on diabetic foot wound care. 1999; 22:1354–1360. 29. eaglestein wh and mertz pm, ‘Inert’ vehicles do affect wound healing. J Invest Dermatol 1980; 74:90. 30. hanson c, Interactive wound dressings. A practical guide to their use in older patients. Drugs Aging 1997; 11:271–284. 31. jones v, grey je and harding kg, Wound dressings. BMJ Apr 2006; 332:777–780. 32. fleck tm, fleck m, moidl r, czerny m, koller r, giovanoli p, hiesmayer mj, zimpfer d, wolner e and grabenwoger m, The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thoracic Surg 2002, 74(5):1596–1600. 33. enoch s, grey je and harding kg, Non-surgical and drug treatments. BMJ Apr 2006; 332:900–903. 34. jonsson k, hunt tk and mathes sj, Oxygen as an isolated variable influences resistance to infection. Ann Surg 1988; 208(6):783–787. 35. wu l et al., Effects of oxygen on wound responses to growth factors: Kaposi’s FGF but not basic FGF stimulates repair in ischemic wounds. Growth Factors 1995; 12(1):29–35. 36. han sk et al., Potential of human bone marrow stromal cells to accelerate wound healing in vitro. Ann Plast Surg 2005; 55:414–419. 37. badiavas ev and falanga v, Treatment of chronic wounds with bone marrowderived cells. Arch Dermatol 2003; 139(4):510–516.
2 Testing dressings and wound management materials S. T. T HOM A S, formerly of Surgical Materials Testing Laboratory, Medetec, UK
Abstract: The development of modern dressings is briefly reviewed and a description is given of how new test methods and specifications have evolved to characterise various key aspects of the performance of the products concerned. For thousands of years man has applied a variety of materials to his wounds to control bleeding and promote healing. For much of that time many of the materials used were largely those that occurred naturally, or which were developed and used primarily for another purpose. Only in the last thirty to fi fty years have large number of increasing complex products been developed specifically for application to open wounds of all types. These new dressings vary widely in composition and construction and, as a result, new families of performance-based test methods and specifications have been developed in order in order to characterise their performance. Key words: wound dressings, wound management, fluid handling, hydrocolloids.
2.1
Introduction
The use of materials to cover or treat wounds stretches back into antiquity but the use of standards and specifications to characterise these materials is relatively new. The fi rst standards that were used to characterise dressings were very simple and concentrated primarily upon the structure rather than the function of the products concerned. As new, ever-more sophisticated dressings were introduced, there was an increasing need for test systems to demonstrate that these materials perform in a consistent manner and delivered the performance claimed for, and expected of them. Whilst it is undoubtedly true that ultimately it is how a product performs clinically that will determine its acceptability and commercial success, well-designed laboratory tests can provide a useful performance indicator, particularly in comparative terms. In this chapter, the need for dressing standards is discussed and how these standards have evolved, and briefly outlines test methods that can be 20
Testing dressings and wound management materials
21
used to assess key aspects of the performance of many different types of products.
2.2
The need for laboratory testing
Laboratory tests for dressings are required for a number of reasons: •
To demonstrate compliance with national or international standards or specifications. • To ensure product meets ‘in-house’ manufacturing standards. • To facilitate comparisons with competitive products. • To generate data to support allocation of shelf life (stability/storage). There are essentially three types of standards or specifications. • Structural standards, which defi ne the structure and/or composition of a product. • Performance standards, which describe one or more key aspects of the function of a dressing. • Safety standards, designed to ensure that a product, when used appropriately, is unlikely to adversely affect the health or wellbeing of the individual to whom it is applied.
2.2.1 The development of dressings For centuries mankind had little option but to apply readily available natural substances to his wounds to staunch bleeding, absorb exudate or promote healing. Initially, these would have consisted of simple materials such as honey, animal oils or fat, cobwebs, mud, leaves, moss or animal dung applied in the crude form in which they were found, but later these and other ‘raw materials’ began to be combined together, either to make them easier to handle, or to improve their clinical effectiveness. Whilst most of these early preparations were probably of little or no value, others, such as honey, used alone or mixed with oils or waxes, undoubtedly conferred some real clinical benefits to the user. Up to the end of the 19th century, whenever dressings were required to cover wounds, absorb exudate or remove blood during a surgical procedure, practitioners of the time used whatever materials were to hand, often recycling old pieces of cloth or linen fabric for this purpose. This was sometimes fi rst unravelled to form short ends of thread called ‘charpie’, or the surface was scraped with knives to produce ‘soft lint’, a soft fluffy material not dissimilar to absorbent cotton (cotton wool) which could be used to pack cavities and soak up exudate or blood. The fi rst product to be manufactured commercially for use as a dressing was absorbent (sheet) lint. This was formed by scraping sheets of old linen
22
Advanced textiles for wound care
with sharp knives to raise a fibrous ‘nap’ on one surface, increasing the absorbency of the cloth but decreasing its tensile properties. Initially a manual process, a lint-making machine was developed in the fi rst half of the 19th century which used new, specially woven, fabric for the purpose. This resulted in a more consistent product with, it is assumed, a considerably lower bioburden! Originally lint was formed from linen but this was eventually replaced by cotton by the middle of the 20th century.
2.2.2 The first standards for dressings As new types of dressings were developed and the production of surgical materials became more mechanised, it became necessary to develop formal standards to ensure that these were consistently produced to an agreed of level of quality. The fi rst of these appeared in two supplements to the British Pharmaceutical Codex (BPC) of 1911 and these were later incorporated into the 1923 edition of this publication. Over 80 products were described, the majority of which consisted of cotton fibre, both medicated and unmedicated, and a variety of cotton fabrics together with a few more complex products such as emplastrums (plasters) and oiled silk. The BPC remained the principal source of standards for surgical dressings within the United Kingdom for over 50 years, but, in 1980, these were transferred to the British Pharmacopoeia (BP). When, as a result of European legislation, dressings became classified as Medical Devices, monographs for these materials were subsequently omitted from the BP.
2.2.3 The importance of performance-based specifications The early pharmacopeial monographs consisted almost entirely of structural specifications supplemented by limit tests for potential contaminants. Whilst such standards undoubtedly have a value as quality control checks to ensure that products which have previously been shown to meet a specific clinical need are produced in a consistent way from a range of well-characterised materials, they do not facilitate comparisons between the performances of different types of dressings. Their proscriptive and inflexible nature also prevents or delays the introduction of new and more innovative products which may be structurally different from the standard materials. Recognising these limitations, in the early 1990s, the Surgical Dressings Manufacturing Association (SDMA) set up a series of working groups, comprising technical staff from the industry and the NHS, to devise a new family of performance-based test methods and specifications. These were based on a number of instances upon work that had been pioneered within the Surgical Materials Testing Laboratory (SMTL), an NHS facility that specialised in testing wound dressings and other medical disposables for the
Testing dressings and wound management materials
23
NHS in Wales. This group published test methods for bandages, alginates, fi lms, hydrocolloids and hydrogels, many of which subsequently became incorporated into the BP and/or adopted as European Standards. The types of tests required to characterise the performance of a dressing should be determined by the nature and condition of the wound to which the product is to be applied. The functions of a dressing have been described more fully in the past,1 but for the purpose of this chapter the principal requirements are summarised below. • • • • • •
Exudate management/environmental control Control or prevention of infection Provide a bacterial barrier Odour control Low-adherence Freedom from toxicity.
2.3
Fluid-handling tests
The effective management of the moisture content of a wound and the surrounding skin is perhaps the most important requirements of any dressing system. In the case of exuding wounds, this implies the removal of excess wound fluid, but, in dry or lightly exuding wounds, the dressing may be required to conserve moisture in order to maintain the exposed tissue in the optimum state of hydration to facilitate epithelialisation or promote autolytic debridement. The ability to control the loss of moisture from a wound is commonly determined by the moisture vapour permeability of the dressing or dressing system. Because excessive exudate can cause maceration of the periwound skin, which in turn can lead to infection, considerable attention has been given by the industry to the development of highly absorbent products that are able to prevent fluid from spreading over the surrounding healthy tissue. Some dressings, such as hydrophilic polyurethane fi lms, are very permeable to water vapour and thus permit the passage of a significant quantity of the aqueous component of exudate from the wound to the environment by evaporation. In practice, however, most permeable products are unable to cope with the volume of fluid that is produced by heavily exuding leg ulcers, burns or malignant wounds. In such situations, products that have the ability to absorb or otherwise retain significant quantities of liquid are required, although many also combine this absorptive function with a significant degree of moisture vapour permeability. These two values determine the ability of a dressing to cope with wound exudate and are described as its fluid handling capacity (FHC). 2 Numerous different tests have been described to characterise the fluid handling properties of dressings, which vary from simple ‘dunk and drip’
24
Advanced textiles for wound care
tests to more sophisticated techniques in which a suitable test fluid is applied to a sample of dressing under controlled conditions, some of which have been incorporated in the European Standard (BS EN 13726-1)3 described below.
2.3.1 Free swell absorptive capacity This, the fi rst standard test described in BS EN 13726-1, measures the uptake of fluid by fibrous dressings such as those made from alginate fibre presented either in sheet or rope form. The dressing is placed in a Petri dish together with a quantity of test solution equivalent to 40 times the weight of the test sample, and held for 30 min at 37 °C after which it is gently removed from the dish, allowed to drain for 30 s and reweighed. The absorbency is then expressed as the mass of solution retained per 100 cm 2 (for sheet dressings) or per gram of sample for cavity dressings. Unless otherwise stated, all absorbency tests are performed using ‘Test solution A’, a mixture of sodium chloride and calcium chloride solutions containing 142 mmol of sodium ions and 2.5 mmol of calcium ions as the chloride salts. This solution has an ionic composition similar to human serum or exudate. The presence of both sodium and calcium ions is required as these both have a marked effect upon the gelling characteristics of alginate fibres. It will immediately be seen that a serious criticism of this method is that the alginate is tested in the absence of any pressure, which means that the results obtained bear little relation to the volume of exudate that the dressing will take up under normal conditions of use. (This point is returned to later.) In the presence of sodium ions, alginate fibres absorb fluid and swell, sometimes taking on a gel-like appearance. The degree of swelling and dispersion is determined by the chemical structure, ionic content and method of preparation of the dressing. Some alginate products, having a high mannuronic acid content, appear to form an amorphous mass, whilst others with a high guluronic acid content tend to retain their structure and swell to a much lesser degree.4 These properties are quite important as they determine how the dressing will perform when introduced into a wound and BS EN 13726-1 describes two simple tests that help to characterise the alginate and determine its dispersion/solubility.
2.3.2 Fluid-handling capacity This test, also described within BS EN 13726-1, and based on a method published previously, 5 provides information on the amount of test fluid
Testing dressings and wound management materials
25
both retained and transpired by products such as hydrogel and hydrocolloid sheets and other dressings made from foam which incorporate an integral waterproof backing layer. The method is not suitable for testing fibrous products or permeable absorbents. The test involves the use of a simple piece of apparatus known as a Paddington Cup. This is described in detail in the standard, but, essentially, it consists of a cylinder with an internal cross-sectional area of 10 cm 2 having a flange at each end. To one end of the cylinder is fitted an annular ring, the internal diameter of which is identical to that of the cylinder, and, to the other, a solid plate, which can be clamped into position forming a watertight seal. A piece of dressing under examination is cut to shape and clamped between the annular ring and one of the flanges. The cylinder together with all the associated parts is then weighed. Approximately 20 ml of test fluid is added to the cup and the plate clamped in position. The cup is then weighed again before being placed in an incubator capable of maintaining the internal temperature and humidity within specified limits (37 ± 1) °C and relative humidity <20% throughout the test. After a predetermined period (usually 24 h) the cylinder is reweighed, the plate removed and the excess fluid is allowed to escape after which the cylinder is reweighed once again. From these weighings, it is possible to calculate the amount of fluid lost through the back of the dressing by evaporation during the period of test, and the weight of fluid retained within its structure. The sum of these two values represents the Fluid Handling Capacity of the dressing. By way of illustration, Tables 2.1–2.3 contain the published results of fluid handling tests performed on 12 hydrocolloid dressings over 24, 48 and 96 h. 5 Individually the tables illustrate the differences between products at each time point, but a comparison of the results achieved with individual products at the two time points clearly demonstrates how the products vary in terms of their rate of hydration. Some products reach full absorbency after 24 h, others are still absorbing after 96 h. These differences clearly have potentially important clinical implications for the use of the products concerned.
2.3.3 Moisture vapour transmission rate (MVTR) This same apparatus described in BS EN 13726-1 may be used in a similar although less complicated fashion, to determine the MVTR of permeable fi lm dressings. This method is described in BS EN 13726-2.6 Although the official method specifies that the apparatus shall be incubated with the solution in contact with the test sample, it is also possible
26
Advanced textiles for wound care
Table 2.1 Fluid-handling characteristics of hydrocolloid dressings after 24 h*
Tegasorb Thin Tegasorb Cutinova Hydro Askina Biofilm Transparent Askina Transorbent Comfeel Plus Plaques Biseautees Comfeel Plus Transparenter Comfeel Plus Flexibler (sample 1) Comfeel Plus Flexibler (sample 2) Varihesive E Granuflex Hydrocoll Algoplaque
Moisture vapour loss [g (s.d.)]
Weight absorbed [g (s.d.)]
FHC [g (s.d.)]
0.58 0.60 0.67 0.27 3.35 1.33 0.65 0.49
(0.03) (0.22) (0.03) (0.02) (0.51) (0.05) (0.10) (0.05)
2.89 (0.26) 4.40 (0.11) 2.53 (0.05) 0.24 (0.07) 0.80 (0.05) 1.53 (0.04) 3.98 (0.12) 3.27 (0.09)
3.47 (0.26) 5.01 (0.26) 3.21 (0.05) 0.51 (0.08) 4.16 (0.55) 2.86 (0.06) 4.63 (0.16) 3.76 (0.11)
0.77 (0.12)
3.33 (0.06)
4.10 (0.11)
0.03 0.03 0.50 0.22
1.94 (0.11) 1.75 (0.13) 5.62 (0.11) 1.32 (0.14)
1.97 (0.12) 1.78 (0.14) 6.12 (0.12) 1.54 (0.38)
(0.01) (0.02) (0.04) (0.45)
*
Reproduced with permission from: A comparative study of the properties of twelve hydrocolloid dressings http://www.worldwidewounds.com/1997/july/ Thomas-Hydronet/hydronet.html.
Table 2.2 Fluid-handling characteristics of hydrocolloid dressings after 48 h* Dressing
Moisture vapour loss [g (s.d.)]
Weight absorbed [g (s.d.)]
FHC [g (s.d.)]
Tegasorb Thin Tegasorb Cutinova Hydro Askina Biofilm Transparent Askina Transorbent Comfeel Plus Plaques Biseautees Comfeel Plus Transparenter Comfeel Plus Flexibler (sample 1) Comfeel Plus Flexibler (sample 2) Varihesive E Granuflex Hydrocoll Algoplaque
1.46 (0.07) 2.27 (1.06) 1.92 (0.02) 0.38 (0.02) 3.90 (0.38) 2.28 (0.21) 3.02 (0.21) 1.55 (0.06) 2.21 (0.12) 0.13 (0.03) 0.10 (0.01) 1.06 (0.05) 0.17 (0.03)
3.70 (0.07) 5.25 (0.39) 2.87 (0.04) 0.12 (0.14) 0.75 (0.03) 4.39 (0.05) 1.68 (0.12) 3.73 (0.09) 3.45 (0.14) 2.77 (0.10) 2.86 (0.08) 6.46 (0.21) 2.81 (0.09)
5.17 (0.08) 7.52 (0.69) 4.80 (0.06) 0.50 (0.13) 4.64 (0.38) 6.67 (0.19) 4.70 (0.28) 5.28 (0.06) 5.66 (0.16) 2.90 (0.11) 2.96 (0.08) 7.52 (0.25) 2.98 (0.07)
*
Reproduced with permission from: A comparative study of the properties of twelve hydrocolloid dressings http://www.worldwidewounds.com/1997/july/ Thomas-Hydronet/hydronet.html.
Testing dressings and wound management materials
27
Table 2.3 Fluid-handling characteristics of hydrocolloid dressings after 96 h* Dressing
Moisture vapour loss [g (s.d.)]
Weight absorbed [g (s.d.)]
FHC [g (s.d.)]
Tegasorb Thin Tegasorb Cutinova Hydro Askina Biofilm Transparent Askina Transorbent Comfeel Plus Plaques Biseautees Comfeel Plus Transparenter Comfeel Plus Flexibler (sample 1) Comfeel Plus Flexibler (sample 2) Varihesive E Granuflex Hydrocoll Algoplaque
3.45 (0.11) 5.50 (0.75) 4.04 (0.07) 0.79 (0.01) 9.89 (0.73) 6.41 (0.31) 9.31 (1.01) 4.28 (0.75) 5.67 (0.58) 0.91 (0.18) 0.63 (0.47) 2.19 (0.11) 0.44 (0.03)
3.59 (0.48) 5.57 (0.66) 2.95 (0.05) 0.19 (0.16) 0.82 (0.05) 4.45 (0.10) 1.45 (0.22) 4.03 (0.24) 3.69 (0.14) 3.35 (0.11) 3.35 (0.36) 5.02 (0.69) 3.81 (0.19)
7.04 (0.51) 11.06 (0.19) 6.99 (0.05) 0.98 (0.17) 10.72 (0.75) 10.85 (0.31) 10.77 (0.81) 8.31 (0.77) 9.36 (0.51) 4.25 (0.19) 3.98 (0.13) 7.19 (0.76) 4.25 (0.20)
*
Reproduced with permission from: A comparative study of the properties of twelve hydrocolloid dressings http://www.worldwidewounds.com/1997/july/ Thomas-Hydronet/hydronet.html.
to undertake the test with the cylinder inverted so that the dressing is not in direct contact with the liquid but exposed only to moisture vapour. This is important because the permeability of some types of polyurethane film will increase dramatically whilst in contact with liquid but revert back to previous values when this is removed – a characteristic that has obvious and important implications for its use as a wound dressing when in contact with intact peri-wound skin. 2
2.3.4 Dynamic MVTR The fluid handling and moisture vapour transmission methods described previously, provide a single value for the amount of fluid which is lost through the back of the dressing during the test period. Whilst this may be suitable for fi lm dressings, the permeability of which remain relatively consistent throughout the test period, the test has serious limitations for products such as hydrocolloids in which the permeability of the dressing changes with time as the adhesive mass on the wound contact surface gradually becomes hydrated. This problem can be overcome by a modification to the standard test which has been described previously. 5 A Paddington Cup is set up as
28
Advanced textiles for wound care
described and placed upon the pan of a top loading balance located in a controlled humidity cabinet which is connected to a data logger. In this way, the weight of the Paddington Cup can be continuous monitored over the test period, and, from the recorded data, the change in moisture vapour transmission rate may be determined. Depending upon the product this may be virtually zero for a number of hours, gradually increasing to reach a steady state some time during the following 24–48 hours. 5,7 The weight of fluid absorbed by the dressing during this time is determined as previously described. Using this method, it is also possible to demonstrate the marked change in permeability that occurs when a hydrophilic polyurethane membrane is brought into contact with liquid. Two similar absorbent polyurethane foam dressings with semipermeable fi lm backing layers were tested as described and after a 6-h incubation with the dressings uppermost, i.e. not in contact with the test solution, the chambers were inverted so that the test materials were allowed to become wet. The results, shown in Fig. 2.1, show a marked increase in the permeability of one product but not the other. This change in permeability has important implications for the relative fluid-handling properties of the dressings when applied to heavily exuding wounds.
14
Loss of moisture vapour (g/10 cm2)
12 10 8 6 4 2 0 0
2
4
6
8
10 12 14 16 18 20 22 24 Time (h)
2.1 Effect of inversion of the test chamber after 6 h on the moisture vapour transmission rate of two film-backed dressings.
Testing dressings and wound management materials
29
2.3.5 Shortcomings of existing test methods Although methods described thus far facilitate comparisons of the fluidhandling properties of similar products within specific groups and provide useful quality control tests to confi rm consistency of production, they do not permit direct comparisons between different groups of dressings such as alginates and hydrocolloids. They also cannot be used to investigate the performance of the different dressings when subjected to pressure – a major factor in the treatment of venous leg ulcers where dressings are often subjected to pressures as high as 40 mm Hg. Some dressings, such as foam sheets are like bath sponges, capable of taking up large volumes of fluid, but unable to retain this under even light pressure. Much research has therefore been devoted to maximising the performance of foam dressings by casting the foam from hydrophilic polymers and/or the inclusion of super-absorbents within the porous structure of the foam itself. These developments have resulted in the formation of a family of products that are among the most absorbent and widely used dressings available. Test systems are therefore required to compare these different dressings under varying levels of pressure in simulated clinical conditions. Over the years, numerous methods for measuring the absorbency of wound dressings have been described, most of which consist of variations on a common theme. The dressing under examination is placed on a simple wound model, which usually consists of a metal or acrylic plate with a small hole or depression in the centre. A weight is then applied to the back of the dressing to simulate the pressure applied by a bandage and test fluid is applied to the dressing through the plate by means of a peristaltic pump or syringe driver. In some test systems, the fluid is not actively pumped into the dressing but is absorbed by the dressing itself from some form of constant head apparatus.8 A particular example of such a test system is the ‘demand wetability’ apparatus that was developed to investigate how fibre pre-treatments and alignment can influence the uptake of water.9 For a surgical dressing, the absorbent capacity is generally taken to be that volume of fluid taken up by the time at which strike-through occurs. Strike-through is defi ned as the point at which absorbed fluid reaches the outer surface or edge of a dressing and this may be determined in a number of different ways. In one early system devised by SMTL,10 the distribution of liquid absorbed by the dressing was monitored electronically by means of sharp steel spikes which penetrated into the body of the dressing. The disruption to the structure of the test sample caused
30
Advanced textiles for wound care
by the spikes cast doubt on the validity of this method and so it was abandoned. Many of the other test systems developed previously also suffered from a series of disadvantages: • •
•
•
•
• •
They can be difficult to automate and therefore may not always be suitable for running unattended over extended periods. The application of a weight and/or strike-through detector on the back of the dressing prevents the loss of moisture vapour, an important mechanism by which some dressings cope with exudate production. If moisture vapour transmission is to be measured, it is not possible to apply a weight or strike-through detector on the back of the dressing to simulate the effect of pressure. The use of a positive feed system for the application of test fluid can produce anomalous results. For example, a hydrocolloid dressing that is fi rmly stuck to the acrylic sheet may appear to be capable of absorbing large volumes of test solution when in fact this is simply being trapped under the dressing in the form of a huge bubble. Most simple test systems provide a single value for the total absorbency of a dressing with little indication of how the product performs over a specified period of time (dynamic performance testing). Many wound models are not suitable for testing hydrogels or packing materials. They do not readily enable predictions to be made of clinical wear times of different types of dressings.
2.3.6 Development of the Wrap rig Research undertaken in the SMTL, led to the development of a new test system (called the Wrap rig), which facilitates comparison of the fluid handling properties of most types of dressings irrespective of their structure and composition even whilst under compression. Design requirements of a test system In order to address some of the shortcomings of test methods described previously and produce a system that more closely approximated to the clinical situation, a series of key design criteria for the new model were derived previously.11 •
Fluid should be provided to the test sample by some form of pump or other suitable positive flow device. A passive uptake technique is not acceptable.
Testing dressings and wound management materials •
•
•
•
• •
• •
• • • •
31
The fluid should not be presented to the test sample under excessive pressure. Previous test systems have, in effect, injected fluid into the dressing under pressure, although there is no evidence that this occurs in wounds. There must be some suitable method for controlling the temperature of the system for the duration of the test, to reproduce the environmental conditions in the wound. The test should provide some indication of the dynamic performance of the dressing, measuring its fluid-handling capacity profi le over time, and not just a single total absorbency figure. The equipment should be capable of delivering test solution at a range of different flow rates, so that the effect of different rates of exudate can be examined. The apparatus should indicate when either vertical or lateral strikethrough has occurred. The apparatus should be suitable for testing a wide range of different types of dressings to permit direct comparison of the results. Previous methods were frequently dedicated to one type of technology, such as alginates. The equipment should be compatible with a range of different test solutions. Where appropriate, the apparatus should permit the application of varying loads to the test samples in order to determine the effect of external pressure. The apparatus should permit the measurement of moisture vapour transmission by the dressing as an integral part of the test. The test should be easy to perform and provide results that can be reproduced within and between laboratories. The equipment should not be excessively expensive to produce. The test should, ideally, provide an indication of the wear time of a dressing in normal clinical use.
In addition to the primary design criteria, a number of additional features were identified, which, although not essential, are considered desirable features in a wound model. • The apparatus should withstand sterilisation or disinfection. • The apparatus should permit analysis of wound fluid that has been in contact with the dressing to measure changes in ionic composition or changes in concentration of solutes such as proteins caused by selective absorbtion by the dressing. • The apparatus should permit microbiological examination of the local environment during the course of the test.
32
Advanced textiles for wound care
2.2 The Wrap rig.
• The test equipment should allow the pressure beneath the dressing to be varied if this is considered desirable. A prototype test system was developed based upon these criteria.11 Following some early validation work, some minor modifications were made and a new version of the rig was produced; the use of this rig has been described in a subsequent publication which also clearly illustrated the effects of compression upon dressing performance.12 Essentially the apparatus consists of a number of separate components. The wound model The Wrap rig model consists of a two-part stainless-steel plate (the ‘wound bed’), mounted on a Perspex table (Fig. 2.2). An electronically controlled heating mat beneath the steel plate keeps the plate and test sample under examination within a narrow temperature band. The central section of the plate is milled from solid stainless steel and includes a shallow circular recess bearing two ports on opposite ends of a 15-mm-long shallow channel. An inlet hole 3 mm in diameter and a outlet hole 7 mm in diameter permit the introduction and unimpaired exit of test solution. The diameter and depth of the circular recess is sufficient to accommodate two thin absorbent pads that ensure the effective transfer of liquid from the channel to the dressing above. Test fluid, introduced by means of a syringe pump, travels along the narrow channel and passes out through the second port, falling verti-
Testing dressings and wound management materials
33
cally down through a short, wide-bore tube. This tube discharges into a receiver placed on the pan of an electronic balance. The liquid in the receiver is covered with a layer of oil to prevent loss by evaporation. The balance is connected to an electronic data capture device that records changes in the balance reading at predetermined intervals throughout the period of the test. A dressing sample typically measuring 10 cm × 10 cm is secured on to the test plate which is set to a predetermined temperature. Test fluid applied to the test rig passes along the open channel some or all of which will be taken up by the dressing. Any unabsorbed fluid continues to pass along the channel until it falls through the outflow pipe into the receiver, causing a change in the balance reading. The amount of fluid that accumulates in this way is inversely proportional to the absorbency of the dressing. A highly absorbent dressing may take up all the liquid that is applied to it, while less absorbent products will absorb only for a short time or take a little while to reach maximum absorbency. During a test, therefore, the maximum weight of fluid that can be taken up by a dressing is determined by the flow rate of the syringe pump. As this test system is designed to simulate the normal use of a dressing, it is important to ensure that the test conditions employed are as clinically relevant as possible, particularly in relation to the production of exudate. Previous studies have found that a heavily exuding wound typically produces around 5 ml per 10 cm 2 per 24 h,13 but in the presence of infection this value can easily double.14 Although it is possible to run the test with these flow rates, for most tests the syringe pump is normally set to deliver a nominal 1 ml h−1 as this value provides a reasonable compromise between clinical relevance and a need to keep testing times to a minimum for practical reasons. When testing cavity wound dressings, alginate fibre or hydrogel dressings, a simple modification is made to the apparatus. A piece of stainless tube is fi xed inside the recess in the centre of the plate to form a chamber into which the dressing is placed. Although strike-through measurements are not appropriate with such dressings, it is possible to apply pressure to cavity dressings such as alginate packing by means of a weighted stainlesssteel piston, which forms a sliding fit in the tube. In all other respects, the test procedures remain the same. When testing hydrogel dressings, the open end of the chamber is sealed with a piece of aluminium foil held in place with impermeable plastic tape to prevent evaporation. The ability of this test system to differentiate between different hydrocolloid dressings is shown in Fig. 2.3. All the products, which were tested in the same way, are superficially similar in appearance but as the figure clearly indicates, marked differences exist in their ability to absorb and retain test solution.
34
Advanced textiles for wound care 8 Fluid uptake (g)
7 6 5 4 3 2 1 0
0
10
20
30 Time (h)
40
50
2.3 Fluid handling properties of four hydrocolloid dressings measured using the Wrap rig.
The pressure/vertical strike-through plate As previously discussed, the application of a weight to the back of the dressing to simulate pressure produced by compression bandages has the undesirable effect of occluding the back of the dressing and preventing the transpiration of moisture vapour, an important part of the function of the dressing. This problem was overcome in this model in a novel way by combining in one piece of apparatus, the functions of strike-through plate, moisture-absorbing-unit, and pressure plate. A stainless-steel box, one surface of which consists of a coarse stainless-steel mesh supported internally by pillars attached to the inner face of the other surface to impart structural rigidity, can be fi lled with silica gel and when placed upon the test sample with the mesh surface downwards it fulfi ls three functions: • It permits the application of pressure to the dressing without occluding the outer surface. • It provides a humidity gradient across the dressing to facilitate passage of moisture vapour. • It acts as an electrical contact to detect strike-through. Recording strike-through A method of recording strike-through was devised that proved to be relatively easy and trouble free. This consisted of a Psion Organiser II (Model XP) fitted with a Digitron Model SF10 Datalogger unit. The SF10 unit plugs into the top of the Psion II, and is a four-channel unit capable of taking up to four external probes to measure temperature, pressure, relative humidity or voltage. For the purpose of this study, a voltage probe,
Testing dressings and wound management materials
35
capable of recording from 0–2500 mV, was used. A 1.5-V (AA sized) alkaline cell was used to supply the necessary electromotive force. Initial experience with this equipment suggested that the combination provided a simple and reproducible technique for measuring strike-through, recording values that changed instantly from 0 mV to in excess of 1000 mV when strike-through occurred. At this point, the contribution made by the loss of moisture vapour to the fluid-handling properties of the sheet dressings may be determined by measuring the change in weight of the silica gel in the strike-through plate. Lateral strike-through detectors Lateral strike-through may be detected by the use of four brass strips, typically 90 mm × 20 mm × 3.5 mm thick, connected with short lengths of flexible cable. The under-surface of each strip is covered with a layer of insulating tape to prevent it from making electrical contact with the stainless-steel plate. In use, the strips, which are connected to the strikethrough detector, can be pushed gently against the exposed edges of the dressing to detect any moisture that appears at the edge of the dressing. The new test rig is currently being evaluated by a multidisciplinary group comprising representatives from most European dressings companies, in addition to others with an interest in dressing design or performance. This group, which was originally funded by a research grant from the Engineering and Physical Sciences Research Council (EPSRC), is concerned with the development and validation of methodologies for medical device evaluation.
2.3.7 Fluid-affinity test Some hydrogel dressings, both in sheet and amorphous form, have the ability to absorb or donate liquid according to the condition of the underlying tissue. This means that they can absorb fluid from a heavily exuding wound or donate moisture to dry or devitalised tissue to promote autolytic debridement. Test systems are therefore required which can be used to assess both these properties. The material in question is placed in contact with other gels made from varying concentrations of agar or gelatine representing a spectrum of tissue types, and the transfer of liquid to or from the test sample to the standard gels is measured by recording any change in weight of the sample. A fairly basic version of this technique was described in three early publications15–17 but this was gradually refi ned and used as the basis of a standard method described in BS EN 13726-1.
36
Advanced textiles for wound care
2.4
Low-adherence tests
2.4.1 Importance of low-adherence The results of a international survey,18 identified that pain and trauma were ranked as the most important factors to consider when changing dressings. A total of 3918 clinicians who responded to a written questionnaire, considered that pain was most commonly associated with dressings drying out or adhering to the wound bed, factors that were also considered to be responsible for wound trauma. Some products like alginates, hydrogels or silicone products show little propensity to adhere to granulating wounds whilst other such as simple gauze or non-woven fabrics perform particularly badly in this context. It is generally believed that there are two mechanisms of adherence. The fi rst is the inherent ‘stickness’ of serum which acts like a simple adhesive that forms a bond between two opposing surfaces. The second mechanism is a little more complex, involving the penetration into the dressing of serous fluid containing cellular debris which dries to form a solid ‘scab’ on the wound surface but which also incorporates some of the structural elements of the dressing which acts like reinforcing bars in concrete. As a result when the dressing is removed the scab, together with underlying new epithelium, is forcibly removed leading to rewounding and delayed healing. Many dressings have therefore been developed with a woundcontact surface that is designed specifically to reduce adherence, examples of which have been described previously.19
2.4.2 Measurement of adherence potential Predicting the way in which dressings will perform clinically in terms of adherence has proved unexpectedly difficult, as no standard laboratory test system has been described for this purpose. In 1982, a method was devised by SMTL in which a cold-cure silicone rubber material was applied onto the surface of a test sample using a plastic former to control the area of application.10 Once the rubber had set, the dressing was removed from the former containing the silicone block by means of a tensiometer to record the applied force, using a 180° peel. Although no absolute values could be applied as limits, the test system was used to rank products in order of their adherence potential. In a later modification to this test, an aqueous solution of gelatine was used to replace the silicone as this more closely represents the in vivo situation. This procedure is still used as a non-official ‘in-house’ test.
Testing dressings and wound management materials
2.5
37
Conformability tests
Dressings applied around joints or to other areas of tissue that are subject to movement or distortion must, to some degree, accommodate this movement without causing excess pressure, or in the case of adhesive products, shearing forces that can cause skin trauma. Whilst products such as bandages tend to accommodate changes in body geometry fairly readily, products such as hydrocolloids, semipermeable fi lm dressings and self-adhesive island dressings can sometimes cause clinical problems. 20 A test designed to assess the extensibility and permanent set conformability of primary wound dressings by measuring its extensibility and permanent set is described in BS EN 13726-4. In this test, strips of dressing 25 mm wide with an effective test length of 100 mm are extended by 20% in a constant rate of traverse machine at 300 mm min−1. The maximum load is recorded and the sample is held in this position for 1 min. It is then allowed to relax for 300 s before being remeasured. Further samples taken from a direction perpendicular to the first are also tested in a similar way to account for ‘directionality’ in structure of the material. The standard requires that the test report records the maximum load, the extensibility and the permanent set which are calculated using the formulae provided. An alternative test method, which eliminates the problems of directionality by extending a sample in all directions at once has been developed using a modification of the Apparatus for the Measurement of Waterproofness described in the BP 1993. This consists of a chamber, open at one end, bearing a flange with an internal diameter of 50 mm. A retaining ring with the same internal diameter as the hole in the flange is mounted over the open end of the cylinder which can be lowered down onto the flange by means of a screw thread. A sample of the dressing under examination is placed on the flange and held fi rmly in place by means of the retaining ring. During the course of this test, air is slowly forced into the chamber by means of a large syringe. The resultant rise in the pressure within the chamber causes the dressing to expand and form a hemisphere which gradually increases in size until the upper surface of the dressing comes into contact with a marker placed 20 mm above the dressing surface at the start of the test. This pressure reading is then recorded by means of a transducer. In this test, the conformability of a dressing is considered to be inversely proportional to the pressure required to deform it by a predetermined amount and is represented by the mean inflation pressure of the samples examined. Results of the test performed on a range of hydrocolloid dressings are shown in Table 2.4.
38
Advanced textiles for wound care
Table 2.4 Conformability of hydrocolloid dressings* Dressing
Mean inflation pressure [mm Hg (s.d.)]
Tegasorb Thin Tegasorb Cutinova Hydro Askina Biofilm Transparent Askina Transorbent Comfeel Plus Plaques Biseautees Comfeel Plus Transparenter Comfeel Plus Flexibler (sample 1) Comfeel Plus Flexibler (sample 2) Varihesive E Granuflex Hydrocoll Algoplaque
107 (4.6) 187 (32.0) 105 (3.7) 103 (5.7) † 164 (11.8) ‡ 166 (13.0) 161 (8.9) 156 (4.6) 162 (5.3) 194 (20.4) 154 (17.3)
*
Reproduced with permission from: A comparative study of the properties of twelve hydrocolloid dressings http://www.worldwidewounds.com/1997/july/ Thomas-Hydronet/hydronet.html. † Dressing is permeable to air and therefore could not be tested. ‡ Dimensions of dressing were too small for testing.
2.6
Microbiological tests
2.6.1 Bacterial barrier properties Wounds of all types represent a potential source of cross-infection, particularly if they are infected with antibiotic resistant organisms such as MRSA. It is therefore important to ensure that wounds, in so far as is possible, are isolated from the environment to prevent the ingress or egress of pathogenic micro-organisms. Many dressings therefore consist of (or include in their construction) a layer which prevents the transmission of micro-organisms into or out of a wound. Most commonly, this layer consists of a piece of cast polyurethane film but sometimes closed cell foams are used for this purpose. The ability of a bacterium to pass through a dressing is determined by the presence of a liquid pathway. For dry wounds, a thick layer of absorbent cotton or gauze may be sufficient to prevent contamination, but, as soon as this becomes wet, the barrier properties are lost and the dressing becomes useless in this regard. It follows, therefore, that a test system for dressings designed to provide an effective bacterial barrier is required which provides the ‘worst-case’ scenario, and once again a method has been devised within SMTL that has gained widespread acceptance.
Testing dressings and wound management materials
39
A sterile dressing is aseptically clamped between two sterile flanged hemispheres (closures of reactions vessels are typically used) such that the dressing is maintained in the vertical plain. A microbiological liquid nutrient medium is introduced into both chambers one side of which contains a heavy inoculum of a suitable test organism. The apparatus is then incubated for an appropriate period after which the chamber containing the previously sterile nutrient solution is examined for evidence of growth. If no growth is visible, the dressing is considered to represent an effective bacterial barrier but, if growth is detected, samples are plated out to confi rm that it is the test organism not extraneous contamination from a failure in aseptic technique. This test is currently being evaluated by the industry before being formally proposed as a new European Standard.
2.6.2 Antibacterial properties Some dressings contain agents that have intrinsic antimicrobial activity such as antibiotics, antiseptics, silver ions or materials which possess a significant osmotic pressure capable of inhibiting bacterial growth. In clinical practice, these materials are released from the dressing to exert an antibacterial effect. Such dressings are often recommended or promoted for the treatment or prevention of soft tissue infections. Other products contain antimicrobials that are immobilised or fi xed within the structure or the wound contact surface of the dressing, i.e. not released into the local wound environment. These materials are claimed simply to prevent the proliferation of micro-organisms within the dressing itself. They have no direct effect upon the wound and as such are more suited for preventing crossinfection than for treating existing wound infections.
Tests for immobilised antimicrobial agents A number of methods have been described for evaluating the antimicrobial properties of immobilised antimicrobial agents. A quantitative procedure for the evaluation of the degree of antibacterial activity of finishes on textile material has been published by the American Association of Textile Chemists and Colorists. 21 According to this method, swatches of test and control material are inoculated with the test organisms using sufficient test material to absorb the total volume of inoculum (1 ± 0.1 ml) leaving no free liquid. After incubation, the samples are eluted with a suitable extractant containing a neutralising agent and the number of viable organisms present in this solution is determined using standard microbiological techniques.
40
Advanced textiles for wound care
Whilst this method may be appropriate for testing a homogeneous mass of material, it is not suitable for evaluating a structured product such as a dressing that has several different components of which only one, the wound contact layer for example, may have antimicrobial activity. Any bacterial suspension that is taken up by the non-medicated part of the dressing will remain unaffected by the antibacterial fi nish on the medicated portion leading to anomalous results. This deficiency in the method is noted in a later test published by ASTM International. 21 This describes an alternative method that ensures good contact between the bacteria and treated substrate by constant agitation of the test specimen in a bacterial suspension for a specified contact time. The suspension is then serially diluted and the number of remaining viable organisms is determined and compared with values obtained using an appropriate control or untreated sample. This method also includes a procedure to ensure that the antimicrobial activity detected is not caused by leaching of the active ingredient as follows. An extract of the dressing is placed into an 8-mm hole in an agar plate inoculated with a test organism and the presence of any zone of inhibition around the well indicates the presence of leaching, thus rendering the test invalid. An alternative test, devised within the SMTL, graphically demonstrates the ability of a dressing to kill or inhibit the growth of micro-organisms that come into contact with it and thereby prevent the transfer of contaminated material into or out of a wound. In this test an agar plate has two channels cut out of it as to effectively form two separate agar areas in the Petri dish. One of the agar blocks is sterile; the other is inoculated with the test organism. A strip of dressing under examination is placed on top of the two blocks forming a bridge. Sterile water is place in the channel on the outer side of the contaminated agar to increase the water content of the gel and provide a ‘driving force’ to encourage the movement of moisture from the contaminated agar along or through the dressing to the sterile agar on the other side of the second channel. The Petri dish is incubated as normal with the dressings in place after which it is examined to detect the presence of growth around the margin of the test sample on the sterile agar surface. This test determines the ability of bacteria to survive on the dressing surface and migrate along it from the contaminated agar to the sterile agar. A positive result in this test suggests that it is possible that micro-organisms could be transported laterally out of a contaminated wound onto the surrounding skin, or potentially move in the opposite direction from the intact skin into the wound itself. No growth on the sterile agar suggests that the dressing does indeed have the ability to kill or prevent the growth of bacteria that come into contact with it.
Testing dressings and wound management materials
41
Tests for antimicrobial agents released from dressings For products that are designed to kill bacteria within the wound, alternative test systems are required based upon the following considerations. The ability of an antimicrobial dressing to exert a beneficial clinical effect is dependent upon three factors: • • •
The nature and spectrum of activity of the agent concerned The concentration of the material present in the dressing The release characteristics (does the material actually get into the wound?).
In its simplest form, the test can consist of the application of a piece of dressing applied to an agar plate that has previously been seeded with the test organism. Antibacterial activity is indicated by the presence of a halo or zone of inhibition around the sample, the size of which is determined at least in part by the concentration and solubility of the active ingredient. Such tests are easy to perform and can involve the use of different test organisms. 22–25 A possible criticism of this type of simple test is that the moisture content of the agar may be insufficient to facilitate extraction of the active agent from the dressing, or that the affi nity of the dressing for moisture may be such that it effectively retains the moisture within its structure and thus limits the amount that is released onto the agar to exert an inhibitory effect. It is also possible that the active agent may require the presence of sodium or calcium ions normally present in exudate or serous fluid to release or activate the biocidal agent within the dressing. Both of these problems may be overcome by a modification to the method in which a well is cut in the agar plate into which the dressing sample is inserted. The residual volume within the well is then fi lled with Solution A (used in absorbency testing) or, for research purposes, calf or horse serum. Alternatively, it is possible to make an extract of the dressing sample using an appropriate solution and place this into the well. A further test involves the incubation of a piece of dressing with a suitable volume of a bacterial suspension containing a known number of micro-organims. Following incubation, the dressing sample is extracted with an appropriate recovery medium and a total viable count performed on the extractant to determine the decrease in the number of viable organisms present. This test has the advantages that it can be conducted over various time intervals, and that it also provides a quantitative result. The tests have been described in detail previously in laboratory-based comparisons of silver containing dressings. 26,27 Unlike previous test systems, which gained fairly rapid acceptance by the industry enabling them to become adopted as official standards, it is
42
Advanced textiles for wound care
more difficult to reach a consensus on tests for antimicrobial activity. Whilst there is a reasonable prospect of achieving agreement on the experimental techniques which can be used, there remains a problem in the interpretation of the results, the levels of activity that are required clinically, and, therefore, the limits which should be attached to each method. 28–31
2.7
Odour control tests
Certain types of wounds such as pressure ulcers, leg ulcers and fungating (cancerous) lesions produce noxious odours which, even in moderate cases, can cause significant distress or embarrassment to a patient and their relatives. 32
2.7.1
Causes of wound odour
The smell from a wound is caused by a cocktail of volatile agents that includes short-chain organic acids (n-butyric, n-valeric, n-caproic, nheptanoic and n-caprylic) produced by anaerobic bacteria, 33 together with a mixture of amines and diamines such as cadaverine and putrescine that are produced by the metabolic processes of other proteolytic bacteria. Organisms frequently isolated from malodorous wounds include anaerobes such as Bacteroides and Clostridium species, and numerous aerobic bacteria including Proteus, Klebsiella and Pseudomonas spp.
2.7.2 Management of wound odour The most effective way of dealing with malodorous wounds is to prevent or eradicate the infection responsible for the odour but, if for some reason this is not possible, it may be necessary to address the problem by some other means. In 1976, Butcher et al., 34 described the use of a charcoal cloth produced by carbonising a suitable cellulose fabric by heating it under carefully controlled conditions. The small pores formed in the surface of the fibres greatly increase their effective surface area and, hence, their ability to remove unpleasant smells, as it is believed that the molecules that are responsible for the production of the odour are attracted to the surface of the carbon and are held there (adsorbed) by electrical forces. Since 1976, a number of odour-absorbing dressings containing activated charcoal have been produced commercially, some of which are intended to be placed in direct contact with the wound whilst other products are designed as secondary dressings which are placed over a primary dressing, but beneath the retaining dressing or bandage.
Testing dressings and wound management materials
43
2.7.3 Testing odour absorbing dressings Despite the relatively widespread use of odour-absorbing dressings, however, little objective comparative data is available on their odour- and fluid-handling characteristics. A number of possible test systems have been described, 35–37 but some of these have only considered the efficacy of the dressing in the dry state, the fluid-handling properties of the dressing being considered separately. 38 This may be important because the presence of liquids, particularly those containing organic solutes, may have implications for the performance of the activated charcoal, competing for active sites with the molecules responsible for the odour and thus reducing its effectiveness. Previous studies have used both chemical, 35–37 and biological materials39,40 to test the efficacy of odour-adsorbing dressings. The former technique is often favoured as the efficiency of the dressing can be determined using standard analytical techniques such as gas–liquid chromatography. Determination of dressing performance using biological materials is currently restricted to more subjective methods of assessment such as the use of a human test panel. Lawrence et al.,40 adopted this second approach when they compared the odour-absorbing properties of five dressings containing activated charcoal with that of a cotton gauze swab, acting as a control. A more objective test system that could be used to compare the ability of different dressings to prevent the passage of a volatile amine when applied to a wound model under simulated ‘in-use’ conditions was devised by SMTL. This apparatus consists of a stainless-steel plate bearing a central recess (50 mm diameter × 3 mm deep) into which is inset a removable perforated stainless-steel disc and a disposable Millipore pre-fi lter. Fitted to the stainless-steel plate is an airtight Perspex chamber with inlet and outlet ports (Fig. 2.4). The dressing under examination is placed over the recess and sealed around the edges with impermeable plastic adhesive tape.
2.4 Apparatus for testing odour-absorbing properties of wound dressings.
44
Advanced textiles for wound care
The test solution, consisting of Solution A to which is added 2% diethylamine and 10% newborn bovine serum, is applied to the dressing through the perforated plate at a rate of 30 ml h−1 by means of a syringe pump. The concentration of diethylamine in the air in the perspex chamber is constantly monitored using a Miran 1B2 portable ambient analyser (Quantitech Ltd, Milton Keynes) and the measured values recorded electronically using a datalogger. The test is continued until the concentration of diethylamine present in the air above the dressing has risen to approximately 15 ppm. By relating the flow rate of test solution to the rate at which wounds normally exude, it is possible to use the apparatus to estimate the useful life of a dressing in the clinical environment. The test system was evaluated in an independent study which compared the odour-absorbing properties of eight different dressings.41 The authors concluded that although there were still shortcomings associated with the use of the technique related to the application and orientation of the test sample, it appears to be the best way of objectively ascertaining quantitative comparable data on the odour-absorbing properties of different dressing products.
2.8
Biological tests
Because dressings come into intimate contact with damaged tissue, blood or body fluids, it is important to ensure that they are free from any agents that can adversely effect wound healing or otherwise cause an adverse reaction within the wound. The standard approach to testing medical devices is described in BS EN ISO 10993. This standard is divided into 18 parts, each of which describes a particular type of test or procedure that may be relevant to specific types of medical devices. For topical wound dressings the most relevant parts are as follows.
2.8.1 Part 5: Tests for in vitro cytotoxicity This part of the standard42 describes test methods to assess the in vitro cytotoxicity of materials using techniques in which cultured cells (typically L-929 mouse fibroblasts) are either exposed to an extract of the test sample, or brought into intimate contact with the sample itself using an agar diffusion or fi lter diffusion method. Cytotoxicity is graded on a fourpoint scale from non-toxic to severely cytotoxic according to the damage occasioned to the cell system used.
2.8.2 Part 10: Tests for irritation and sensitisation This part of the standard43 describes a technique in which extracts of the dressing are injected subcutaneously into multiple sites on the backs of
Testing dressings and wound management materials
45
rabbits following which the injection sites are examined visually for evidence of irritation (erythema and oedema) immediately and after 24, 48 and 72 h. The sensitisation potential is determined by intradermally injecting and occlusively patch testing multiple sites on 10 guinea pigs. The treated sites are examined visually for evidence of a skin reaction after 24, 48 and 72 h.
2.9
References
1. thomas s. Wound management and dressings. London: Pharmaceutical Press, 1990. 2. thomas s. Fluid handling properties of Allevyn Dressing. Wound management communications 2007; http://www.medetec.co.uk/Documents/ Fluid%20handling%20properties%20of%20Allevyn%20foam%20dressing 24-4-07.pdf. 3. BS EN 13726-1:2002 Test methods for primary wound dressings. Part 1: Aspects of absorbency. London: BSI, 2002. 4. thomas s. Observations on the fluid handling properties of alginate dressings. Pharm. J 1992; 248:850–851. 5. thomas s, loveless p. A comparative study of the properties of twelve hydrocolloid dressings. World Wide Wounds 1997; http://www.worldwidewounds. com/1997/july/Thomas-Hydronet/hydronet.html. 6. BS EN 13726-2:2002 Test methods for primary wound dressings. Part 2: Moisture vapour transmission rate of permeable fi lm dressings. London: BSI, 2002. 7. thomas s, loveless p. Moisture vapour permeability of hydrocolloid dressings. Pharm J 1988; 241:806. 8. williams aa. Proficiency of contemporary wound dressings. In: Turner TD, Brain KR, eds. Surgical dressings in the hospital environment. Cardiff: Surgical Dressings Research Unit, UWIST, Cardiff, 1975; 163–179. 9. harrison g, d’silva ap, horrocks ar, rhodes d. An apparatus to measure the water absorption properties of fabrics and fibre assemblies. Med Text 1997; 96:134–140. 10. thomas s, dawes c, hay np. Wound dressing materials – testing and control. Pharm J 1982; 228:576–578. 11. thomas s, fram p. The development of a novel technique for predicting the exudate handling properties of modern wound dressings, 2001. 12. thomas s, fram p, phillips p. The importance of compression on dressing performance. World Wide Wounds 2007; http://www.worldwidewounds.com/2007/ November/Thomas-Fram-Phillips/Thomas-Fram-Phillips-CompressionWRAP.html. 13. lamke lo, nilsson ge, reithner hl. The evaporative water loss from burns and water vapour permeability of grafts and artificial membranes used in the treatment of burns. Burns 1977; 3:159–165. 14. thomas s, fear m, humphreys j, disley l, waring mj. The effect of dressings on the production of exudate from venous leg ulcers. Wounds 1996;8(5): 145–149. 15. thomas s, hay np. Assessing the hydro-affi nity of hydrogel dressings. J Wound Care 1994; 3(2):89–92.
46
Advanced textiles for wound care
16. thomas s, hay p. Fluid handling properties of hydrogel dressings. Ostomy Wound Manage 1995; 41(3):54–56, 58–59. 17. thomas s, hay np. In vitro investigations of a new hydrogel dressing. J Wound Care 1996; 5(3):130–131. 18. moffatt c. The principles of assessment prior to compression therapy. J Wound Care 1998; 7(7):suppl 6–9. 19. thomas s. Low-adherence dressings. J Wound Care 1994; 3(1):27–30. 20. ravenscroft mj, harker j, buch ka. A prospective, randomised, controlled trial comparing wound dressings used in hip and knee surgery: Aquacel and Tegaderm versus Cutiplast. Ann R Coll Surg Engl 2006; 88(1):18–22. 21. ASTM E 2149-101 Standard Test Method for determining the antimicrobial activity of immobilised antimicrobial agents under dynamic contact conditions. Pennsylvania: ASTM International, 2001. 22. AATCC TEST METHOD 147-1998 Antibacterial Assessment of Textile Materials: Parallel Streak Method. North Carolina: American Association of Textile Chemists and Colorists, 1999. 23. thomas s, russell ad. An in vitro evaluation of Bactigras, a tulle dressing containing chlorhexidine. Microbios Lett 1976; 2:169–177. 24. thomas s. An experimental evaluation of a chlorhexidine medicated tulle gras dressing (letter). J Hosp Infect 1982; 3:399–400. 25. thomas s, dawes c, hay np. Improvements in medicated tulle dressings. J Hosp Infect 1983; 4:391–398. 26. thomas s, mccubbin p. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 2003; 12(3): 101–107. 27. thomas s, mccubbin p. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care 2003; 12(8):305–308. 28. lansdown ab, jensen k, jensen mq. Contreet Foam and Contreet Hydrocolloid: an insight into two new silver-containing dressings. J Wound Care 2003; 12(6):205–210. 29. lansdown ab. Silver-containing dressings: have we got the full picture? J Wound Care 2003; 12(8):317; author reply 317–318. 30. thomas s, mccubbin p. Silver dressings: the debate continues. J Wound Care 2003; 12(10):420. 31. thomas s, ashman P. In vitro testing of silver containing dressings. J Wound Care 2004; 13(9):392–393. 32. van toller s. Psychological consquences arising from the malodours produced by skin ulcers. Proceedings of 2nd European Conference on Advances in Wound Management 1992, Harrogate: 70–71. 33. moss cw, dees sb, guerrant go. Gas chromatography of bacterial fatty acids with a fused silica capillary column. J Clin Microbiol 1974; 28:80–85. 34. butcher g, butcher ja, maggs fap. The treatment of malodorous wounds. Nurs Mirror 1976; 142:76. 35. schmidt rj, shrestha t, turner td. An assay procedure to compare sorptive capacities of activated carbon dressings: the detection of impregnation with silver. J Pharm Pharmacol 1988; 40:662–664. 36. shaw rj, maher ga. A test method for quantifying absorptive capacities of intact charcoal-containing wound management products. Proceedings of the
Testing dressings and wound management materials
37.
38.
39.
40.
41. 42.
43
47
7th European Conference on Advances in Wound Management, Harrogate 1977. griffi ths b, jacques ej, jones sa. Determination of malodour reduction performance in various charcoal containing dressings. Proceedings of the 7th European Conference on Advances in Wound Management, Harrogate, UK 1997, Harrogate, UK. griffi ths b, jacques ej, waring mj, bowler p, bishop s. Investigation into the fluid-handling characteristics of various charcoal containing dressings. Proceedings of the 7th European Conference on Advances in Wound Management, Harrogate, UK 1997, Harrogate, UK. myles vm, griffi ths b, bishop s. An investigation into the selective adsorption of malodour molecules onto charcoal containing dressings. Proceedings of the 7th European Conference on Advances in Wound Management, Harrogate, UK 1997, Harrogate, UK. lawrence c, lilly ha, kidson a. Malodour and dressings containing active charcoal. Proceedings of the 2nd European Conference on Advances in Wound Management 1992, Harrogate, UK: 70–71. lee g, anand sc, rajendran s, walker i. Efficacy of commercial dressings in managing malodorous wounds. Br J Nurs 2007; 16(6):S14, S16, S18–20. bs en iso 10993-5:2003 Biological evaluation of medical devices. Test methods for primary wound dressings. Part 5: Tests for in vitro cytotoxicity. London: BSI, 1999. bs en iso 10993-5:2003 Biological evaluation of medical devices. Part 10: Tests for irritation and sensitization. London: BSI, 1999.
3 Textile materials and structures for wound care products B. S. GU P TA, North Carolina State University, USA, and J. V. E DWA R D S, United States Department of Agriculture – Agricultural Research Service, USA
Abstract: A thorough understanding of the healing mechanism and dressing requirements for different types of wound repair is necessary before optimum products based on textiles could be engineered. In this chapter, fi rst a general overview of the wounds and their healing, and of the available dressings and bandages, is presented. This is followed by a detailed discussion of the polymer and fiber materials of which the dressings are composed and of the textile processes that are used in forming the wound care products. Key words: wounds, wound healing strategies, dressings, bandages, dressing polymers and fibers, textile processes.
3.1
Introduction
In a human’s fast-paced life, characterized by external hazards and physiological neglects, physical injury of one or the other form is a commonly encountered event. It must be attended to in order to protect body health, function and appearance. The primary procedure used is the application of a dressing, which, in the main, protects the site against external assaults and aids in generating the needed physiological environment for efficient repair. The dressing can be as simple as a strip of plain textile, or as complex as an engineered composite that contains layers of different geometries and reactive materials, including medicines. The type of dressing depends on the type and the condition of the wound. Wound repair may be simple and inconsequential and performed by the patient itself or it may be complex enough to warrant surgery and hospitalization. An effective treatment requires a thorough understanding of wound types and healing mechanisms and knowledge of the interventions that are available and would ideally assist in the repair process. A major increase in the understanding of the requirements for a dressing emerged in the 1970s when the pioneering work of Winter1 showed that the wounds healed faster and more satisfactorily if the environment at the site was kept moist. Until then, the primary function of a dressing was 48
Textile materials and structures for wound care products
49
considered as one or more of absorbing the exudate, keeping the wound dry, and protecting it against external pathogens as well as further injury. The structure was also required to be comfortable. With the progress already made in terms of the understanding of the healing steps and requirements for different types of wounds, a wide variety of dressings are now available. A minor wound may be defi ned as one that is not chronic and also not seriously acute. However, if not attended to properly, the same wound could become infected, enlarged and acute enough to require advanced dressing and medical procedure. The fi rst line of treatment of a minor wound is a passive dressing, which is product that is textile in origin and may be made by a weaving, knitting or non-woven process. The dressing can also be a solid fi lm, cast directly from a polymer. If there is bleeding and the potential for swelling, a bandage may be required in conjunction with absorbent gauze in order to exert transverse pressure and control both hemorrhage and edema. Like the passive dressings, the bandages are also primarily textile structures that are made by one of the fabric-forming technologies. In this chapter, after a general review of wounds, healing, and dressing requirements, a brief description of the various types of dressings and the bandages available to choose from is given. A more in-depth coverage of some of the advanced dressings, touched on in the chapter, can, however, be found in other chapters of the book. In the second half of this chapter, a detailed discussion of the fiber materials and the textile structures used in producing the dressing and bandage products is presented.
3.2
The role of wound dressings
Skin is the largest organ of the body and has multiple components and, therefore, functions: the epidermis, which is the outer layer and composed of dead cells, is hydrophobic and responsible for protecting against the environment;2 the dermis, or the middle layer, which is made up of living cells with a network of blood vessels and nerves, is responsible for registering external stimulus, i.e. touch/feel, and thermal regulation of the enclosed body; and the subcutaneous layer, which is mainly made up of fat, is responsible for insulating the body against shock. The cells on the surface are constantly replaced by those below, causing the top layer to slough off. The repair of an epithelial wound then is essentially a scaling up of this process by the use of interventions. Much has been learnt during the past half a century about wounds, the healing process and the nature of the products required to successfully treat the lesion. A wet environment, composed of isotonic saline and wound fluids, has been shown experimentally to be most favorable for rapid healing of wounds. The inflammatory and proliferative phases of dermal repair in healing are also accelerated. 3
50
Advanced textiles for wound care
It was realized that bacteria did not generate in the wound but were acquired from an external source; thus simply washing with soap and water alleviated much of the risk of infection. Use of a protective covering formulated the simple but effective aseptic means for the treatment. An essential part of any wound management is wound dressing, important considerations for which are the extent to which it restricts evaporation of water from the wound surface, buffers pain and trauma, manages exudates and protects against bacterial invasion. Although wound healing which is the stated part of a wound management protocol has been described in recorded history, our understanding of its basic principles has grown more in the past half century than in the preceding two millennia.4 The recent outstanding growth in our knowledge about healing is highly promising and has already led to introduction of new and exciting concepts, novel therapeutic modalities, and innovative wound management products. As new materials are discovered, new dressings emerge which promise to play an active role in modifying healing of all types of wounds. 5,6 As the products become more sophisticated, they also tend to become more ‘wound-specific’. In order to select an optimum treatment for a wound and for different stages during healing, it is important that we understand the types of wounds we encounter, the sequence of events that take place during repair, and the treatment options we have available to choose from.
3.3
Categorization of wounds
Wounds have been categorized in many different ways, but they all reflect commonly the differences in the required treatment, and the expected time and prospects of healing. The classification of wounds recognizes the type of injury (blunt contusion, sharp laceration, thermal, chemical, etc.), the extent of tissue loss, and the presence of infection, foreign bodies, and underlying structural injuries (fracture of bone, exposure of vital parts such as tendons and blood vessels). A general classification of wounds is as follows: 1. 2.
Wounds with no tissue loss. Wounds with tissue loss. This generally includes three types of wounds; those that are (a) caused by burning, trauma or abrasion; (b) the result of secondary events involving chronic ailments, as, for example, venous statis, diabetic ulcers, and pressure sores; or (c) induced as a part of the treatment of the wound itself, as, for example, the wound arising at the donor site for skin grafting, or the wound due to derma-abrasion.
Textile materials and structures for wound care products
51
From the standpoint of the extent of injury, a wound may also be classified in terms of the layers involved: 1. 2. 3.
The superficial wounds, involving only the epidermis. The partial thickness wounds, involving also the dermis. The full thickness wounds, involving, additionally, the subcutaneous fat or deeper tissue.
Most wounds can also be broadly characterized as acute and chronic. In the former type, that may or may not have tissue loss, healing tends to proceed through a timely and orderly reparative process. In the chronic wounds, on the other hand, healing has failed to proceed through this process or it has proceeded without establishing a sustainable anatomical and functional result. The chronic wounds are classically subdivided into venous statis ulcers, pressure ulcers, and diabetic ulcers. To a lesser extent, the traumatic wound with extensive cutaneous loss that has not been replaced for some reasons also may fall in the category of chronic wounds.4,7
3.4
Minor wounds
A wound that has no tissue loss and is not chronic can be classified as minor with high prospects of healing with minimum scarring. Minor wounds often occur as the result of unanticipated trauma and may include injuries, such as lacerations, abrasions and blisters, and more serious wounds such as skin tears and bites. In many instances, such as superficial wounds, the skin may only require protection from further injury and can be treated at home with due regard given to the possibility that infection may be present or could arise. Infection is usually one of the biggest risks for minor traumatic wounds. A visual check for the presence of foreign material, its removal and careful cleansing may precede the application of a wound dressing. If, on the other hand, the wound is deep, as for example caused by penetration, then the possibility that an underlying structure may have been damaged needs to be considered. Some of the causes of minor wounds are:8 •
Lacerations. This wound occurs when soft body tissue has become torn and it is often irregularly shaped and jagged. It is highly common for this type of wound to be contaminated with debris and or bacteria by the object that caused it. • Abrasions or grazes. These are more exactly superficial wounds in which the top layer of the skin is damaged or removed, e.g. by the skin sliding across a rough surface. Small blood vessels may become visible and bleed. These injuries often contain dirt and gravel. Abrasions are
52
•
•
•
• •
Advanced textiles for wound care considered the most common type of wound, and perhaps the least dangerous.9 Blisters. These are usually the result of friction between the top two layers of the skin. Puncturing the blister, draining the fluid and removing the top layer often allow the area to heal more quickly. In many cases, the blister will burst of its own accord. In both instances, a protective dressing is required. Cut (incision). Such wounds usually have clean edges which are the result of surgery, or injury caused by a sharp-edged object. Since blood vessels are cut straight across, there can be profuse bleeding. Among all types of wounds, incisions are the least likely to become infected, because the abundance of flowing blood serves to protect against pathogens fi nding their way in. Puncture. A puncture wound typically occurs when the skin is pierced by a cylindrical object such as a needle or a nail. These wounds can be dangerous as one cannot easily identify the depth to which the puncture has reached; they can be particularly dangerous if the wound is located on the abdomen or thorax.9 With this type of wound, bleeding will occur, in a similar way to the wound caused by a knife. Figure 3.1 depicts the difference between a laceration and a puncture wound.10 Penetration. A penetration is a type of puncture but the damage is deeper such as it happens when a knife or bullet enters the body. Bites. These may be human or animal and are of special concern, especially if caused by an animal, as bacteria from the mouth can enter and
(a)
3.1 Wound types: a) laceration, b) puncture. 9
(b)
Textile materials and structures for wound care products
53
result in an increased risk of tetanus and infection. Most animal bites are sustained from pets, usually dogs, and can cause abrasions, deep scratches, and lacerations as well as puncture wounds. Cat bites are considered more serious due to the high incidence of infection.
3.4.1 General treatment strategy for minor wounds Cleaning the wound and the surrounding skin is usually the fi rst stage in treating a minor wound. This step removes debris and other foreign material which, if left, could cause infection. Abrasions require thorough irrigation as dirt is frequently embedded in the ruptured skin. An antiseptic solution may be used to cleanse the wound. Clean surgical wounds that have been sutured simply require the cleaning of old blood before the application of a dry dressing. In some cases it may be necessary to debride the wound before proceeding; in others, repair to underlying structures may need to be addressed before applying a dressing. Wounds greater than 6–8 h old have an increased risk of infection. In all cases of traumatic injuries, the patient’s tetanus status needs to be assessed for coverage. Following this, an assessment of the wound in terms of the location, size and depth and any additional trauma to the underlying structures needs to be determined. Animal bites need to be monitored for 24–48 h for signs of infection. After thorough cleansing and assessment, a choice of dressing is then made, which may be a simple low-adherent or an advanced multi-layer composite to not only protect the wound but also to absorb blood or exudates and keep the wound moist. A detailed discussion of dressings is given later in this chapter.
3.5
Healing mechanisms
The various phases involved in wound healing are seen in all wounds irrespective of whether it is a carefully opposed, clean, incised, wound that is healed by primary intention or one that is not opposed, has tissue loss, or is infected and exuding and is healed by secondary intention. The length of each phase varies with wound type and extent, and can be manipulated to promote or delay healing. The body’s natural healing process can be broken down into several steps: hemostasis, inflammation, proliferation, and maturation or remodeling. Immediately after injury, the platelets from the severed blood vessels begin to aggregate and form a platelet plug. This reduces bleeding. A clot forms in the opening of the wound, which dehydrates in contact with the air and forms a scab. In the second phase, neutrophils, monocytes and macrophages emerge, which tend to demolish or debride any devitalized
54
Advanced textiles for wound care
tissue and foreign bodies present, such as bacteria. The phagocytes act to clear debris and destroy the ingested material.11 In the third stage, new vessels are formed which carry the oxygenated blood to the site bed. The fibroblast cells lay down a network of collagen fibers surrounding the neo-vasculature of the wound. In the fi nal stage, the process of remodeling of the collagen fibers laid down in the proliferation phase occurs, and this may take a long time (Fig. 3.2).12 A problem arises in the last steps of the healing process for large or cavity wounds as the body is not able to completely seal the site with a scab-like formation. The cavity must be plugged with an appropriate dressing to assist in the process. Depending on the type of wound, healing treatment is considered to be by one of three processes: primary, secondary, or tertiary (often called delayed primary).6 Healing by primary intention occurs in most surgical
Skin surface
Red blood cell
Wound
Fibrin
Platelet
PMN
Epidermis and dermis of skin
Macrophage (a) Injury
(b) Coagulation
TGF-β PDGF
Macrophage (d) Late inflammation (48 h) Collagen
PMN (c) Early inflammation (24 h)
Fibroblast
(e) Proliferation (72 h)
(f) Remodelling (weeks to months)
3.2 Phases of cutaneous wound healing (a) injury, (b) coagulation, (c) early inflammation (24 h), (d) late inflammation (48 h), (e) proliferation (72 h), (f) remodelling (weeks to months).12
Textile materials and structures for wound care products
55
wounds in which the edges have been adequately approximated. Such wounds are usually clean and heal rapidly. Large wounds with significant tissue loss are allowed to heal by secondary intention. Such wounds are often encountered following massive trauma, surgical ablation of large tumors, or deep burns. Tertiary or, more appropriately, delayed primary healing is induced by reconstruction using skin grafts or flaps. Tissue gaps and poorly approximated edges will ultimately heal by secondary intention accomplished by re-epithelialization from the wound edges and mostly by wound contraction. Clearly, primary or delayed primary wound healings are by far preferable and superior to secondary healing.
3.6
Wound dressings
3.6.1 Historical The history of surgical wound management indicates how, with research and understanding of wounds and their healing, dressings have evolved over time and set the criteria for the design of new and better dressings and effective wound management. Until the research by Winter1 which illustrated the benefits of a moist environment for healing in the second half of the twentieth century, relatively few advances had taken place in wound care management. Since the early nineteenth century, advances in wound treatment occurred largely due to experience gained in military surgery. These observations brought out the benefits of a sterile environment in healing and led to clean and sterile gauze replacing the nonsterile products. In 1880, Joseph Gamgee developed the famous composite dressing consisting of absorbent cotton or rayon fiber enclosed in a retaining sleeve.13 The dressings used were sometimes medicated with iodine or phenol. Gauzes impregnated with paraffin were introduced as non-adherent dressings for the treatment of burns and other similar wounds. Medicated versions of these, the so-called ‘tulle gras’ were subsequently introduced and some of these are still being used. The work of Winter led to the development of a whole range of new dressings: films, gels, foams, polysaccharide materials and chitosan. These have revolutionized the treatment of wounds of all types. Some of the requirements for ideal wound dressing mentioned are:14–17 1. 2. 3. 4. 5. 6. 7.
Absorbing exudates and toxic components from the wounds surface Maintaining a high humidity at the wound/dressing interface Allowing gaseous exchange Providing thermal insulation Protecting the wound from bacterial penetration Being non-toxic Easily removable without causing trauma to the wound.
56
Advanced textiles for wound care
Properties that were added later include (1) having acceptable handling qualities, and (2) being sterilizable and comfortable.9 Having acceptable handling qualities means that product will not tear easily and disintegrate into wound.
3.6.2 Case for moist environment The most significant advance in wound care resulted from the work of Winter1 which showed that the occluded wounds, i.e. those in a moist environment, healed faster than the dry wound. An open wound, which is exposed to air, dehydrates and results in the formation of a scab or a scar. The latter forms a mechanical barrier against migrating epidermal cells, causing them to move through a deeper level of tissue, retarding healing (Fig. 3.318). A moist environment prevents the formation of scab and allows the cells to move unhampered.19 If exudate is present, such as from an ulcer, it should be absorbed by the dressing, so that it does not solidify in the wound.
3.6.3 Dynamic nature and requirements Each wound is different from any other even on the same individual, occurring because of the same reason, and in about the same region. Although it may fall in a given category, it still itself remains unique. This is because a wound is influenced by so many variables within the host and the environment that each will act independent of all others. 20 This is exacerbated by the facts that both the wounds and the hosts are dynamic and constantly change. Thus, there is the ongoing challenge faced in selecting the wound care dressing at each stage for each different person, and this requires a frequent reassessment of the lesion. Surgical wound assessment is an ongoing nursing responsibility that should be conducted every time a
Occlusive dressing
No dressing Normal scab
Moist exudate
Epidermis
Wound surface
3.3 Healing under a moist environment.18
Dry exudate Wound surface Dry dermis
Textile materials and structures for wound care products
57
dressing is changed, until the healing is complete. Assessment tools are available that determine the following aspects:21,22 • Type of wound – superficial or cavity. • Age of wound – fresh, days, weeks, dehisced (split along a natural line). • Stage of healing – granulating, epithelializing. • Progress of wound – healing, deteriorating, become necrotic, infected or static.
3.6.4 General classification Broadly, dressings may be classified as (1) passive, (2) interactive, and (3) bioactive, based on the nature of dressing action required. However, as illustrated above, the concept of wound occlusion to promote moist healing has probably impacted dressing design as much as any other development over the last thirty years. Wound occlusion does require careful regulation of the moisture balance at the site with vapor permeability helping the dressing to stay within its absorption limit. Thus, occlusive dressing types have been developed depending on the nature of the wound and the accompanying exudate. The theory of moist wound healing has led to approximately eight or nine separate types of materials and devices (Table 3.1), useful for different treatment indications. Each material type that represents these distinct groups has molecular and mechanical characteristics that confer properties to promote healing under specifically defi ned clinical indications. For example, it has been recommended that wounds with minimal to mild exudate be dressed with hydrocolloid, polyurethan, and saline gauze, and wounds with moderate to heavy exudate be dressed with alginate dressings. Dressings may also be selected based on wound tissue color, infection, and pressure ulcer grade. 23 When taken together, the combined properties of the dressing materials given in Table 3.1 would constitute an ideal dressing. Improvements in dressings that function at the molecular or cellular level to accelerate healing or monitor wound function are included among the ideal characteristics and may be termed interactive and intelligent materials, respectively. For example, a dressing that removes harmful proteases from the wound to enhance cell proliferation is an example of an interactive product. A dressing having a detection device in the material signaling ‘timeto-change,’ because the material has reached its capacity for deleterious protein levels, or reached a pH or temperature imbalance, may be termed ‘intelligent’. Currently, there is not a universal dressing that will work for all wound types. Therefore, a dressing for a wound should be chosen on a case by case basis. When choosing a product, there are several factors to
Semipermeable, polyurethane membrane with acrylic adhesive
Solid, non-adhesive gel sheets that consist of a network of crosslinked, hydrophilic polymers which can absorb large amounts of water without dissolving or losing structural integrity. Thus, they have a fixed shape. Semipermeable polyurethane film in the form of solid wafers; contain hydroactive particles as sodium carboxymethyl cellulose which swells with exudate or forms a gel. Soft, open cell, hydrophobic, polyurethane foam sheet 6–8 mm thick. Cells of the foam are designed to absorb liquid by capillary action.
Similar in composition to sheet hydrogels in their polymer and water make-up. Amorphous gels are not crosslinked. They usually contain small quantities of added ingredients such as collagen, alginate, copper ions, peptides, and polysaccharides
Thin films
Sheet hydrogels
Amorphous hydrogel
Semipermeable foam
Hydrocolloids
Description
Dressing and fiber type
Permeable to gases and water vapor, but not to aqueous solutions and exudate. Absorbs blood and tissue fluids while the aqueous component evaporates through the dressing. Cellular debris and proteinaceous material is trapped. Gels clear, yellowish, or blue from copper ions. Viscosity of the gel varies with body temperature. Available as tubes, foil packets, and impregnated gauze sponges
Impermeable to exudate, microorganisms, and oxygen. Moist conditions produced promote epithelialization
Carrier for topical medications. Absorbs its own weight of wound exudate. Permeable to water vapor, and oxygen, but not to water and bacteria. Wound visualization
Permeable to water and oxygen providing a moist environment
Properties
Used for full-thickness wounds to maintain hydration. It may be used on infected wound or as wound filler
Used for leg and decubitus ulcers, sutured wounds, burns and donor sites.
Shallow or superficial wound with minimal to moderate exudate.
Minor burns, pressure areas, donor sites, post-operative wounds Light to moderately exudative wounds. Autolytic debridement of wounds. Stage II and III pressure sores.
Indications
Table 3.1 Classes of occlusive wound dressings with a description of their properties, clinical indications, and contraindications
Wound vacuum assisted closure
Gauze packing
Contact layer dressings (tulle gauze with petroleum jelly)
Fillers
Calcium alginate which consists of an absorbent fibrous fleece with sodium and calcium salts of alginic acid (ratio 80 : 20). Dextranomer beads consist of circular beads, 0.1 to 0.3 mm in diameter, when dry. The bead is a three-dimensional crosslinked dextran, and long-chain polysaccharide Greasy gauzes consisting of tulle gauze and petroleum jelly. Silicone-impregnated dressing sheet consists of an elastic transparent polyamide net impregnated with a medicalgrade crosslinked silicone Cotton gauze used both as a primary and secondary wound dressing. Gauze is manufactured as bandages, sponges, tubular bandages and stockings. Improvement in low-linting and absorbent properties. Gauze is still a standard of care for chronic wounds Polyurethane foam accompanied by vacuum negative pressure in the wound bed Wound filled with foam and sealed with a film. Vacuum is obtained over wound
Cotton gauze may be wetted with saline solution to confer moist properties. Possesses a slight negative charge, which facilitates uptake of cationic proteases. Absorbent and elastic for mobile body surfaces
The dressing which is porous nonabsorbent and inert is designed to allow the passage of wound exudate for absorption by a secondary dressing
Heavily exudating wounds, including chronic wounds as leg ulcers, pressure sores, fungating carcinomas. Wounds containing soft yellow slough, including infected surgical or post-traumatic wounds
Deep wound to stimulate the growth of granulation tissue
For chronic wounds it fills deep wound defects and is useful over wound gel to maintain moist wound; needs to be packed lightly. May traumatize wound if allowed to dry
Shallow or superficial wounds with minimal to moderate exudate
Heavily exudating wounds
60
Advanced textiles for wound care
consider, such as: (1) location, (2) size, (3) wound depth, (4) exudates amount, (5) infection, (6) frequency and difficulty of dressing change, (7) cost, and (8) comfort. Traditional products like gauze and tulle that account for the largest market segment are passive products. Interactive materials composed of polymeric fi lm products are mostly transparent, permeable to water vapor and oxygen but impermeable to bacteria. These film products are recommended for low exuding wounds. Bioactive dressings are ones that deliver substances active for wound healing; either by delivery of bioactive compounds or the dressing is constructed from a material having endogenous activity. These materials include proteoglycans, collagen, noncollagenous proteins, alginates or chitosan.
3.7
Types of dressings available
The range of dressing products is so large that there is potential for confusion when deciding which one to use. No single product is suitable for all types of wound and, when deciding which dressing to use, it is important to assess the wound and the stage of healing. Specific objectives must be identified; for example, if a wound is sloughy, the prime objective will be to de-slough by absorbing exudate; if the wound is clean and granulating, the aim will be to provide a moist environment to aid in healing. If the wound has a large cavity, it must be plugged. Based on considerations such as these, the available range of wound care materials can be described as below. 24–28
3.7.1
Gauze dressings
A gauze is a traditional dressing and is still one of the most widely used product. In general, it is used for many purposes: skin preparation, cleansing, wiping, absorption, and protection. It can be either woven or nonwoven. Cellulose fibers (cotton and rayon) are the typical materials used in making gauze. Synthetic fibers, in particular polyester, are also employed to modify properties and reduce cost. If woven, the pattern used is plain but it can vary from loose to tight. The non-woven dressings are highly homogeneous and soft. Figure 3.4 shows a comparison between a woven gauze and a non-woven sponge. Gauze comes in pad, strip, roll, and ribbon form and is easy to handle; it packs easily which makes it a good choice when the wound is located in hard to reach areas. Gauze can be dry, moist, or impregnated. There are some disadvantages associated with the use of gauze: it is not a good thermal insulator and, when removed, it can cause damage to the wound. The damage occurs because the fibers of the gauze get embedded into the wound exudates and when removed it often peels off some of the newly
Textile materials and structures for wound care products
61
3.4 Woven and non-woven gauze. 29
formed epithelium. Impregnation of the fabric in a suitable compound alleviates this difficulty. Dry gauze Dry gauze, which is perhaps the most widely used material in home care, is used as a cover, as a means to prevent contamination, or to trap and lessen exudate. It is used as a primary absorbent dressing on a wound with a high amount of exudate. It is also used on closed wounds to prevent infection or additional trauma. The main problem encountered with gauze is that it tends to adhere to the wound and when removed from a large lesion may pull some of the newly formed tissues with it. If not being used for mechanical debridement as described below, it should be moistened before removal if it appears to be dry and adherent to the wound. Moist gauze This type of product is used to help maintain a moist environment and most often to promote granulation or protect a granulating wound, which is one of the fi rst visual signs of healing. 30 It has been noted that ‘wet-to-dry’ and ‘wet-to-moist’ gauze dressings are often used in practice in a way that makes them indistinguishable. 31 In fact, it should be noted, they have two different end purposes. Wet-to-dry dressings have been traditionally used as a means of mechanical debridement. The Agency for Healthcare Research and Quality has promoted the use of these for the debridement function. However, there are a variety of alternative methods for debridement, for example surgical debridement (when such is possible) and debridement using proteases, including collagenase-based and papain/ urea-based formulations. The wet-to-dry gauze method for mechanical debridement is a controversial method as it is known to cause pain to the patient on removal. On the other hand, the wet-to-moist gauze is used for creating moist wound healing. For treatment of open ulcerating wounds,
62
Advanced textiles for wound care
gauze is made moist by soaking in normal saline. Normal saline dressings, which are still a standard of in-home and nursing home care, appear to act as an osmotic dressing. It has been shown that the osmolarity, sodium and chloride concentrations in dressings, placed on chronic wounds, remain relatively isotonic with time. The reason for this is that the dressing as a result of evaporation increases its tonicity. This draws fluid from the wound into the product so that a dynamic equilibrium occurs and the dressing regains isotonicity. Thus, the dressing remains functional for as long as it removes fluid from the wound. Impregnated gauze Further work has been done to fi x the limitations of gauze by impregnating it with substances that promote wound healing. Substances currently used include; hydrogels, saline, and antimicrobial agents, as well as a wide variety of other materials, including paraffi n wax. One such gauze, known for its vast improvement, is referred to as ‘Smart Gauze’, and has been found to be both super-absorbent as well as non-adherent to the tissue. Both the moist and the impregnated gauzes fall into the category of advanced occlusive dressings.
3.7.2 Impregnated dressings With the work of Lister in 1867, in which bandages were impregnated with carbolic acid, the use of antiseptic treatment arose, and, shortly thereafter, Joseph Gamgee produced the fi rst composite product containing cotton or viscose fiber medicated with iodine. 32 Some of these dressings are still in use. These materials include gauzes and non-woven sponges, ropes and strips saturated with either saline, hydrogel, or other wound-healing promoting compounds, including peptides, polysaccharides, alginate, copper ions, and collagen. They are non-adherent and require a secondary dressing.
3.7.3 Transparent film dressings Films are homogeneous materials, which come in different thicknesses and consist of a polymer sheet that has one adhesive side. Film dressings are acceptable coverings for superficial wounds; being impermeable to liquids, water and bacteria, but permeable to moisture vapor and atmospheric gases, makes them suitable for use as occlusive structures. Because of their transparent nature, the fi lms facilitate visual inspection without having to remove the dressing. They are applied to partial thickness wounds with very little or no exudate. They are also used to manage intravenous (IV) sites, lacerations, abrasions and second-degree burns.
Textile materials and structures for wound care products
63
3.7.4 Composite dressings These dressings combine physically different components into a single product and provide multiple functions, such as bacterial barrier, absorption, and adhesion. The dressings, comprising multiple layers, have a semiadherent or non-adherent contact layer that covers the wound and may include an adhesive border. The inner is the contact layer that is designed to accept the fluid and allow it to pass into the layer above where it is absorbed and held. The outer most layer is designed for protection and to secure the dressing to the skin. They are used as primary or secondary dressing; the latter, for example, for daily applications of creams, ointments etc. An example of how different types of carbohydrate combinations, involving cellulose, alginate and other components, can be designed into composite dressings is shown in Fig. 3.5.
3.7.5 Biological dressings In 1975, Rheinwald and Green33 developed a method that made it possible to cultivate human keratinocytes so that a 1–2 cm 2 keratinocyte cultured graft could be generated in about 3 weeks. This work paved the way for the eventual development of skin substitutes and biomaterials with wound interactive properties and biological activity, which have progressed
ids
and s ug dress ar-based ings Fillers
llo co
dro hy
nd dre con ssi tact ng lay
nd
ea
ls a
uz
ge
dro
ings
dress
Ga
Hy
rbing
Crosslinking chemistry
r-abso
Cotton dressing
Odou
er
Carbohydrate-based dressing
Carbohydrate-based Alginates and Charcoal cloth hydrogels and dextranomer beads/ dressing carboxymethyl cellulose sucrose and honey
Composite dressings that enhance the properties of both alginate and cotton while incorporating proteasesequestering properties
3.5 Various materials from carbohydrate sources present in wound dressings may be combined to form composite dressings with enhanced properties.
64
Advanced textiles for wound care
from the mid-1990s through the present. Biological dressings are derived from a natural source. Collagen dressings, derived from bovine, porcine, or avian sources, fall in this group. All these products are meant to accelerate healing. The biological dressings are available in many forms, including gels, solutions or semi-permeable sheets. While gels and solutions can be applied directly to the wound surface and covered with a secondary dressing, the sheet form can be simply used as a membrane and left in place for undisturbed healing. Biological dressings are indicated to be used for partial thickness wounds such as burns, abrasions, donor sites, skin tears, etc. Skin substitutes that also fall under this category are being increasingly used. These contain both cellular and acellular components that appear to release or stimulate important cytokines and growth factors that have been shown to be associated with accelerated healing. 34 Some basic materials may also play a role in up-regulating growth factor and cytokine production and blocking destructive proteolysis. In this regard, the biochemical and cellular interactions that greatly promote healing have only recently been elucidated for some of the occlusive dressings described in Table 3.1. Some carbohydrate-based dressings stimulate growth factors and cytokine production. For example, certain types of alginate dressings have been shown to activate human macrophages to secrete pro-inflammatory cytokines. 35 Interactive dressing materials may also be designed with the purpose of either entrapping or sequestering molecules from the wound bed and removing the components responsible for deleterious activity from it as the product is removed, or stimulating the production of beneficial growth factors and cytokines through unique material properties. They may also be employed to improve recombinant growth factor applications. The impetus for material design of these dressings derives from advances in the understanding of the cellular and biochemical mechanisms underlying healing. With the knowledge of the interaction of cytokines, growth factors and proteases in acute and chronic wounds, 35–38 the molecular modes of action have been elucidated for dressing designs as balancing the biochemical events of inflammation. The use of polysaccharides, collagen, and synthetic polymers in the design of new fibrous materials that optimize wound healing at the molecular level has stimulated research on dressing material interaction with wound cytokines, 34 growth factors, 39–41 proteases,42–45 reactive oxygen species,46 and extracellular matrix proteins.45
3.7.6 Absorptive dressings Absorptive dressings are usually multilayer wound dressings which provide either a semi-adherent quality or a non-adherent layer. They are combined with highly absorptive layers of fibers such as cotton, rayon, etc. These
Textile materials and structures for wound care products
65
dressings are designed in a way so as to minimize its adherence to the wound so that the secondary trauma is as less as possible. These dressings are generally used as primary or secondary dressings for surgical incisions, lacerations, abrasions, burns, skin grafts or any draining wound.
3.7.7 Alginate dressings These advanced absorbent dressings are non-woven, non-adherent, pads and ribbons composed of natural polymers derived from brown seaweed. Alginates provide many benefits for use as dressings: they swell and retain large amounts of water (100 to over 1000% of their dry mass), thus providing an optimal moist environment; the act of swelling and diffusion throughout the gel allows the wound exudates to be absorbed, which, in turn, speeds up healing; and, because of the wet structure, the dressing does not stick to the wound bed and cause secondary trauma upon removal. The alginate dressing can be applied either pre-wetted, to supply a desiccated wound with moisture, or dry, to aid in the absorption of exudates. They must, however, be used with a secondary dressing. As for the mechanism, when a dry mass of the material is applied to the site, it begins to absorb exudates during which a reversal in the ionexchange process (from calcium ion in the dressing to sodium ions in the blood and exudates) occurs. This transforms the water-insoluble calcium alginate into water-soluble sodium alginate, thus absorbing a large amount of fluid.47 The moist gel formed fi lls and covers the wound. The process is also said to make the dressing an excellent hemostatic agent, thus promoting clotting.48 For dressings, alginates are made as ropes for packing deep wounds and as sheets for treating shallow wounds. Alginate dressings act as a antimicrobial by absorbing micro-organism-infected exudates, which are then removed when the dressing is changed.47
3.7.8 Chitosan dressings Chitosan is well known for its haemostatic properties and its bacteriostatic and fungistatic behaviors, all of which are particularly useful for wound treatment. As a haemostat, chitosan helps in natural blood clotting and in blocking of nerve endings, thereby reducing pain. The polymer gradually depolymerizes to release N-acetyl-β-d-glucosamine, which initiates fibroblast proliferation, helps in ordered collagen deposition, and stimulates an increased level of natural hyaluronic acid synthesis at the wound site. These processes aid in increased wound healing and decreased scar formation. Figure 3.6 gives a schematic representation of the mechanism by which chitosan works. It shows that chitosan, which is a polymeric amine, becomes
66
Advanced textiles for wound care
3.6 Haemostatic properties of chitosan.49
positively charged when wet and attracts the negatively charged ions in blood and exudates.49 Such attraction allows the material to clot blood quickly and also to act as an antibacterial agent on account of it attracting the negatively charged particles, including bacteria (Fig. 3.6), which are then removed at the dressing change.47 An increase in healing rate of as much as 75% has been reported.48 Because of the similarities in the chemical structures between chitosan and cellulose, the two are frequently mixed at both the polymer and the fiber levels. Such blending allows a manufacturer to engineer products with desired properties at lower cost. An example of a commercial product is 25% chitosan and 75% rayon. The improved fiber properties obtained allow the material to be converted into dressing by knitting, weaving or one of the available non-woven processes or by casting the polymer into a fi lm. The functionality of the polymer also allows it to have built-in compounds that provide additional antimicrobial, and even deodorizing, characteristics. 50 One of the heaviest uses of chitosan is in making dressings for use by military in the combat zone. The claim of a product is that it will bond with the blood in 1 to 5 min and will also form an adhesive-type structure to protect the wound until access to a medical facility becomes available. Such quick response is needed in managing combat related injuries, as nearly 80% of all battlefield deaths result from bleeding in less than 10 min.49 More specifically, chitosan has been developed as a sponge for use in controlling lethal extremity arterial hemorrhages in arteries. 51
Textile materials and structures for wound care products
67
Chitosan is among a number of currently deployed haemostatic agents used within the armed services and has recently been contrasted with other materials for its efficacy in this application. 52,53 Chitosan-based haemostatic products have also been compared with the more highly ordered crystalline structures of glycosaminoglycan materials54 to learn more about the relative roles that carbohydrate structure and charge play in eliciting haemostatic activity. In addition to its use in fabric or fi lm form, the material may also be incorporated into dressings in the form of powder and beads, and it has been grafted onto cotton to study its antimicrobial and haemostatic activities.
3.7.9 Chitosan/alginate bicomponent fiber dressings Some wound products even combine chitosan and alginate to form a fiber. 55 With these bicomponent fibers (Fig. 3.756), the positively charged chitosan on the outside attracts the negatively charged microbes on the skin, promoting antimicrobial activity. The alginate polymer inside is still able to absorb the exudates. Thus, a non-toxic, biocompatible, absorbent and antimicrobial wound dressing could be made that combined the best attributes from both polymers to generate a faster healing product for large exuding wounds.
3.7.10 Hydrocolloid dressings Hydrocolloid dressings can have various compositions, but the most common composition has a backing (outer layer) of either a vaporpermeable fi lm or thin sheet of foam on which a mixture of sodium carboxymethyl cellulose, elastomers, adhesives and gelling agents are coated. Once the dressing is fi xed on the wound, the warmth softens the lining of the dressing providing a gel cover for the wound bed. Hydrocolloid dressings are able to absorb a minimal amount of wound exudate and once its capacity is reached the remainder may leak out from under the dressing, termed ‘strike-through’. The strike-through can be fast and, Chitosan Alginate
3.7 Core-sheath alginate/chitosan.56
68
Advanced textiles for wound care
therefore, these dressings are best suited for rehydrating dry black/ brown necrotic tissues and wounds containing dry yellow slough. The hydrocolloid dressings are available in many shapes and some also have an additional adhesive border to prevent leakage or sliding of the dressing over the wound.
3.7.11 Hydrogel dressings There are two types of hydrogel dressings. Amorphous gels Amorphous gels donate moisture to a dry wound and are, therefore, used for rehydrating dry necrotic or sloughy tissues and keeping granulation tissues moist – in much the same way as do the hydrocolloids. If the wound is sloughy and wet, this dressing will not be suited for the application. The amorphous gels come in a variety of forms and some have hydrocolloid or alginate added in an attempt to make them better at debriding or coping with wet wounds. The amorphous gels require a secondary dressing, usually a vapor-permeable fi lm. The viscosity of amorphous hydrogels contributes to its function, and its ability to maintain integrity after absorbing wound fluid determines its role in moist wound healing. Less viscous types liquify after absorbing small amounts of exudate, and thereby add fluid to the wound. The more viscous types, on the other hand, maintain their structure and form a protective barrier over the site, thereby sequestering wound fluid and increasing the bioavailability of the exudate constituents, including proteases, for autolytic debridement and wound repair. Non-amorphous gels The non-amorphous gels provide a moist interface at the wound bed but do not donate as much water as do the amorphous gels and are, therefore, not the fi rst choice for rehydrating a wound. However, they do provide a moist cover for granulating wounds. They are very soothing to wounds, making the dressings particularly suitable for use on superficial burns, including those caused by radiotherapy reactions. As they are gentle on removal, they are also suitable for use on easily damaged skin. The sheet gels come in adhesive and non-adhesive versions. Foam dressings Foam dressings usually consist of coatings of foamed solutions of polymers on sheets. The foam has small and open cells capable of holding fluids. Their absorption capacity depends on the thickness of the layer, and the material. Foams are permeable to gases and water vapor, but not to aqueous
Textile materials and structures for wound care products
69
solutions and exudate. Foams absorb blood and tissue fluids while the aqueous component evaporates through the dressing. Cellular debris and proteinaceous material are trapped in the material. These dressings are generally used on partial and full thickness wounds.
3.7.12 Antimicrobial dressings Almost any type of dressing, i.e. sponge, gauze, film, or absorptive, can be made to have antimicrobial properties by incorporating agents such as silver and iodine. Silver is easily incorporated into chitosan and alginate products, thus greatly enhances their antimicrobial protection for the wound. A unique benefit of using silver in dressing is that it is highly effective in minute amounts (∼1 ppm).47
3.7.13 Silicone dressing These are atraumatic dressings (they do not cause trauma to newly formed tissue or tissue in the peri-wound area) based on soft silicones, which are a particular family of solid silicones, that are soft and tacky, and which, therefore, tend to adhere to dry surfaces. A silicone dressing consists of a contact layer that is coated with silicone. These materials are inert and their main attribute is that they can be removed from a sensitive wound without causing trauma. The exudates can also be absorbed but this is accomplished by using an absorbent dressing that is given a coating of silicone. These dressing are particularly recommended for use as the first-line prophylactic treatment against development of hypertrophic scar and keloid after surgery. 57
3.7.14 Categories based on the management of moisture The dressings discussed above can be further grouped into three main types:16 Dressings that absorb exudates Absorbent dressings have a very high capacity for holding fluid. Hence, for a wound generating high levels of exudate, absorbent dressings will require fewer changes within a set period of time. Two of the materials that can support this function are the alginate and the foam products. Dressings that maintain hydration As a wound heals more, its exudate generation becomes less. This is when the wound starts to granulate or fi ll in with new connective tissue. When exudate levels decrease, it is not advisable to use absorbent dressings as
70
Advanced textiles for wound care
they may result in the dehydration of the tissues. In such a situation, all that is required is to maintain the hydration level. The hydrocolloid and the fi lm products are suited for this application. Dressings that donate moisture When wounds are completely dry, they become covered by a layer of dead tissue, which needs to be removed to allow the wound to heal optimally. Often such tissues are removed by autolysis debridement which is slow digestion of the dead cells by enzymes. In such cases, maintaining a moist environment helps the process. The dressing should actively add moisture to the wound, and this is best performed by a hydrogel material.
3.8
Bandages
The functions of bandages are to (1) hold a dressing in place, (2) apply compression in some applications, such as to arrest bleeding in heavily hemorrhaging wounds or to treat varicose vein or leg ulcers, (3) immobilize fractures, (4) tie anesthetic tubes, and (5) hold cuffs, masks and other parts of textiles worn by a medical person for personal protection, safety or ease of mobility. Commonly, bandages performing a load-bearing function are made up of knitted or woven textiles, some containing elastomeric threads for required stretch and recovery force. Many types of products are available, including relatively inextensible, highly extensible, adhesive/cohesive, tubular, and medicated paste bandages. 58 The non-extensible bandages, essentially woven with open weave for breathability and low weight, are used for holding an absorbent pad or dressing in place at sites where stretch is not required, for example finger, arm or lower leg, tying anesthetic tubes and drains in position, and holding up a surgeon’s trousers. The extensible bandages are used for retaining a dressing and applying compression for control of edema and swelling in the treatment of venous disorders of the lower limb. The bandage should keep the dressing in close contact with the wound, and not inhibit movement or exert significant pressure that causes pain or restricts blood flow. The compression dressing falls in a class by itself and is used primarily for treatment of varicose vein ailment. The optimum pressure needed varies with condition and place on the leg. The highest pressure is required at the ankle and the lowest on the upper thigh. Stockings in different sizes and having various mechanical properties are now available to fit a range of patients and provide gradient pressures of magnitudes suited for different specific categories of venous disorders. The pressures used are as low
Textile materials and structures for wound care products
71
as 14 and as high as 40 mm Hg. Mathematical analysis gives the bandage pressure P (Pa) on the surface as a function of the bandage tension T (N)– itself a function of the extension and the elastic modulus–, the radius of curvature of the limb R (m) and the width of the bandage W (m) as: P=
T RW
[3.1]
As the effects of superimposed layers are additive, a configuration involving two turns of a bandage will essentially double the pressure. Because the bandage pressure is inversely proportional to R, wrapping a bandage at a given tension T will give the highest pressure at the ankle, where R is lowest, medium pressure at the calf, and the lowest pressure at the thigh. Adhesive bandages are made of woven cotton or rayon fabric that is coated with a suitable adhesive. Highly twisted or crepe yarns in warp provide a degree of stretch and elasticity to the bandage that can serve as a structure for treatment of varicose veins and for immobilizing orthopedic fractures resulting from sport and other injuries. Cohesive bandages combine some of the characteristics of ordinary stretch bandage with those of adhesive products. Whilst they do not adhere to the skin, a special coating on the surface enables layers to adhere to each other, thus preventing slippage and untying during use, including sports activity. The simplest form of a tubular bandage consists of a knitted tube of a lightweight fabric. These are used under orthopedic casts, or placed over arms or legs that are covered with a medication. In summary, it is clear that bandages are more directly textile structures that supplement dressings in treatment of wounds, both external and internal.
3.9
Materials used in dressings and bandages
A number of polymeric materials are used as fi lms, fibers and other structures for developing wound-dressing products. Some of the primary materials employed are cotton, rayon, polyester, nylon, polyolefi ns, acrylic, polyurethan, chitosan and alginate. No doubt some other materials have been considered, for example recombinant silk, but for economic or technical reasons, they have either not passed beyond the experimental stage or are used in a limited way. A brief introduction to the chemical nature, the physical structure and the properties of the materials used in wound management products follows. An understanding of these can provide the manufacturer with a means of selecting the most appropriate material for a dressing for each different application.
72
Advanced textiles for wound care
3.9.1 Cotton The fiber that has been historically the most highly used in construction of dressings, absorbent pads, and bandages, is cotton, which still accounts for a significant volume of wound-care products in the world. The chemical structure of one repeat unit of the cellulose chain is shown in Fig. 3.8. Each repeat has three hydroxyl groups that are capable of linking with neighboring chains by hydrogen bonds. These groups, when free or weakly bonded, also attract and bond with water. The oxygen bridges between the repeat units allow chains to bend and twist, making the polymer flexible. The chains are quite long, and the fiber has over 60% crystalline structure. The most commonly used cotton in wound products is short (<2.5 cm). The cross-section is kidney bean shaped, i.e. relatively flat, but it becomes round when swollen with aqueous fluids. Once the waxes and impurities, normally present on raw fiber, are removed by a chemical scouring/ bleaching step, the fiber surface becomes greatly hydrophilic and instantly wettable. Under ambient conditions, the material has a moisture regain (mass of water absorbed per dry mass of fiber, expressed as percentage) of about 8%, but when soaked can take up to about 30% water and swell significantly. One unique characteristic of cotton that separates it from other fibers is that it becomes stronger when wet. This makes the fiber preferred for use in towels, pads, sponges, swabs and many other absorbent wound care and surgical products, where mechanical integrity along with absorption are important. With an abundance of functional groups on the chains, the structure can be chemically modified to incorporate additional hydrophilic groups to enhance the fiber’s absorptive properties, or therapeutic agents for imparting antibacterial or healing characteristics. The highly absorbent carboxymethyl cellulose (CMC) is a cellulosic material (usually based on wood fibers) that has been grafted with groups such as acrylic acid and which allows the structure to swell enormously and absorb many times the fiber’s weight in water.
3.9.2 Rayon The fiber, although chemically similar to cotton (Fig. 3.8), differs from it in physical structure: rayon’s molecular weight is about one-fifth and crystallinity about one-half of that of cotton. These differences make rayon relatively weaker and more extensible, but more absorbent (about two times) than cotton. Thus, under ambient conditions, the fiber absorbs about 14% moisture, and when soaked, can swell and absorb almost 70% by weight water. The fiber, however, becomes significantly weaker when wet and, therefore, requires care when used directly on open wounds. One of the major applications of the fiber has been in disposable absorbent
Textile materials and structures for wound care products
Cellulose (cotton, rayon, lyocell)
CH2OH HH O O OH H
H OH OHH HH O CH2OH
H OH
Elastomer
73
O H O C N R' N C O ( R O )n C N R' N C O H
O
RO – aliphatic structure (n ~ 10–30) R' – ring structure CH2OH HH O O OH H
Chitosan
H
Polyester (PET)
NH2
H
OHH HH O CH2OH
NH2
O CH2 CH2 O
O
O
C
C n
O
Polyamide Nylon 6
O
C (CH2 )5 NH
NH O C
Nylon 66
O
(CH2 )4
NH (CH2 )6 NH
C
n
Polyacrylonitrile
Polyolefin UHMWHD polyethylene
Polypropylene (iPP)
H
H
C
C
H
CN
H
H
C
C
H
H
n
n
CH3
CH3
C
C
CH2
O HO O
3.8 Molecular structures of a fiber.
CH2
H
H
Alginic acid
C n
OH O OH
O O HO m
n
OH OH O
O
n
74
Advanced textiles for wound care
pads, sponges, and sanitary napkins. For use in absorbent dressings, usually a multilayer structure with rayon sandwiched between a permeable wound contact layer and an outer fi lm layer is preferred. Being endowed by even more free functional groups than cotton, desirable compounds can be grafted readily to the material for specific uses.
3.9.3 Polyester Polyester is one of the most versatile of the manufactured fibers that fi nds applications in many categories of textile products and is one of the widely used synthetic fibers in medical products. It is also the fiber frequently selected for combining with cotton and rayon in developing needled and spunlaced non-wovens for dressings. The chemical constitution of the commonly used material, poly(ethylene terephthalate) or PET, is shown in Fig. 3.8. The fiber has an aromatic component and an aliphatic sequence. Although the polymer lacks strong functional groups, the molecules, when drawn, pack closely and lead to a semi-crystalline mechanically strong and thermally stable fiber. Because of the lack of polar groups, the fiber has a low attraction for water (moisture regain ∼0.4% under normal conditions); this makes the material largely hydrophobic. A number of variations of the basic repeat are available but they vary primarily in terms of the proportion of the aromatic and the aliphatic components and, as a result, lead to fibers with different physical and mechanical properties. Some low molecular weight aliphatic polyesters are used as low melt adhesives for binder applications. Aliphatic polyesters capable of hydrolytic degradation are also used in the manufacture of bioabsorbable products, in particular surgical sutures. The polymer can be melt-extruded both as a fi lm and a fiber, the latter in different cross-sectional shapes and sizes to provide materials with various surface, physical, and mechanical properties.
3.9.4 Nylon Although many different types of nylons can be produced, the two widely used are nylon 66 and nylon 6 (Fig. 3.8). The chains, being void of aromatic compounds, lead to fibers that have low modulus and high extensibility. The presence of amide groups in the chains, however, allows hydrogen bonding between NH and CO groups of adjacent chains; this gives the fiber excellent mechanical and thermal stability. The amide groups in the chains also attract water, thus making the fiber reasonably hydrophilic (moisture regain 4%) and wettable. Being one of the most stretchable and elastic of the common textile materials, in addition to being acceptably hydrophilic, nylon is a preferred material for the manufacture of tubular bandages and stretchable pressure hosiery for treatment of venous leg ulcers.
Textile materials and structures for wound care products
75
3.9.5 Polyolefins The two materials of interest are polyethylene and polypropylene (Fig. 3.8). The one based on the simplest of the hydrocarbon polymers, polyethylene, can be produced in the extended form using the gel spinning process. This leads to the extended chain structures with ultra high modulus and tenacity (HMPE) suitable for use in many high-performance technical textiles. In the non-extended folded chain form, the polymer does not have adequate mechanical properties to lead to fibers, but the material can be made into flexible fi lm or low melt adhesive or wax. The second material is polypropylene which is also made into fiber and fi lm. For making fibers, the chains must be in a stereo regular form. The olefi n fibers have the lowest density (0.91–0.96 g cm−3) of all fibrous materials. Both materials being strictly hydrocarbons are truly hydrophobic and, therefore, do not wet. They also have very low surface energy (∼24 mN m−1), which, among textile polymers, is only higher than that for polytetrafluoroethylene (∼12 mN m−1). Accordingly, olefi ns generally lead to lowadhesion fi lm products, which are used for developing low-adhesion contact layers for dressings. The fibers also have low melting points (<175 °C), which vary with chain length and, in the case of polypropylene, with tacticity. Accordingly, olefi ns are frequently used as low-melt coatings on regular fibers or as binder fibers for making fabrics by the non-woven methods. In dressings, the polymer fi nds extensive use in the development of contact layer fi lms.
3.9.6 Acrylic The chemical structure of the basic polymer is illustrated in Fig. 3.8. The pendant acrylonitrile groups (C≡N) are highly polar and lead to extensive bonding between chains. Because of this, a second component, up to about 15% by weight, which is another vinyl monomer, e.g. methyl acrylate or vinyl acetate, is inserted into chains to improve polymer solubility for extrusion into fiber. The fiber, with only about 2% moisture regain, has limited interaction with aqueous fluids. A major attribute of the fiber that particularly suits its use in dressings is its naturally high resistance to colonization of micro-organisms.
3.9.7 Elastomeric fibers The unique characteristic of elastomeric materials, whether used as shaped fibers or fi lms, is that they are soft and highly stretchable and elastic. The synthetic elastomers are linear block copolymers containing soft amorphous sections that provide stretch and hard crystalline components that
76
Advanced textiles for wound care
3.9 Illustration of fine structure in elastomeric fibers, composed of blocks of crystallizable hard segments and non-crystallizable coiled soft segments.
act as tie points and hold the structure together in a memory-endowed mechanically stable material. These polymers are usually known as the segmented polyurethanes, whose general chemical structure is given in Fig. 3.8. The hard segments of neighboring chains tend to associate with each other and crystallize, while the soft segments remain largely coiled and unassociated (Fig. 3.9). Stretch of the order of 100% or more is common. The material being elastic and having the ability to return back to its original shape and size, its major application is in developing products that are required to exert transverse pressure of the required level for treatment of skin disorders. Thus, using elastomeric fibers in a bandage, one can keep an absorbent dressing pressed on a puncture wound to stop bleeding, or in hosiery one can apply desired pressures on different parts of leg to treat venous disorders.
3.9.8 Chitosan Chitosan is a natural biopolymer and is derived from chitin. The latter is the second most abundant natural polysaccharide on earth, with cellulose being the fi rst. It is found in the shells of crabs, shrimps, prawns and other crustaceans. While chitin itself can be used in dressings, it is its deacetylated derivative chitosan that is used extensively in this application. Figure 3.10 shows the difference between chitin and chitosan, where the acetyl group is eliminated and replaced with an amino group. 59 The degree of substitution varies from product to product but is typically about 80%.60 The modification makes the material a poly(β-(1-4)-2amino-2-deoxy-d-glucopyranose), which is a polycationic biopolymer that is also found in some insects and species of fungi.48 The deacetylation process provides open groups that cause the chemical and biochemical reactivity of chitosan to be relatively much greater and is one reason why
Textile materials and structures for wound care products OH
OH O
OH O
O O HO
HO
77
O
O HO
NH
NH
NH
C=O
C=O
C=O
CH3
CH3
CH3
Chitin
OH
OH O
OH
HO
O
O O HO
O
O HO
NH2
NH2
NH2
Chitosan
OH
OH O
OH
O HO
HO
O
O
O
O HO
OH
OH
OH
Cellulose
3.10 Chitin, chitosan and cellulose.
this form is used more frequently. Another reason is that chitosan is more soluble than chitin. Chitosan-based composite fi lms are gaining attention for their ability to stop bleeding in wounds and promote healing. Chitosan is biodegradable, biocompatible, non-toxic, and has great antibacterial properties. Its properties make it an excellent choice for many medical applications. As a fiber or fi lm it is used for wound care, and, in microcapsule or bead form, it is utilized for drug delivery.61 For use as a fi lm, that has some mechanical integrity, chitosan is mixed with another polymer.62
3.9.9 Alginate Alginate is a natural polysaccharide which is derived from brown seaweeds.63–65 It has been used for a variety of purposes, ranging from thickening agents in food, to pharmaceutical additives. It is a block copolymer made up of 1,4-linked b -d-mannuronic acid (M) and a-l-guluronic acid
78
Advanced textiles for wound care COO– O
COO–
OH O
OH
OH O
–
OOC
OH
O HO
OH
COO– G
G
O
O
OH O
OH
O
OH
O
O
OH
COO– G
G –OOC
O
OH
O
HO O
O
OH OOC M
O O
HO
–
M
M –OOC
OH O –OOC
O
HO O O
O HO M
HO O
O
HO
OH COO– G
M
3.11 Mannuronic (M) and guluronic (G) block structures in alginate polymers.65
(G) residues (see Fig. 3.11 for stereochemical structures). There are three block structures present: M/M blocks, G/G blocks and M/G blocks. There are a variety of seaweeds that alginate is derived from and each species has a different composition of the acids. These result in a range of properties found in the material. Those containing a higher percentage of gluronic acid tend to be stronger and stiffer than the ones containing a higher percentage of the mannuronic acid. The latter, however, tend to have better swelling properties. In order to achieve alginate fibers from seaweeds, sodium alginate must be extracted from crushed and washed raw material. The sodium alginate is soaked in water where a viscous solution is formed which is then extruded into a calcium chloride bath. In the process, the sodium ions are replaced by the calcium ions. After washing and drying of the gel, the insoluble calcium alginate fibers remain.66 Webs containing the fibers may be composed by fi rst airlaying or carding-cum-crosslapping and then needle punching, to make the dressing. Fibers may also be converted into knitted or woven fabrics or assembled in a rope form. When the calcium alginate dressing is used on a wound, a reverse ion-exchange process takes place. The sodium ions in the blood and wound exudates are exchanged with the calcium ions in the alginates.66 Moisture is necessary for the alginate dressings to work properly, which is why they will not be beneficial on dry wounds and are used mainly on heavily exuding wounds.
Textile materials and structures for wound care products
79
During production, other desired molecules can be introduced resulting in altered physical and chemical properties. For instance, silver, chitosan, and other antimicrobial molecules can be integrated either physically during fiber formation or chemically by grafting them onto the alginate chains.67 Molecules are also frequently added to improve the mechanical properties of the dressing. The fibers produced can be processed to form a non-woven mesh by one of the methods available.
3.10
Textile processes involved in formation of dressings and bandages
3.10.1 Introduction Dressings are made from polymers and fibers in a variety of types. The form in which these materials are used may be film, rope, ribbon or fabric. The latter are made by a weaving, knitting, braiding or a number of non-woven processes. Unless the product required is primarily load bearing, the fabric used is most likely the non-woven. The latter is usually soft and bulky and is porous and absorbent. Non-wovens are also homogeneous and most economical to produce. Films used as dressings are also non-wovens, but they are cast or extruded directly from polymer. These are thin and flexible but usually not as three-dimensionally drapeable and conformable as are the woven and the knitted fabrics. The same limitation also applies to the regular non-woven fabrics, i.e. they lack drape and conformability. A description of the methods of forming fabrics for dressings is given below. Since the non-woven fabrics are the largest used in forming dressing products and there are several technologies involved in making these fabrics, a more detailed description is presented of these processes and the structures made from them.
3.10.2 Yarns Fibers or fi laments obtained from extrusion of polymers are twisted (for short fibers) or entangled (for continuous fi laments) to form a continuous thread that has mechanical integrity enough to support stresses imposed on them during their weaving, knitting, or braiding into fabrics. A typical short fiber or staple yarn will contain about 100 individual fibers in the cross-section and have a diameter of the order of 0.2 mm. These onedimensional structures are therefore quite strong and flexible.
3.10.3 Woven fabrics A significant fraction of gauze fabrics are based on woven structures. These fabrics are manufactured on a loom that has a running sheet of yarns,
80
Advanced textiles for wound care
Filling cross-section
Warp cross-section
3.12 Plain weave and leno weave.
known as warp, within which are inserted cross-threads, known as weft, at right angles. The woven fabrics used in wound management applications have the simplest structure called plain weave, shown in Fig. 3.12. Woven fabrics are relatively inextensible but dimensionally very stable structures with porosity that can be varied from nearly zero value to very high value (gauze, cheese cloth). A major problem with the woven fabric is the tendency of threads to unravel at the cut edge. A special weave know as ‘Leno’ in which two warp threads twist around a weft reduces this tendency.68
3.10.4 Knitted fabrics Knitted fabrics are categorized as either ‘weft’ or ‘warp’ constructed. Of the two, the faster and the more economical to produce is the weft knitted fabric that can be accomplished with a single package of yarn. The warp knitting process, on the other hand, requires a warp beam, i.e. a running sheet of yarns as does the weaving process. Loops are formed transversely in the case of the weft knitting and essentially vertically in the case of the warp knitting (Fig. 3.13). Simplest or plain weft knits tend to be very extensible and dimensionally unstable. One could improve on these properties by using additional yarns that interlock the loops. In contrast, the warp knitted structures are basically more interlocked and dimensionally stable. The knitted fabrics are more flexible, compliant and conformable than the woven fabrics, and one of them, the warp, also does not unravel as easily when cut to fit an application. A major limitation of knitted fabrics in some applications is porosity which, owing to the nature of the loop structure, tends to be high. The knitted nets and bandages can be draped more effectively than woven materials over areas that require three-dimensional conformability. One of the primary applications of knitted structures in wound care is in compression hosiery used for treatment of venous stasis.
Textile materials and structures for wound care products Face wale
81
Back wale
1 х 1 rib
Half-tricot structure
3.13 Weft knit and warp knit structures.
3.10.5 Braided fabrics Although not used as extensively as the other two types in wound care, the braided fabrics are unique structures that are particularly suited for producing small diameter tubular and mechanically stable rope structures, the latter suitable for packing cavity wounds. The braids (Fig. 3.14) resemble woven fabrics except that the crisscrossing is not at right angle. One can have flat braids and tubular braids, the latter with and without a core. The braids are mechanically stable structures like the woven, but they are more flexible and conformable than the woven. The criss-crossing pattern in braids also leads to porosity.
3.10.6 Non-woven fabrics As a major function of dressings is to provide a soft and resilient hand, absorb and retain exudates, if present, and serve as a protective covering, non-woven structures suit the application and fi nd extensive utilization in the products. Such structures have been used as the facing, as well as the entire absorbent pad of a wide variety of dressings. These fabrics (Fig. 3.15) differ from woven and knitted in that the former are more homogeneous, softer, and more resilient, than the latter. The processes involved are also faster and more economical. A reason for the latter is that the fabric is made directly from the fibers, without the intermediate step involving the yarns, or even from the polymer itself. Many different types of processes are involved in the manufacture of non-wovens used in wound care products. These lead to different structures
82
Advanced textiles for wound care
(a)
(b)
3.14 Braided structures a) without and b) with core.
3.15 Non-woven fabric.69
and properties and, therefore, suit different functions of a dressing. Accordingly, it will be useful to include here an introduction to the different processes involved and the structures produced by them. Considering that there is a high similarity between the design of an advanced multi-layer composite dressing and an engineered absorbent sanitary product (napkin, diaper, or an incontinence pad), a highly relevant but detailed discussion of non-woven processes, structures produced by them, materials used in producing them, and the properties obtained, can be found in a chapter, titled ‘non-wovens in absorbent materials,’ by Gupta and Smith.70
Textile materials and structures for wound care products
83
A non-woven fabric consists of a web based on fibers or fibrils. A binder may be incorporated to hold fibers more fi rmly and provide mechanical integrity and strength as required. The manner in which the fibers are assembled into a web and bonded has a profound effect on the web properties. A web structure can range from the extremes of a highly oriented fiber configuration produced by the carding process to one of completely random arrangement obtained from the air laying or spunbonding process. An intermediate arrangement obtained by cross-lapping can also be developed. The bonding of fibers is accomplished either mechanically through entanglements, chemically through use of a binder, or thermally through melting and fusing, or using a combination of these methods. A non-woven web is generally considered ‘fi nished’ as soon as the fibers are assembled into an appropriate structure and bonded by one of the methods mentioned. It is possible, however, to give additional chemical or mechanical treatment to the bonded web, which can have an important influence on web characteristics. These include, as examples, a chemical repellent, wetting or antimicrobial treatment, and mechanical embossing, aperturing or glazing treatment. Uni-directional dry form process This is a carding process in which fibers are teased, combed and oriented by wires and formed into a web a few fibers thick, with the fibers predominantly oriented along the longitudinal direction. A structure based on such a web will usually be characterized by good tensile properties in the longitudinal or the machine direction, but poor properties in the transverse direction. Cross-lapping of the web is done to alleviate this deficiency and also to increase its weight. The cross-laying (Fig. 3.16) is done in a continuous manner, often onto another carded uni-directional web. The result is a fiber web with one layer having a uni-directional orientation in the machine direction and the other succeeding layers having a unidirectional web oriented at an angle close to but less than 90° to the machine direction. By proper selection and juxtaposition of the layers of different webs, it is possible to control the orientation in the fi nal web. Random laid or air laid process In this process, individualized fibers are suspended into an air stream, and allowed to be deposited on a moving perforated belt or drum (Fig. 3.17). The web obtained has fibers distributed randomly. In addition to the typical textile length fibers (0.9–2 in.), very short wood pulp fibers (∼0.3 in.) can also be used in this method. The process of deposition prompts some fibers
84
Advanced textiles for wound care Carded web Feed conveyor
Upper conveyor belt Web Lower conveyor belt Delivery conveyor
3.16 Carding cross-lapping process.71
Air Suspended fibers
Random web
Suction
Apron
3.17 Random air laying process.72
to be lifted out of the X–Y plane and become partially oriented in the Z direction. This results in a web having higher bulk and larger void volume, which enhances the web’s fluid absorbing and holding capability. Chemical and thermal bonding of webs A bonding method frequently employed for the dry form web is chemical, involving an acrylic or a latex binder.73 The proprietary formulation will include other ingredients as well, which are a catalyst (for cross-linking), a viscosity modifier, a defoaming agent, and a surfactant. The resin add-on
Textile materials and structures for wound care products
85
can vary over a wide range, but the typical value will lie in the 10–25% range. The binder can be applied by a variety of procedures, including saturation of fabric, spraying the web, or printing binder on the web with a roll. The saturation method is normally not considered for absorbent materials, as the binder covers essentially all fiber surfaces. Spray bonding with careful adjustment of parameters can provide bonding at just the cross-over points, leaving the rest of the web material largely binder free. The placement of the binder resin can be even more finely controlled by print bonding, in which the binder is positioned on the web in a discrete predetermined pattern utilizing engraved rolls74 or a rotary screen. More recently, the use of binder in the form of foam has been utilized.75 This leads to a reduction in the drying cost of the printed web, as the binder is diluted with air rather than water. A modification of the bonding process has also been used, which is suited in particular for the contact layer of the dressing. This involves the use of thermal techniques for bonding.76,77 The fabric contains a blend of low melt fibers (polyethylene and polypropylene) and other fibers, natural or man-made, and is bonded with heat using engraved hot rolls. Another version of the thermal method involves the use of bicomponent fibers that have a higher melting core with a lower melting sheath. When heat is employed by embossed calendar rolls or by hot air, the sheath layers bond. Spunbond process A polymer melt is extruded through a large number of spinnerets to form numerous continuous fi laments. These fall onto a moving conveyer and form a web by overlapping with each other. Fibers are oriented randomly, which is achieved by oscillating spinnerets, field-induced by electrical charges, and/or the controlled flow of air. Webs may be bonded by thermal or chemical means over their entire area to produce a thin, smooth, fabric. Such a structure is stiff, but bonding at strategic points can be used to produce a softer and more flexible fabric. The polymers used in spunbonding are mainly polyester, nylon and polypropylene. Although made from a hydrophobic polymer, the web having a high porosity lends itself to use as a wound contact layer. Print bonding used for dry form non-wovens can also be utilized in bonding these webs.78 The amount of bonding area for a typical spunbond fabric ranges from about 10 to 35%. Needlepunch process In the needlepunch process, in which primarily the cardedcum-crosslapped or random laid webs are used, the bonding is achieved by the penetration of a set of barbed needles through the structure (Fig. 3.18). The barbs are designed such that, as a needle penetrates, groups
86
Advanced textiles for wound care
Stripper plate Fibers
Bed plate
3.18 Needlepunch process with magnified view of the needling action.71,72
of fibers from the top layer of the web are engaged and driven through the thickness of the web. As the needle retracts, the fibers are released from the one-way barbs. This results in mechanical entrapment and orientation of the portions of fibers in the thickness direction. By control of the needle penetration and the repetition of the needling action from the opposite side of the fabric, a three-dimensional, mechanically entangled network can be achieved.79 The process tends to consolidate the web but creates oriented capillaries or channels along the thickness. This imparts resiliency to the web and the capability to efficiently imbibe and hold large volume of fluid. There is a minimum amount of fiber that is required for effective mechanical engagement. Consequently, most needle-felt structures have a weight of 60 g m−2 or more. Wet laid process The wet laid non-woven process bears a considerable resemblance to the paper manufacturing process. Short fibers (generally one-quarter inch or less) are suspended in an aqueous slurry along with minor amounts of other constituents. The slurry is subjected to strong agitation in order to cause the fibers to be uniformly distributed. The slurry is conveyed to a moving wire belt, where the liquid drains through and the fibers are left in the form of a mat in largely random configuration. The web is then removed from the conveyor, taken through a bonding process, dried and then wound up onto a roll. In paper manufacturing usually 100% pulp (∼3 mm) is used and bonding by hydrogen linkages is extensive, which leads to the typical thin and stiff structure. In the wet laid non-woven process, on the other hand, compositions can range from sizeable wood pulp content to a completely synthetic
Textile materials and structures for wound care products
87
fiber furnish. Also, in these structures, usually the fibers used are longer and crimped or convoluted, and the frequency of bonding is lower. This leads to a fabric that is relatively bulkier and softer. If pulp is used as one of the constituents, its fraction and, therefore, the resulting hydrogen bonding, are small. An external binder is often employed to increase strength while maintaining bulk. Bonding is usually achieved by either the chemical or the thermal methods described earlier. Spunlace process This process, which also leads to mechanical bonding, utilizes high-energy, closely spaced, water jets that emerge from an injector and impinge on a web substrate and entangle loose arrays of fibers (Fig. 3.19).80,81 The process is claimed to have the capability of producing a variety of surface and fabric patterns from many different precursor webs made from essentially any fiber that is not too stiff or brittle to bend or move. Figure 3.20 shows a spunlaced web made from a blend of polyester and rayon fibers. The injectors are positioned above the moving backing belt or rotating drums, which are perforated and carry the unbonded web through the unit.82,83 The impaction of water jets forces fibers onto and into the backing belt, giving the fiber web surface the texture of the surface of the belt. If the backing belt has large holes, an apertured web is obtained; if it has very fi ne holes, a web approaching a non-apertured structure is obtained. This versatility associated with the configuration of the supporting belt provides the capability to produce a wide range of surface and structural features in a spunlace fabric. Wood pulp/polyester fiber blended spunlace fabrics were originally the largest volume of products produced by the process; however, other
High water pressure Water jet head Base web Entangled web Web support Drum Air and water return
3.19 Spunlace process.71
88
Advanced textiles for wound care
3.20 Spunlace web from rayon and polyester.
spunlace fabric types have become significant commercial successes, including those based on 100% bleached cotton and its blend with synthetic fibers. In addition to drylaid and wetlaid precursors, a direct-laid web from the spunbonding or meltblowing process has also been used, but usually as part of a multilayer construction. Composite fabrics have been produced by hydroentangling a drylaid or a wetlaid staple fiber web superimposed on a direct-laid fabric that serves as a reinforcing scrim.84 This variant is especially useful in producing a composite of a lightweight spunbound fabric of olefi n or polyester around whose filaments a wood pulp layer has been entangled. This can provide a strong yet absorbent fabric from relatively low-cost raw materials. Modifications of the hydroentangling system have also been used. One such process involves fiber entanglement at a relatively low level, which is still sufficient to convey some mechanical integrity; this is then supplemented by a limited amount (1–5%) of external latex binder, which conveys additional strength and integrity to the structure.85 In another modification, the low level of fiber entanglement is supplemented by adding a small amount (∼15%) of thermoplastic binder fiber. After drying the fabric, additional heat is applied to melt and thus activate the latter. A polyolefi n bicomponent fiber is used for this process, although other binder fibers can also be employed. This same technique, involving addition of a low melt fiber, is now used at times to enhance the physical properties of needle punched fabrics as well.
Textile materials and structures for wound care products
89
A vast majority of spunlace fabrics are produced in basic weights ranging from about 20 g m−2 to about 100 g m−2 . A web of weight less than 20 g m−2 does not develop enough integrity unless an auxiliary means of bonding or very low denier fibers providing high number of fibers are used. Webs weighing more than about 100 g m−2 are usually too heavy to be penetrated by water jets, unless very high energy levels are used. Meltblown process Meltblowing is a unique, one-step process in which the melt of a polymer emerging from orifices is blown into super fi ne fibers by hot, high-velocity air. A molten polymer is blown into ultrafi ne fibers and collected on a rotary drum or a forming belt with a vacuum underneath the surface to form a nonwoven web. Two hot air streams at near sonic velocity at the polymer exit attenuate the extruded stream of polymer (Fig. 3.21). A typical meltblown web contains fibers of a range of sizes (Fig. 3.22); however, typically, the fibers are 1–10 μm in diameter. The fibers are tacky and tend to stick to each other and take the shape of the apron or object on which they are collected. It is recognized that the fibers are weak Heated air
Polymer
Screw extruder Collecor
Gear Die body
3.21 Schematic of a meltblowing process.
3.22 Micrograph of a meltblown fabric showing variable fiber size. 86
90
Advanced textiles for wound care
and the web lacks uniformity. This currently restricts the application of meltblown structures to non-load-bearing products. However, a meltblown web may be combined with a web made by another method and form a composite that not only has improved mechanical properties but also other desirable physical properties. Such products contain fibers of different types and sizes, which can lead to novel structures with properties not possible from a single material or process.87 Although polypropylene has been the material used most widely, other polymers have also been used successfully, these being polyethylene, polyester, and nylon. Essentially, any thermoplastic polymer, including biodegradable, can be used. Polymer web process These processes essentially lead to sheet materials such as thin foams, plastic nets,82,88 perforated fi lms,83,89 and similar materials. The methods of manufacturing these miscellaneous materials are as diverse as their natures. They frequently arise from modified plastic processing techniques and often represent the combination of technologies. In general, the products are not hydrophilic and, hence, not inherently absorbent. Because of their structure and characteristics, however, these materials can often substitute for a component of an absorbent product, including non-adherent contact layer and protective outer layer of a dressing. Advanced composites from combination of technologies Attractive composites can be made by a combination of airlaid and spunlace processes. One example is infusing pulp by airlaying onto a regular cotton or rayon web during hydroentangling. Such a product has similar or superior absorbency of 100% cotton or rayon fabric but at a fraction of the cost. A typical blend for pulp and fiber will be 50/50. Such a structure can be used as the absorbent layer in a dressing. Another structure that has received great emphasis during the past two decades is one that combines spunbond and meltblown processes in producing a composite fabric. Examples of these are the spunbond (SB)/meltblown (MB), known as SM, and the SB/MB/SB or SMS composites. Often two layers of meltblown are sandwiched between two of spunbond to lead to SMMS. The production and properties of these are particularly enhanced by the use of polypropylene/polyethylene bicomponent materials in the preparation of MB webs.90,91 The spunbond fabric, combined with ultralightweight meltblown fabric, is suited for use as facing for absorbent products (Fig. 3.23). Most interesting of the composite structures, however, that can lend to direct use as dressings, are the cellulose-centered non-wovens that are capable of being produced on an integrated line.70,92 These are laminates
Textile materials and structures for wound care products
91
that have cotton, or another cellulosic fiber web, sandwiched as a core between two layers of meltblown and/or spunbond webs, with the size and the characteristics of each of the three adjusted to suit the application. For developing such products, the absorbent material used could be cotton or rayon of regular length, fed from a pre-formed roll, or pulp of short length, deposited directly from an airlaying system on the site in coordination with the formation of the spunbond/meltblown webs (Fig. 3.24).
3.23 Micrograph of a polypropylene SMMS fabric.91
Cotton centered spunbonded/meltblown composite
Spunbond extrusion system
Cotton nonwoven
Heated calender rollers Melt blown fabric
3.24 Preparation of cotton-centered composite with spunbond and meltblown webs forming the outer surfaces.
92
Advanced textiles for wound care
3.11
Acknowledgement
The figures included in this chapter were put together by Mr Venugopal Boppa, a graduate student in Textile Engineering at the North Carolina State University, Raleigh, NC 27695-8301. The authors express their thanks to Mr Boppa for this valuable assistance.
3.12
References
1. winter g, ‘Formation of a scab and the rate of epithialization of superficial wounds in the skin of the young domestic pig’, Nature, 193, 293–294, 1962. 2. paul w, sharma cp, ‘Chitosan and alginate wound dressings: A short review’, Trends Biomater Artif Organs, 18(1), 18–23, 2004. 3. dyson m, young s, pendle l, webster df, lang sm, ‘Comparison of the effects of moist and dry conditions on dermal repair’, J Invest Dermatol, 91, 434–439, 1988. 4. atiyeh bs, ioannovich j, al-amm ca, el-musa ka, ‘Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing’, Curr Pharm Biotechnol, 3, 179–195, 2002. 5. cohen ki, ‘The biology of wound healing’, Contemp Surg Suppl, 4, 2–3, 2000. 6. cohen ki, diegelmann rf, yager dr, womum iii il, graham mf, crossland mc, ‘Wound care and wound healing’, in Principles of Surgery, Schwartz International edition, Spencer S and Galloway DF, eds, McGraw–Hill Book Company, New York, 269–290, 1999. 7. cohen ki, ‘Wound healing: Key advances in research and clinical care’, Contemp Surg Suppl, 4, 4–8, 2000. 8. smith and nephew, Wound Management Website, http://www.smith-nephew. com/ 9. stashak ts, farstvedt e, othic a, ‘Update on wound dressings: indications and best use’, Clinical Techniques in Equine Practice, 3, 148–163, 2004. 10. adam medical illustration team, US National Library of Medicine. Laceration versus puncture wound, 2004. Retrieved from http://www.nlm.nih. gov/medlineplus/ency/imagepages/19616.htm 11. boateng js, matthews kh, stevens hn, eccleston gm, ‘Wound healing dressings and drug delivery systems: A review’, J Pharm Sci, Oct 26, 2007. 12. steven rb, catherine d, chia s, kang t, ‘Skin repair and scar formation: the central role of TGF-β’, Expert Rev Mol Med, 5(8), 1–22, March 2003. 13. gamgee s, ‘A new sponge,’ Lancet, 1, 795–796, 1884. 14. turner t, 1985, ‘Which dressing and why’, in Wound Care, S. Westaby, ed., Heinman Medical Books, London, 1985. 15. morgan d, ‘The application of the “ideal dressing” theory to practice’, Nurs Scot, 16–18, July, 1998. 16. thomas s, (2003) ‘Atraumatic Dressings’, Worldwide Wounds (online), available: http://www.worldwidewounds.com/2003/january/Thomas/AtraumaticDressings.html
Textile materials and structures for wound care products
93
17. shwartz r, (2007) ‘Surgical Dressings’, eMedicine (online), available: http:// www.emedicine.com/derm/topic826.htm 18. winter gd, ‘Epidermal wound healing’, in Maibach HI and Rovee DT, Ed., Surgical dressings in the hospital environment, Chicago, Year Book Medical publishers, 1972, 71–112. 19. balakrishnan b, mohanty m, umashankar pr, jayakrishnan a, ‘Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin’, Biomaterials, 26(32), 335–342, 2005. 20. mendez-eastman s, ‘Wound Dressing Categories’, Plast Surg Nurs, 25(2), 95–99, 2005. 21. thomas s, ‘Assessment and management of wound exudate’, J Wound Care, 6(7), 327–330, 1997. 22. worley c, ‘So, what do I put on this wound? Making sense of the wound dressing puzzle part II’, MEDSURG Nursing, 15, 182–183, 2006. 23. bello ym, phillips tj, ‘Recent advance in wound healing’, JAMA, 283(6), 716–718, 2000. 24. ovington l, ‘Advances in wound dressings’, Clin Dermatol, 25, 33–38, 2007. 25. worley c, ‘Clinical ‘How To’-1’, MEDSURG Nurs, 15, 106–107. 2006. 26. worley c, ‘Clinical ‘How To’-3’, MEDSURG Nurs, 15(4), 251–254, 2006. 27. eastman s, ‘Wound dressing categories’, Plast Surg Nurs, 25(2), 95–100, 2005. 28. yudanova t, reshetov i, ‘Modern wound dressings: manufacturing and properties’, Pharm Chem J, 40(2), 24–31, 2006. 29. Retrieved from http://www1.istockphoto.com/fi le_thumbview_approve/ 788040/2/istockphoto_788040_white_guaze_on_dark_background.jpg 30. thomas bc, Advances in skin and wound care, Springhouse Corporation, PA, USA, 2000. 31. armstrong mh, price p, ‘Wounds wet-to-dry gauze dressings: fact and fiction’. Volume 16(2), 56–62, February 2004. 32. elliot imz, A short history of surgical dressings, London, Pharmaceutical Press, 1964. 33. rheinwald jg, green h, ‘Formation of a keratinizing epithelium in culture by a cloned cell line teratoma’, Cell, 6, 317–330, 1975. 34. falling v, isaacs c, packet d, downing g, kowtow n, butter eb, hardenyoung j, ‘Wounding of bioengineer skin: cellular and molecular aspects after injury’, J Invest Dermatol, 119, 653–660, 2002. 35. thomas a, harding kg, moore k, ‘Alginates from wound dressings activate human macrophages to secrete tumor necrosis factor-α, Biomaterials, 21, 1797–1802, 2000. 36. schultz gs, sibbald rg, falanga v, ayello ea, dowsett c, harding k, romanelli m, stacey mc, teot l, vanscheidt w, ‘Wound bed preparation: a systematic approach to wound management’, Wound Rep Reg 11, 1–28, 2003. 37. mast ba, schultz gs, Interactions of ctyokines, growth factors and proteases in acute and chronic wounds, Wound Rep Reg, 4, 411–420, 1996. 38. baker ea, leaper dj, ‘Proteinases, their inhibitors, and cytokine profi les in acute wound fluid’, Wound Rep Reg, 8, 392–398, 2000. 39. trengove nj, bielefeldt-ohmann h, stacey mc, ‘Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers’, Wound Rep Reg, 4, 234–239, 1996.
94
Advanced textiles for wound care
40. christoforou c, lin x, bennett s, connors d, skalla w, mustoe t, linehan j, arnold f, guskin e, ‘Biodegradable positively charged ion exchange beads: a novel biomaterial for enhancing soft tissue repair’, J Biomed Mater Res, 42, 376–386, 1998. 41. connors d, gies d, lin h, gruskin e, mustoe ta, tawil nj, ‘Increase in wound breaking strength in rats in the presence of positively charged dextran beads correlates with an increase in endogenous transforming growth factor-β1 and its receptor TGF βR1 in close proximity to the wound’, Wound Rep Reg, 8, 292–303, 2000. 42. cullen b, smith r, mcculloch e, silcock d, morrison l, ‘Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers’, Wound Reg Rep, 10, 16–25, 2002. 43. edwards jv, yager dr, cohen ik, diegelmann rf, montante s, bertoniere n, bopp af, ‘Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution’, Wound Rep Reg, 9, 50–58, 2001. 44. edwards jv, batiste sl, gibbins em, goheen sc, ‘Synthesis and activity of NH 2- and COOH-terminal elastase recognition sequences on cotton, J Peptide Res, 54, 536–543, 1999. 45. wright jb, lam k, buret ag, olson me, burrell re, Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing, Wound Reg Rep, 10, 141–151, 2002. 46. moseley r, leaver m, walker m, waddington rj, parsons d, chen wyi, embery g, ‘Comparison of the antioxidant properties of HYAFF- 11p75, AQUACEL and hyaluronan towards reactive oxygen species in vitro’, Biomaterials, 23, 2255–2264, 2002. 47. qin y, ‘Novel antimicrobial fibres (Chitosan and alginates)’, Text Mag, 31(2), 14–17, 2004. 48. ghosh s, jassal m, ‘Use of polysaccharide fibres for modern wound dressings’, Indian J Fibre Text Res, 27(4), 434, 2002. 49. hemcon incorporated, ‘How HemCon Dressings Work’, retrieved from http:// www.hemcon.com/EducationCenter/HowHemConDressingsWork.aspx 50. yoshikawa m, midorikawa t, otsuki t, terashi t, ‘Process for producing articles of regenerated chitin–chitosan containing material and the resulting articles’, In Omikenshi Company Limited (Osaka, JP), Koyo Chemical Company Limited (Tokyo, JP) (Eds.), (424/402, 424/443, 424/445, 424/446, 424/447, 604/289, 604/304 ed.). Japan: A01N 025/34; A61L 015/16, 1998. 51. gustafson sb, fulkerson p, bildfell r, aguilera l, hazzard tm, ‘Chitsosan dressing provides hemostasis in swine femoral arterial injury model’, Prehosp Emerg Care, 11(2), 172–178, 2007. 52. pusateri ae, holcomb jb, kheirabadi bs, alam hb, wade ce, ryan kl, ‘Making sense of the preclinical literature on advanced haemostatic products’, J Trauma, Injury, Infect, Crit Care, J Trauma, 60, 674–682, 2006. 53. ward kr, tiba mh, holbert wh, blocher cr, draucker gt, proffi tt ek, bowlin gl, ivatury rr, diegelmann rf, ‘Comparison of a new haemostatic agent to current combat haemostatic agents in a swine model of lethal extremity arterial hemorrhage’, J Trauma, 276–284, 2007. 54. favuzza j, hechman hb, ‘Hemostasis in the absence of clotting factors’, J Trauma, 57, S42–S44, 2004.
Textile materials and structures for wound care products
95
55. holme i, ‘Smart surgery’, Nonwovens Rep Int, (February): 40–41, 2004. 56. hiroshi tamura, yukihiko tsuruta, seiichi tokura, ‘Preparation of chitosancoated alginate fi lament’, Mater Sci Eng C, 20, 143–147, 2002. 57. thomas s, ‘Soft silicone dressings: Frequently asked questions’, World Wide Wounds, Oct 2003, http://www.worldwidewounds.com/2003/october/Thomas/ Soft-Silicone-FAQ.html 58. thomas s, ‘Bandages and Bandaging’, in Wound management and dressings, The Pharmaceutical Press, London’, 88–98, 1990. 59. dalwoo, ‘Structure of chitin / chitosan and cellulose’, 2002. http://members. tripod.com/∼Dalwoo/structure.htm 60. meron biopolymers: a division of marine chemicals, ‘Applications of chitin’. http://www.meronbiopolymers.com/html/mbio2apln.htm 61. smart g, miraftab m, kennedy j, groocock m, ‘Chitosan: crawling from crab shells to wound dressings’, Medical textiles and biomaterials for healthcare, Woodhead Publishing, 2005. 62. wittaya-areekul s, prahsarn c, ‘Development and in vitro evaluation of chitosan-polysaccharides composite wound dressings’, Int J Pharm, 313, 123–128, 2006. 63. qin y, ‘Absorption characteristics of alginate wound dressings’, J Appl Polym Sci, 91(2), 953, 2004. 64. qin y, ‘Gel swelling properties of alginate fibers’, J Appl Polym Sci, 91(3), 1641. 2004. 65. qin y, ‘Alginate fibres: An overview of the production processes and applications in wound management’, Polym Int, 57(2), 171–180, 2008. 66. schenck k, ‘Wound dressings (1), Calcium alginates for moist wound treatment’, http://www.hartmannonline.de/english/produkte/wundbehandlung/ wundforum/default.htm. 67. wang l, khor e, wee a, lim ly, ‘Chitosan–alginate PEC membrane as a wound dressing: assessment of incisional wound healing’, J Biomed Mater Res, 63(5), 610–618, 2002. 68. kapadia i, ibrahim im, ‘Woven vascular grafts’, US Pat. 4,816,028, 1989. 69. wei q, liu y, wang x, huanga f, ‘Dynamic studies of polypropylene nonwovens in environmental scanning electron microscope’, Polym Test, 26(2–8), 2007. 70. gupta bs, smith dk, ‘Nonwovens in absorbent materials’, in Absorbent Technology, Chatterjee and Gupta eds., Elsevier 349–388, 2002. 71. albrecht w, fuchs h, kittelmann w, Nonwoven fabrics, Wiley-VCH, 2003. 72. russell sj, Handbook of nonwovens, Cambridge, Woodhead Publishing, 2007. 73. dewitt wg, brodnyan jg, ‘The development of a soft latex binder for durable nonwovens’ 8th INDA Technical Symposium, 1980. p. 12. 74. drelich ah, in Modern Non-wovens Technology, edited by D. T. Ward, Texpress, Manchester’, 1977. p. 61. 75. jarvis cw, danforth pa, ko1inofsky ba, vaughn ea, ‘A comparison of foam and saturate banded nonwovens: effects of fiber and binder blends’, 8th INDA Technical Symposium, New York, March 1979, p. 175. 76. mansfi eld rg, Advanced Forming/Bonding Conference, INSIGHT 82, Marketing/Technology Service, Kalamazoo, Michigan’, 1982. Section II.
96
Advanced textiles for wound care
77. drelich ah, Advanced Forming/Bonding Conference, INSIGHT 81, Marketing/Technology Service, Kalamazoo, Michigan (September 1981), Section VI. 78. debrunner re, 5th Annual TANDEC, Knoxville, TN p 5.6–1, 1995. 79. hearle jws, purdy at, jones jj, ‘A study of needle action during needle punching’, J Text Inst, 64, 617, 1973. 80. evans fj (to DuPont), US Patent, 3,485,706 (December 23, 1969). 81. bolton a (to Johnson & Johnson), US Patent 4,144,370 (March 13, 1979). 82. lloyd r (to Smith & Nephew Research Ltd.), UK Patent 1,496,786 (January 5, 1978). 83. raley ge, adams jm (to Ethyl Corporation), US Patent 4,252,516 (February 24, 1981). 84. medeiros fj, Proc. INDA-TEC 96, International Nonwovens Conference, Crystal City, VA p 5.1, 1996. 85. brooks ba (to Johnson & Johnson), US Patent 2,045,825 (November 5, 1980). 86. bodaghi h, ‘Melt Blown Microfiber Characterization’, INDA JNR, 1(1), 14–27, 1989. 87. wadsworth lc, Proc. 2001 Beltwide Cotton Conference, National Cotton Council, January 9–13, Anaheim, CA, 1, 629, 2001. 88. madsen wb, jensen fh, rasmussen gb, goldstein g, roussin-moynier y (to Beghin-Say), UK Patent 1,455,981 and 1,455,982 (August 11, 1976). 89. thompson ha (to Procter & Gamble Co.), US Patent 3,929,135 (December 30, 1975). 90. berger rm, US Patent 5,633,082, May 27, 1997. 91. madsen jb, ‘New generation of hydrophilic spunmelt composites’, Nonwovens World, August–September’, 69–75, 2001. 92. sun c, zhang d, wadsworth lc, mclean m, ‘Processing and property study of cotton-surfaced non-wovens’, Textile Res J, 70(5), 449–453, 2000.
4 Interactive dressings and their role in moist wound management C. W E L L E R, Monash University, Australia
Abstract: Technological advances in the development of interactive wound dressings are reviewed. An important original work was that of George Winter, who demonstrated the value of a moist wound environment in wound healing. Recent advances in wound management incorporate new technologies that interact with the wound at a cellular level rather than simply reducing moisture loss. The balance of moisture is critical to healing and this principle has been the driving force in the development of products that are currently available such as hydrogels, hydrocolloids, alginates, and foams and fi lms. Many interactive dressings are able to work actively with wound properties such as wound exudate, tissues, cells and some growth factors to enhance healing. Key words: moist wound healing, tissue repair, interactive dressings, hydrogels, hydrocolloids, alginates.
4.1
Introduction
As with many aspects of medicine, the field of wound management has had an interesting journey. We have come a long way since the 16th century when Ambroise Pare travelled with the French army as a barber–surgeon. To counteract the purported poisonous effects of gunpowder, the wounds of injured soldiers were scalded with boiling oil. A shortage of boiling oil at the Battle of Turin forced Pare to concoct another therapeutic intervention for the doomed soldiers. He mixed a portion of egg yolks, turpentine, and oil of roses to help heal gun power wounds (an ancient roman turpentine remedy) and found, to his surprise, that the soldiers deprived of boiling oil not only survived but their wounds healed more quickly and with less pain. Pare had created the first clinical trial in wound care (Baxter 2002). Pare may have, unknowingly, also concocted one of the fi rst interactive moist wound dressings. Since the 16th century, there have been many periods of enlightenment in the area of wound management. Through World War I, the task of changing dressings was the realm of physicians and medical students. In the 1930s, the dressing changes were performed by nurses. For the next 40 97
98
Advanced textiles for wound care
years, the mainstay dressings were gauze, cotton wool pads, paraffin impregnated gauze and absorbent cotton. A major development in moist wound healing was the original work by George Winter which demonstrated the value of a moist wound environment in wound healing, although the concept of moist wound healing did not begin to receive serious consideration until the 1970s and 1980s. Our understanding of the function of wound healing has increased remarkably since Winter’s work ‘Formation of a scab and the rate of epithelialisation of superficial wounds in the skin of young domestic pigs’ was published in Nature (Winter 1962). This work was the foundation of the concept of moist wound management as it showed that wounds that heal under moist conditions healed 50% faster than those wounds that healed in dry, open to air, conditions. Moist wound healing not only facilitates fragile epithelial cells to migrate more freely it also enhances viability of the epithelial cells as the cells are protected from dehydration and scab formation. Epithelialisation of the wound therefore occurs more quickly if a moist wound environment is maintained (Weller 2005). Before the work of Winter and the human validation of Winter’s research (Hinman and Maibach 1963), practitioners commonly accepted the notion that wound healing depended on maintaining a dry wound bed, The scab has, in the past, been described as ‘nature’s dressing’. Today, most clinicians are more likely to accept that a moist wound environment facilitates the healing of wounds and promotes the growth of new tissue. Recent advances in wound management incorporate new technologies that interact with the wound at a cellular level rather than simply reducing moisture loss (Leaper et al. 2002). A balanced moist wound environment aids cellular growth and collagen proliferation within a non-cellular matrix. The balance of moisture is critical to healing and this principle has been the driving force in the development of products that are currently available. These are hydrogels, hydrocolloids, alginates, and foams and fi lms. Nowadays, many of these dressings also incorporate antibacterials in their delivery systems (Leaper et al. 2002).
4.2
Normal wound healing
The healing of a wound requires a well-orchestrated integration of complex biological and molecular events of cell migration, cell proliferation and extracellular matrix (ECM) deposition. In cutaneous injuries that heal readily and do not have an underlying pathophysiological defect (acute wounds), the main aim of the body is to achieve a quick repair expending the least amount of energy. This often means such wounds will heal with a scar and no regeneration (Falanga 2005). In wounds with underlying
Interactive dressings and their role in moist wound management
99
pathophysiological abnormalities such as venous leg ulcers, diabetic foot ulcers and full thickness burn injury evolutionary adaptations may not have occurred and impaired healing is the result.
4.2.1 Phases of wound healing The basic elements of wound healing, with information mainly derived from experimental wounds in animals, cannot be separated and categorised in a clear defi nitive way. It is useful to divide the repair process into four overlapping phases of coagulation, inflammation, migration– proliferation (including matrix deposition) and remodelling (Falanga 2005), each phase being modulated by different cytokines and growth factors (Leaper et al. 2002). The inflammatory phase of wound repair starts almost immediately after wounding and lasts for up to several days when symptoms such as oedema, erythema, heat and pain are well known. The initial response to injury is vasoconstriction which stops blood loss and platelet activation promotes fibrin clot formation. The fibrin plug consists of platelets enmeshed in fibrinogen, fibronectin, vitronectin and thrombospondin which not only forms a temporary wound cover but also protects against bacteria. Substances released by platelets include a wide range of growth factors including platelet-derived growth factor (PDGF) and transforming growth factor. These, as well as other growth factors have an early role in cell recruitment and ECM formation. Injury to the wound creates a hypoxic episode owing to blood vessel damage. Hypoxia increases keratinocytes migration, early angiogenesis, proliferation of fibroblasts and the synthesis of crucial growth factors and cytokines including PDGF and vascular endothelial growth factor. Once the inflammatory phase is almost complete, wound contraction begins. Formation of ECM, proteins, angiogenesis, contraction and keratinocytes migration are important elements of these phases. The balance between contraction and wound closure depends on the depth and location of the wound and the presence of complications such as infection which could impair healing (Falanga 2005). Acute wounds progress through the linear process of overlapping biological and molecular events, whereas chronic wounds are often in different phases at the same time and progression may not occur in synchrony (Falanga 2005). This ‘normal’ wound healing model has helped us understand the basic biology of tissue repair and use that knowledge when the healing process is impaired. We now know that chronic wounds contain decreased levels of some intrinsic growth factors, including PDGF, basic fibroblast factor, extracellular glycoprotein (ECG) and Transforming Growth Factor beta (TGFβ), compared with acute wounds (Harding et al. 2002).
100
Advanced textiles for wound care
4.3
Wound characteristics
The type, size, and depth of wound will all have important implications for healing events at the cellular and molecular level. In acute wounds and surgical wounds, there is usually less tissue damage and the wound will close by primary intention. Wounds that are restricted to the superficial layer of the dermis still have some keratinocytes in the hair follicles in the wound bed and therefore can heal from the edges as well as from within the wound bed (Enoch et al. 2006b). Determining wound duration, size and depth and wound bed condition are important aspects to consider in wound assessment. Specific wound characteristics correlate with healing. Patients with a large wound area (>2 cm 2), an ulcer of long duration (>2 months), and ulcer depth (exposed tendon, ligament or bone) were three important factors that would delay healing (Margolis et al. 1999; Margolis et al. 2002; Margolis et al. 2004). As research and understanding improves at a cellular level, we are better able to assist the body not only by covering the wound to protect it but also by providing wound dressings to aid the healing process. Normal wound healing processes require restoration of epithelisation and collagen formation. The fi rst occurs by migration and proliferation of keratinocytes from the wound edges and by differentiation of stem cells from remaining hair follicle bulbs. The second occurs by influx of growth factors secreted by macrophages, platelets and fibroblasts, by fibroblast proliferation and subsequent synthesis and remodelling of collagenous dermal matrix. However, for full thickness burn injuries and chronic wounds such as pressure ulcers, venous ulcers and diabetic foot ulcers, these processes are damaged. Interactive wound dressings have been developed to improve healing in these chronic conditions (Sibbald et al. 2003). The time it takes for a chronic wound to heal will vary due to the idiosyncratic nature of each wound and inherent complex factors, which may impede healing. If a wound is slow to heal, there may be an underlying reason for non-healing. This may because of vascular disease or mechanical injury such as trauma or pressure. The cause will need to be identified and addressed if the wound is to be healed. For venous ulcers, we would not only consider the dressing choice but we would also need to use compression bandaging in order for the wound to heal. Controlling factors affecting healing requires an understanding of both intrinsic and extrinsic factors and addressing these where possible to improve healing. Physical factors such as diabetes mellitus, obesity, venous insufficiency, decreased perfusion, malnutrition, old age, organ failure, sepsis, and restrictions on mobility have an impact on healing (Phillips et al. 2000). Correcting underlying pathology and any co-morbidities is
Interactive dressings and their role in moist wound management
101
central to managing the wound. The inflammatory process is important in acute wound healing and if disturbed will affect healing and increase the risk of wound chronicity. Immunosuppressive states and the use of immunosuppressive drugs such as corticosteroids or methotrexate that are known to affect the immuno-inflammatory response all adversely affect wound healing and increase the risk of sepsis. (Burns and Pieper 2000, Troppmann et al. 2003). Tissue repair research and advances in moist wound healing pharmaceuticals have been pivotal in improving wound dressing technology and facilitating the moist wound healing principles (Schonfeld et al. 2000). Different products are able to simplify debridement by aiding autolysis and wound hydration, facilitate the wound cleansing process, aid in the granulation and epithelialisation process and in some instances allow growth factors, cells and enzymes to be activated to an optimal level for healing to take place. Wound bed preparation is paramount to improved healing. An important factor in wound bed preparation is the maintenance of moisture balance, which often involves exudate management. Failure to manage exudate adequately can expose the peri wound skin to toxic wound exudate that may impede the healing process. The TIME (Table 4.1) principle of wound bed preparation was developed by an International Advisory Board on wound bed preparation (Schultz et al. 2004; Schultz et al. 2003). The TIME principle is based on four factors: wound factors, clinical action factors, suggested product selection and the healing outcome.
Table 4.1 TIME wound bed preparation Description
Factors
Clinical action
Tissue non-viable
Slough or necrotic tissue present
Inflammation and/or infection
Increased exudate, surface discoloration or increased odour
Moisture imbalance
Heavy exudate, risk of maceration or dry wound bed – risk of desiccation Chronic wound with prolonged inflammation
Remove defective tissue (surgical or autolytic debridement) Remove or reduce bacterial load (antimicrobials, debridement of devitalised tissue) Restore moisture balance (absorb exudate or add moisture to dry wounds)
Edge of wound not advancing
Address T/I/M factors
102
Advanced textiles for wound care
Moist wound healing processes that have been researched and determined to be significantly more effective than the dry healing of the past have improved healing outcomes. However, it has become evident that moist wound healing alone may not be sufficient to improve healing outcomes. Equally as important is a holistic approach to wound care. A holistic approach addresses the whole patient in a medical, environmental and social context. Four simple actions underlie moist wound management practice: 1. 2.
Determine aetiology of the wound; Identify any co-morbidities or complications that may contribute to wound recurrence or delay healing; Assess the status of the wound and select dressing product; and Review management plan with patient.
3. 4.
4.4
Dressings
An ideal dressing not only maintains a moist environment but also: • absorbs excess exudate and prevent maceration of surrounding skin and prevent the wound from desiccation; • allows gaseous exchange so that oxygen, water vapour and CO2 may pass in and out of the dressing; • provides thermal insulation to maintain the optimum wound core temperature, and • provides a barrier to bacteria to minimise contamination of the wound. The interactive ideal dressing should also be: • • • •
free of toxic or particulate components, atraumatic on removal, comfortable and conformable, and cost effective.
(adapted from Ovington and Pierce 2001)
4.4.1 Choosing the appropriate dressing product As wounds are dynamic and undergo different phases of healing, the choice of dressing will change with each phase (Cutting and White 2002). Dressing choice is based on three simple criteria: the colour of wound bed tissue, the depth of the wound and the level of exudate. Dressing choice can be based on the colour, depth and exudate (CDE) rule as shown in Table 4.2.
Interactive dressings and their role in moist wound management
103
Table 4.2 Wound assessment and dressing selection Colour
Exudate
Aim and dressing selection
Pink
Nil
Maintain moist environment, protect and insulate. Foams, thin hydrocolloids, thin hydroactives, film dressings and simple non-adherent dressing such as the modern tulles will provide the necessary cover.
Red unbroken
Low
Prevent skin breakdown. Thin hydrocolloids or film dressings provide protection.
Red
High
Maintain moist environment, absorb exudate and promote granulation and epithelialisation. Foams, alginates and hydroactive dressings help control exudate. Hydrocolloids as paste or powder for deeper areas.
Red
Low
Maintain moist environment and promote granulation and epithelialisation. Hydrocolloid, foams, sheet hydrogels and film dressings will maintain a moist environment. It is possible to use a combination of amorphous hydrogels with a foam cavity dressing in deeper wounds.
Yellow
Low
Remove slough absorbs exudate and maintain a moist environment. Hydrogel in particular will re-hydrate the slough. Hydrocolloids will also aid in autolysis.
Yellow
High
Remove slough and absorb exudate Hydrocolloids as paste or powder for the deeper wounds. Alginates will aid in the removal of the slough and absorb the exudate.
Black
Low
Rehydrate and loosen eschar. Surgical debridement is the most effective method of removal of necrotic material; Dressings can enhance autolytic debridement of the eschar. Amorphous hydrogels, hydrocolloid sheet.
Green
High
Absorb infected exudate. Hypertonic saline, silver products, cadexamer iodine.
104
Advanced textiles for wound care
4.4.2 Colour The Red wound is a granulating wound with new tissue fi lling the deficit and possibly with some islets of epithelium present. The aim is to absorb any excess exudate, maintain a moist environment and protect the wound. The Yellow wound contains a level of slough. This is non-viable tissue that must be removed or healing will not take place. The methods of removal are surgical, re-hydration with dressings such as hydrogels or hydrocolloids. The aim is slough removal by re-hydration and absorption of exudate. The Pink wound is in the fi nal stages of healing with new epithelium covering the wound. The aim is to protect this very delicate tissue, prevent the wound from drying out so as to maintain a moist environment, and insulate the wound. The Black wound has an outer layer of thick hard eschar; this must be removed to commence the healing process. The fastest and most effective method is by surgical removal. The use of dressings such as hydrogels to aid autolytic debridement will at best be slow. The Green wound term is often used to describe an infected wound. The use of topical antibiotics is generally discouraged. The most appropriate treatment is to control high exudate levels, protect surrounding skin from toxic wound exudate, identify micro-organisms by wound biopsy and treat the client with systemic antibiotics.
4.4.3 Depth The wound may be superficial, partial thickness, deep or a cavity. The product choice will depend on the shape, location and type of wound. The shape and depth of the wound will vary depending on underlying aetiology. For example, venous ulcers are often superficial and highly exudating whereas arterial ulcers are deeper and have a ‘punched out’ appearance with little exudate. In some instances, the wound may have undermined edges and a careful assessment is paramount to ensure that the dressing product chosen will be easily removed and prevent residual product from being left in the cavity.
4.4.4 Exudate Exudate is produced from fluid that has leaked out of blood vessels and closely resembles blood plasma. Fluid leaks from capillaries into tissue at a rate that is determined by the permeability of the capillaries
Interactive dressings and their role in moist wound management
105
and the hydrostatic and osmotic pressures across the capillary walls. Most wounds will contain some exudate; this will vary from very little to copious levels. In a healing wound, exudate production generally reduces over time. In a chronic wound that is not healing, exudate production may continue and be excessive due to ongoing inflammatory processes (WUWHS). Studies suggest that wound fluid from acute wounds may have a beneficial effect on wound healing, whereas that of chronic wounds may inhibit healing. Any unexpected change in exudate characteristics may indicate a change in wound status and may indicate the presence of infection. Careful monitoring of the exudate can provide information for the application of systemic and local therapies. Individual wound care products have specific functions which relate to the volume, viscosity and nature of the exudate and these should guide skin care and dressing selection (Vowden and Vowden, 2003). The choice of both primary and secondary dressing will depend on the exudate level and the depth of the wound (White and Cutting 2004). The balance of moisture in the wound environment can be maintained primarily by applying newer generation interactive wound dressings.
4.5
Interactive wound dressings
Modern interactive dressings facilitate wound healing by altering the environment and interacting with the wound surface to optimise the healing process. Many interactive dressings have the ability to work actively with wound properties such as wound exudate, tissues, cells and some growth factors to enhance healing. Interactive dressings have different properties and vary in the ability to absorb exudate (Bale et al. 2001). Selecting the most appropriate dressing to treat the wound can be complicated and understanding form and function is often a challenge for busy clinicians (Carville 2006). Effective wound management requires knowledge of the process of tissue repair and the knowledge of the properties of the dressings available. Dressing selection is only one part of a holistic wound management plan, it is necessary to assess the patient’s concerns before assessing the wound and choosing the dressing (Schultz et al. 2003). Interactive dressings alter the wound environment and interact with the wound surface to optimise healing. Interactive dressings use the environment provided by the body to encourage normal healing. Bioactive dressings stimulate the healing cascade. Interactive dressing form, function, properties and some of the indications of the commonly used dressing groups in clinical practice are outlined in Table 4.3.
Brand names
Opsite (Flexigrid, Flexifix, Post-op), Tegaderm, Bioclusive, Cutifilm, Polyskin, Hydrofilm and Aqua Protect Film
Allevyn (adhesive, cavity), Lyofoam (Flat, Extra, C, T, A), Curafoam, Hydrosorb, Tegafoam, Permafoam, Truefoam and Cavicare
Kaltostat, Sorbsan, Algoderm, Curasorb, Comfeel Seasorb and Algisite M. Melgisorb
Dressing form
Semi-permeable films
Foams
Alginates
Table 4.3 Interactive dressings: form, properties and indications
Need wound exudate to function. Most suitable for heavily exudating wounds such as venous ulcers, pressure ulcers and dehisced abdominal wounds. Forms moist gel in wound. Highly absorptive. Fills dead space.
Protects wound and periwound. Thermal insulation. Useful for moderately to heavily exudating wounds. Not effective for wounds with dry eschar. Superficial and cavity wounds, Venous ulcers (with compression), pretibial lacerations, infected ulcers, skin tears, pressure ulcers, skin grafts or donor sites and pilonidal sinuses. May require secondary dressing.
Non-absorbent, semi-permeable, waterproof, allow wound visualisation. Superficial burns, grazes, closed surgical incisions, small skin tears and IV sites. May be used as a secondary dressing. Contraindications: Known infection or fragile skin.
Properties and indications
Duoderm (Extra thin, CGF, paste), Comfeel (ulcer dressing, transparent, contour dressing), Tegasorb, Replicare, Combiderm and Hydrocoll
Intrasite Gel (amorphous unpreserved). Intrasite Conformable (gauze impregnated). Solosite Gel (amorphous preserved). Solugel (amorphous preserved and unpreserved). Duoderm Gel (amorphous unpreserved). Nu-gel (sheet hydrogel). Comfeel Purilon Gel (amorphous). Curafil (amorphous). Curagel (sheet hydrogel). Aquaclear (sheet hydrogel). Hypergel (hypertonic saline) (amorphous). Steri Gel (amorphous). Second skin (sheet hydrogel)
Hydrocolloids
Hydrogels
Absorbency of hydrogels is limited and best used in minimally exudating wounds or dehydrated wounds such as minor burns, grazes/lacerations, donor sites and pressure ulcers. Soothing and reduces pain. Rehydrates dry wound. Comes in amorphous gel, sheets, and freeze dry forms. Indications for the thicker gel products include protection of exposed tendon and/or bone from dehydrating and rehydrating eschar before debridement. The thinner gel products are useful for soothing burns and acute chickenpox lesions.
Useful for light to moderately exudating wounds that would benefit from autolytic debridement. Leg ulcers, pressure ulcers, burns and donor sites. Thin sheets are useful over suture lines and IV sites. Do not use occlusive sheets on infected wounds. Reduces pain.
108
Advanced textiles for wound care
4.5.1 Semi-permeable film dressings Film dressings are adhesive, thin transparent polyurethane, which are permeable to gas but impermeable to liquid and bacteria. Films are elastic, conformable and transparent allowing inspection of wound. As fi lms are non-absorbent, they are not suitable for exudating wounds, although island dressings with a central non-stick pad are available and can absorb slightly more exudate that the simple fi lms. The three factors that most drastically affect the pattern, speed and quality of healing are dehydration of exposed tissues, the status of the blood supply bringing oxygen and nutrients to the area, and sepsis. Wounds exposed to the air lose water vapour, the upper dermis dries and healing takes place beneath a dry scab. Covering a wound with an occlusive dressing prevents scab formation and radically alters the pattern of epidermal wound healing (Winter 2006). Film dressings are indicated as primary dressings in minor burns, simple abrasions and lacerations. It is also common to use films as a post-operative layer over dry sutured wounds. Films can also be used as secondary dressings to waterproof a primary dressing such as foam. Films can be used as a protective layer on skin that is prone to superficial pressure ulcers, although incorrect removal of fi lm dressings when applied to fragile skin may cause trauma to surrounding skin so they should be used with care. Films should be discontinued if the level of exudate results in pooling under the dressing as not only is the dressing choice incorrect but it may also cause maceration to the surrounding skin and increase the risk of infection. Films may stay in place for up to one week and frequency of change may be dependent on position of wound, type and size of wound.
4.5.2 Foam dressings Foam dressings are made from polyurethane, which may in some cases have been heat-treated on one side to create a semi-permeable membrane. This allows the passage of exudate through the non-adherent, semi-permeable surface into the insulating foam. These open-cell sheets with varying cell sizes come in single, double or multilayer products. Foams have several advantages; they are highly absorbent, cushioning and protective, and insulate and conform well to body surfaces. Foams facilitate a moist wound environment and absorb excess exudate to decrease the risk of maceration. Foam dressings are also available with charcoal impregnation for malodorous wounds. Foam wound cavity dressings reduce dead space in the wound, conform to wound shape and absorb large amounts of exudate therefore reducing the need for frequent dressing changes, although cavity foam dressings
Interactive dressings and their role in moist wound management
109
require secondary dressings that adds to cost. Foams are generally nonadhesive and require a secondary dressing or tape/bandage to keep in place. Depending on the level of exudate, foams can be left in place for up to 7 days (Carville 2006). A prospective open-label study to assess the clinical performance of foam dressings in chronic wounds found a significant decrease in the level of exudate from the wound bed, the proportion of patients with peri-wound skin problems and the percentage of patients with wound pain. Foam dressings are indicated in venous ulcers with high exudate levels (Zoellner et al. 2006).
4.5.3 Alginate dressings Alginate may be either calcium or calcium/sodium salts of alginic acid. These products are highly absorbent, biodegradable dressings derived from seaweed. An active ion exchange of calcium ions for sodium ions at the wound surface forms soluble sodium alginate gel that provides a moist wound environment. The polysaccharides are made up as textile fibre or as freeze-dried sheets. Calcium dressings need exudate from the wound to function and therefore are not suitable for dry wounds or wounds with hardened eschar. When placed into an exudating wound, the sodium ions present in the wound fluid displace the calcium and forms sodium alginate. The fibrous nature of most alginates can leave residual fibres in the wound if there is insufficient wound exudate to gel the fibres. This may precipitate an inflammatory reaction as it stimulates a foreign body response. Caution is also needed when using alginate rope dressings into very deep or narrow sinuses, as complete removal can be difficult. Studies have shown that some calcium alginate products promote haemostasis in bleeding wounds owing to the active release of calcium ions that aids the clotting mechanism (Segal et al. 1998). The calcium ions released by this type of dressing are a natural co-factor in the coagulation therapy. Alginate dressings are available in sheet, ribbon or rope form in various sizes and require a secondary dressing. Alginates are used for wounds with moderate to heavy exudate, haemostasis post-debridement or biopsy.
4.5.4 Hydrocolloid dressings Hydrocolloids are moisture-retentive dressings, which contain gel-forming agents such as sodium carboxymethylcellulose and gelatin. Many products combine the gel-forming properties with elastomers and adhesives are applied to a carrier such as foam or fi lm to form an absorbent, selfadhesive, waterproof wafer. In the presence of wound exudate hydrocolloids absorb liquid and form a gel, the properties of which are determined
110
Advanced textiles for wound care
by the nature of the formulation (Heenan 2007). In sheet form, the polymer outer layer can be either semi-occlusive or occlusive. Hydrocolloid interaction debrides by autolysis and can reduce dressing frequency by up to 7 days’ wear time depending on amount of exudate and the type of the hydrocolloid product (Segal et al. 1998). The product is also available in paste and powders for increased absorption and to decrease dead space in the wound cavity. Generally, hydrocolloids are not recommended on clinically infected wounds due to the semi-occlusive nature of the dressing. There have been reports of hypergranulation with prolonged use of hydrocolloids in moderate to highly exudating wounds, so wound tissue assessment is paramount when applying hydrocolloids over a period of months so that the product can be discontinued before hypergranulation occurs. Hydrocolloid dressings are indicated for chronic venous ulcers, pressure ulcers, burns, partial thickness wounds, diabetic foot ulcers.
4.5.5 Hydrogel dressings Hydrogel dressings are semi-occlusive and composed of complex hydrophyllic polymers with a high (90%) water content. As the name implies, hydrogels are designed to hydrate wounds, re-hydrate eschar and aid in autolytic debridement. Hydrogels are insoluble polymers that expand in water and are available in sheet, amorphous gel or sheet hydrogelimpregnated dressings. Hydrogels provide a moist environment for cell migration and absorb some exudate. Autolytic debridement without harm to granulation or epithelial cells is another advantage of hydrogel dressings. Hydrogels are recommended for wounds that range from dry to mildly exudating and can be used to degrade slough on the wound surface. Hydrogels have a marked cooling and soothing effect on the skin, which is valuable in burns and painful wounds. In addition to their use in wounds, the thin hydrogels are helpful in the management of chicken pox and shingles. The viscosity varies between products, Purilon and IntraSite gel are two of the thickest gels available to help the product stay in the cavity of the wound and Solugel and Solosite are two of the thinnest for easy spread over a larger area (Carville 2006). Some amorphous gels contain propylene glycol that can cause allergic reactions in elderly skin. Amorphous hydrogels are applied liberally onto or into a wound and covered with a secondary dressing such as foam or fi lm. Hydrogels can remain in situ for up to 3 days. Hydrogels are indicated in dry, sloughy wounds with mild exudate, partial thickness wounds.
4.6
Future trends
Novel techniques are being developed to improve healing in difficultto-treat wounds. Emerging dressing types include bioactive dressings and
Interactive dressings and their role in moist wound management
111
tissue engineered skin substitutes. Randomised controlled clinical trials to examine safety and efficacy of many of the new materials are lacking and clinical uptake has been slow (Begg et al. 1996; Enoch et al. 2006b). When choosing the optimum treatment for patients, it is important to take into account ease of use, patient satisfaction and cost effectiveness (Carville 2006). Research into genetic coding mechanisms to identify factors influencing wound healing will be an area to monitor. Several markers that could form the basis of new diagnostic tools for use in wound care are currently under investigation, ongoing research is likely to discover others. Some markers under current investigation are: platelet-derived growth factor, sex steroids, thyroid hormones, immunohistochemical markers, inflammatory mediators such as cytokines and interleukins to monitor healing status. Nitric oxide could be clinically useful in predicting wound outcomes and interventions to alter wound nitric oxide levels may be of benefit. These markers may be able to aid the clinician in choosing appropriate dressing products depending on the phase of the wound, tissue colour, depth of wound and exudate level (Enoch et al. 2006a). Current areas of research include regulation of target genes of cells involved in wound healing. New methods of delivery of cell products to the wound bed include stem cells that are capable of differentiating into essential cells involved in wound healing. To date, there is only experimental evidence for gene and stem cell therapy in the treatment of chronic wounds (Enoch et al. 2006b). The cost-effectiveness of new treatments compared with standard care must also be considered, not only in terms of direct treatment costs, but in terms of length of initial hospital stay, requirements for home and community care, secondary dressing needs, and the quality of the overall outcome.
4.7
Conclusions
Technological advancement in interactive dressing development has grown since Winter’s research. Availability of different types of wound products has increased remarkably in the last decade. New wound dressing technologies continue to be developed to improve healing in difficult to treat wounds (Embil et al. 2000). Wound care practitioners have at their disposal an extensive range of interactive dressings. Emerging dressing types include bioactive dressings and tissue-engineered skin substitutes. Wound dressings have come a long way since Pare’s effort in the battle of Turin. Tissue repair research and advances in moist wound healing pharmaceuticals has been pivotal in the improvement of wound product technology. This review has characterised the different types of